Cover Page
Cover Page - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Feb. 18, 2022 | Jun. 30, 2021 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2021 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 1-10235 | ||
Entity Registrant Name | IDEX CORP | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 36-3555336 | ||
Entity Address, Address Line One | 3100 Sanders Road, | ||
Entity Address, Address Line Two | Suite 301, | ||
Entity Address, City or Town | Northbrook, | ||
Entity Address, State or Province | IL | ||
Entity Address, Postal Zip Code | 60062 | ||
City Area Code | 847 | ||
Local Phone Number | 498-7070 | ||
Title of 12(b) Security | Common Stock, par value $.01 per share | ||
Trading Symbol | IEX | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 16,710,929,496 | ||
Entity Common Stock, Shares Outstanding | 76,119,749 | ||
Documents Incorporated by Reference | Portions of the proxy statement with respect to the IDEX Corporation 2022 annual meeting of stockholders (the “2022 Proxy Statement”) are incorporated by reference into Part III of this Form 10-K. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0000832101 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2021 | |
Audit Information [Abstract] | |
Auditor Name | DELOITTE & TOUCHE LLP |
Auditor Location | Chicago, Illinois |
Auditor Firm ID | 34 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Current assets | ||
Cash and cash equivalents | $ 855.4 | $ 1,025.9 |
Receivables - net | 356.4 | 293.1 |
Inventories | 370.4 | 289.9 |
Other current assets | 95.8 | 48.3 |
Total current assets | 1,678 | 1,657.2 |
Property, plant and equipment - net | 327.3 | 298.3 |
Goodwill | 2,167.7 | 1,895.6 |
Intangible assets - net | 597.3 | 415.6 |
Other noncurrent assets | 146.9 | 147.7 |
Total assets | 4,917.2 | 4,414.4 |
Current liabilities | ||
Trade accounts payable | 178.8 | 152 |
Accrued expenses | 259.8 | 208.8 |
Short-term borrowings | 0 | 0.1 |
Dividends payable | 41.4 | 38.1 |
Total current liabilities | 480 | 399 |
Long-term borrowings | 1,190.3 | 1,044.4 |
Deferred income taxes | 196.4 | 163.9 |
Other noncurrent liabilities | 247.4 | 266.8 |
Total liabilities | 2,114.1 | 1,874.1 |
Commitments and contingencies (Note 11) | ||
Preferred stock: | ||
Authorized: 5,000,000 shares, $.01 per share par value; Issued: None | 0 | 0 |
Common stock: | ||
Authorized: 150,000,000 shares, $.01 per share par value Issued: 90,067,996 shares at December 31, 2021 and 90,071,763 shares at December 31, 2020 | 0.9 | 0.9 |
Additional paid-in capital | 795.6 | 775.2 |
Retained earnings | 3,126.5 | 2,841.5 |
Treasury stock at cost: 13,872,555 shares at December 31, 2021 and 14,111,221 shares at December 31, 2020 | (1,050.3) | (1,063.9) |
Accumulated other comprehensive loss | (69.6) | (13.5) |
Total shareholders’ equity | 2,803.1 | 2,540.2 |
Noncontrolling Interest | 0 | 0.1 |
Total equity | 2,803.1 | 2,540.3 |
Total liabilities and equity | $ 4,917.2 | $ 4,414.4 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares issued (in shares) | 90,067,996 | 90,071,763 |
Treasury stock, shares (in shares) | 13,872,555 | 14,111,221 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Statement [Abstract] | |||
Net sales | $ 2,764.8 | $ 2,351.6 | $ 2,494.6 |
Cost of sales | 1,540.3 | 1,324.2 | 1,369.6 |
Gross profit | 1,224.5 | 1,027.4 | 1,125 |
Selling, general and administrative expenses | 578.2 | 494.9 | 525 |
Restructuring expenses and asset impairments | 9.3 | 11.8 | 21 |
Operating income | 637 | 520.7 | 579 |
Other expense - net | 16.2 | 5.6 | 1.8 |
Interest expense | 41 | 44.8 | 44.3 |
Income before income taxes | 579.8 | 470.3 | 532.9 |
Provision for income taxes | 130.5 | 92.5 | 107.4 |
Net income | 449.3 | 377.8 | 425.5 |
Net loss attributable to noncontrolling interest | 0.1 | 0 | 0 |
Net income | $ 449.4 | $ 377.8 | $ 425.5 |
Earnings per common share: | |||
Basic earnings per common share attributable to IDEX (in dollar per share) | $ 5.91 | $ 4.98 | $ 5.62 |
Diluted earnings per common share attributable to IDEX (in dollar per share) | $ 5.88 | $ 4.94 | $ 5.56 |
Share data: | |||
Basic weighted average common shares outstanding (in shares) | 76 | 75.7 | 75.6 |
Diluted weighted average common shares outstanding (in shares) | 76.4 | 76.4 | 76.5 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 449.3 | $ 377.8 | $ 425.5 |
Other comprehensive (loss) income: | |||
Reclassification adjustments for derivatives, net of tax | 2.5 | 4.6 | 4.9 |
Pension and other postretirement adjustments, net of tax | 17 | 1.4 | (3.1) |
Cumulative translation adjustment | (75.6) | 107.8 | 0.1 |
Other comprehensive (loss) income | (56.1) | 113.8 | 1.9 |
Comprehensive income | 393.2 | 491.6 | 427.4 |
Comprehensive loss attributable to noncontrolling interest | 0 | 0 | 0 |
Comprehensive income attributable to IDEX | $ 393.2 | $ 491.6 | $ 427.4 |
CONSOLIDATED STATEMENTS OF EQUI
CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions | Total | Total Shareholders’ Equity | Common Stock and Additional Paid-In Capital | Retained Earnings | Cumulative Translation Adjustment | Retirement Benefits Adjustments | Cumulative Unrealized Gain (Loss) on Derivatives | Treasury Stock | Noncontrolling Interest |
Beginning balance at Dec. 31, 2018 | $ 1,994.6 | $ 1,994.6 | $ 739.2 | $ 2,342.1 | $ (94.5) | $ (22.7) | $ (12) | $ (957.5) | $ 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 425.5 | 425.5 | 425.5 | ||||||
Cumulative translation adjustment | 0.1 | 0.1 | 0.1 | ||||||
Net change in retirement obligations, net of tax | (3.1) | (3.1) | (3.1) | ||||||
Net change on derivatives designated as cash flow hedges (net of tax) | 4.9 | 4.9 | 4.9 | ||||||
Issuance of shares of common stock from issuance of unvested shares, performance share units and exercise of stock options | 38.8 | 38.8 | 38.8 | ||||||
Repurchase of common stock | (54.7) | (54.7) | (54.7) | ||||||
Share-based compensation | 22.1 | 22.1 | 22.1 | ||||||
Shares surrendered for tax withholding | (12.5) | (12.5) | (12.5) | ||||||
Cash dividends declared | (152.5) | (152.5) | (152.5) | ||||||
Ending balance at Dec. 31, 2019 | 2,263.2 | 2,263.2 | 761.3 | 2,615.1 | (94.4) | (25.8) | (7.1) | (985.9) | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 377.8 | 377.8 | 377.8 | ||||||
Cumulative translation adjustment | 107.8 | 107.8 | 107.8 | ||||||
Net change in retirement obligations, net of tax | 1.4 | 1.4 | 1.4 | ||||||
Net change on derivatives designated as cash flow hedges (net of tax) | 4.6 | 4.6 | 4.6 | ||||||
Issuance of shares of common stock from issuance of unvested shares, performance share units and exercise of stock options | 44.6 | 44.6 | 44.6 | ||||||
Repurchase of common stock | (110.3) | (110.3) | (110.3) | ||||||
Share-based compensation | 14.8 | 14.8 | 14.8 | ||||||
Shares surrendered for tax withholding | (12.3) | (12.3) | (12.3) | ||||||
Cash dividends declared | (151.4) | (151.4) | (151.4) | ||||||
Contributions received from joint venture partner | 0.1 | 0 | 0.1 | ||||||
Ending balance at Dec. 31, 2020 | 2,540.3 | 2,540.2 | 776.1 | 2,841.5 | 13.4 | (24.4) | (2.5) | (1,063.9) | 0.1 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 449.3 | 449.4 | 449.4 | (0.1) | |||||
Cumulative translation adjustment | (75.6) | (75.6) | (75.6) | ||||||
Net change in retirement obligations, net of tax | 17 | 17 | 17 | ||||||
Net change on derivatives designated as cash flow hedges (net of tax) | 2.5 | 2.5 | 2.5 | ||||||
Issuance of shares of common stock from issuance of unvested shares, performance share units and exercise of stock options | 19.7 | 19.7 | 19.7 | ||||||
Share-based compensation | 20.4 | 20.4 | 20.4 | ||||||
Shares surrendered for tax withholding | (6.1) | (6.1) | (6.1) | ||||||
Cash dividends declared | (164.4) | (164.4) | (164.4) | ||||||
Ending balance at Dec. 31, 2021 | $ 2,803.1 | $ 2,803.1 | $ 796.5 | $ 3,126.5 | $ (62.2) | $ (7.4) | $ 0 | $ (1,050.3) | $ 0 |
CONSOLIDATED STATEMENTS OF EQ_2
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | |||
Tax benefit (expense) on change in retirement obligations, tax | $ 5.3 | $ 0.1 | $ 1.6 |
Tax benefit from change on derivatives designated as cash flow hedges, tax | $ 0.8 | $ 1.4 | $ 1.4 |
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans (in shares) | 258,875 | 688,563 | 696,133 |
Repurchase of common stock (in shares) | 0 | 876,423 | 388,953 |
Deferred compensation plan, tax | $ 3.1 | $ 5 | $ 5.5 |
Cash dividends declared, per common share outstanding (in dollars per share) | $ 2.16 | $ 2 | $ 2 |
Net income | $ 449.4 | $ 377.8 | $ 425.5 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Cash flows from operating activities | |||
Net income | $ 449.3 | $ 377.8 | $ 425.5 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Asset impairments | 0.8 | 3.1 | 10.2 |
Depreciation and amortization | 46.6 | 41.7 | 39.6 |
Amortization of intangible assets | 56.4 | 41.8 | 37.3 |
Amortization of debt issuance expenses | 1.7 | 1.7 | 1.4 |
Share-based compensation expense | 20.4 | 14.8 | 22.1 |
Deferred income taxes | (6.1) | 8.2 | 6.6 |
Non-cash interest expense associated with forward starting swaps | 3.3 | 6 | 6.3 |
Termination of the U.S. pension plan, net of curtailment | 8.6 | 0 | 0 |
Changes in (net of the effect from acquisitions/divestitures and foreign exchange): | |||
Receivables | (49.4) | 20.9 | 22.3 |
Inventories | (46.1) | 36.5 | (3.3) |
Other current assets | 9 | (10.3) | (2.4) |
Trade accounts payable | 22.9 | 2.7 | (9.1) |
Deferred revenue | 19.8 | 39 | 8.7 |
Accrued expenses | 25.8 | (13.7) | (44) |
Other - net | 2.3 | (0.9) | 6.9 |
Net cash flows provided by operating activities | 565.3 | 569.3 | 528.1 |
Cash flows from investing activities | |||
Purchases of property, plant and equipment | (72.7) | (51.6) | (50.9) |
Acquisition of businesses, net of cash acquired | (577.4) | (123.1) | (87.2) |
Note receivable from collaborative partner | (4.2) | 0 | 0 |
Purchase of marketable securities | (45.2) | 0 | 0 |
Other - net | 1.4 | 2.1 | 1.1 |
Net cash flows used in investing activities | (698.1) | (172.6) | (137) |
Cash flows from financing activities | |||
Borrowings under revolving credit facilities | 0 | 150 | |
Payments under revolving credit facilities | 0 | (150) | 0 |
Proceeds from issuance of long-term borrowings | 499.4 | 499.1 | 0 |
Payment of long-term borrowings | (350.1) | (300.4) | (50.1) |
Payment of make-whole redemption premium | (6.7) | (6.8) | 0 |
Debt issuance costs | (4.6) | (4.7) | 0 |
Dividends paid | (161.1) | (151.8) | (147.2) |
Proceeds from stock option exercises | 19.7 | 44.6 | 38.8 |
Repurchases of common stock | 0 | (110.3) | (54.7) |
Shares surrendered for tax withholding | (6.1) | (12.3) | (12.6) |
Other - net | 0 | 0 | (1.8) |
Net cash flows used in financing activities | (9.5) | (42.6) | (227.6) |
Effect of exchange rate changes on cash and cash equivalents | (28.2) | 39.2 | 2.7 |
Net (decrease) increase in cash and cash equivalents | (170.5) | 393.3 | 166.2 |
Cash and cash equivalents at beginning of year | 1,025.9 | 632.6 | 466.4 |
Cash and cash equivalents at end of year | 855.4 | 1,025.9 | 632.6 |
Cash paid for: | |||
Interest | 36 | 35.2 | 36.7 |
Income taxes - net | 118.2 | 87.2 | 109 |
Significant non-cash activities: | |||
Debt acquired with acquisition of business | $ 0 | $ 0 | $ 51.1 |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Business IDEX is an applied solutions provider specializing in the manufacture of fluid and metering technologies, health and science technologies and fire, safety and other diversified products built to customers’ specifications. IDEX’s products are sold in niche markets across a wide range of industries throughout the world. The Company’s products and services include positive displacement pumps, valves, small volume provers, flow meters, injectors and other fluid-handling pump modules and systems, flow monitoring and other services, precision fluidics, rotary lobe pumps, roll compaction and drying systems, pneumatic components and sealing solutions, including very high precision, low-flow rate pumping solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, precision gear and peristaltic pump technologies, firefighting pumps, valves and controls, rescue tools, lifting bags and other components and systems for the fire and rescue industry, engineered stainless steel banding and clamping devices and precision equipment for dispensing, metering and mixing colorants and paints. These products and services are grouped into three reportable segments: Fluid & Metering Technologies (“FMT”), Health & Science Technologies (“HST”) and Fire & Safety/Diversified Products (“FSDP”). Principles of Consolidation The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, allowance for credit losses, inventory valuation, recoverability of long-lived assets, valuation of goodwill and intangible assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions. Revenue Recognition The Company accounts for a contract with a customer when it has approval from both parties, the rights and payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company determines the appropriate revenue recognition by analyzing the terms and conditions of the contract. Revenue is recognized when control of products or services is transferred to a customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring the products or providing the services. Control is transferred to customers when performance obligations within a contract are satisfied. A performance obligation is a promise to transfer a distinct product or service to a customer. For contracts that require complex design, manufacturing and installation activities, certain performance obligations may not be separately identifiable and, therefore, not distinct. As a result, the entire contract is accounted for as a single performance obligation. For contracts that include distinct products or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct products or services. Certain contracts have multiple performance obligations for which the Company allocates the transaction price to each performance obligation using an estimate of the standalone selling price of each distinct product or service and recognizes as revenue when, or as, the performance obligation is satisfied. For product sales, each product sold to a customer generally represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the standalone selling price. In certain cases, the Company may be required to estimate the standalone selling price using the expected cost plus margin approach, under which it forecasts the expected costs of satisfying a performance obligation and then adds an appropriate margin for the distinct product or service. The Company’s performance obligations are satisfied at either a point in time or over time as work progresses. Revenue recognized at a point in time is approximately 95% while revenue recognized over time is approximately 5%. For performance obligations satisfied at a point in time, generally revenue recognition occurs with the transfer of control of the asset, which is in line with shipping terms. For performance obligations satisfied over time, revenue is recognized as work is performed based on the relationship between actual costs incurred to date for each contract and the total estimated costs for such contract at completion of the performance obligation (i.e. the cost-to-cost method) or ratably over the contract term for service revenue. The Company defines service revenue as revenue from activities that are not associated with the design, development or manufacture of a product or the delivery of a software license. When accounting for over-time contracts, the Company uses an input measure to determine the extent of progress towards completion of the performance obligation. The Company believes this measure of progress best depicts the transfer of control to the customer which occurs as the Company incurs costs on its contracts. Incurred cost represents work performed, which corresponds with the transfer of control to the customer. Contract costs include labor, material and overhead. Contract estimates are based on various assumptions to project the outcome of future events. These assumptions include labor productivity and availability; the complexity of the work to be performed; the cost and availability of materials; the performance of subcontractors; and the availability and timing of funding from the customer. Revenues, including estimated fees or profits, are recorded proportionally as costs are incurred. As a significant change in one or more of these estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its estimates regularly. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised. Such revisions to costs and income are recognized in the period in which the revisions are determined as a cumulative catch-up adjustment. The impact of the adjustment on profit recorded to date on a contract is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, the Company recognizes provisions for estimated losses on incomplete contracts in the period in which such losses are determined. The Company records allowances for discounts and product returns at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties (primarily assurance-type) and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company. Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred. Advertising Costs Advertising costs of $10.7 million , $9.9 million and $15.7 million for 2021, 2020 and 2019, respectively, are expensed as incurred within Selling, general and administrative expenses. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of 3 months or less to be cash and cash equivalents. Marketable Securities The Company holds investments in marketable securities, which are recorded in Other current assets in the Consolidated Balance Sheets. These investments are recorded at fair value, with gains and losses, dividends and interest income included in Other expense - net in the Consolidated Statements of Income. See Note 9 for further discussion on the marketable securities held by the Company. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at face amount less an allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts for expected losses as a result of customers’ inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. Inventories The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor and overhead, is determined on a first in, first out basis. The Company makes adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolete, zero usage or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes. Impairment of Long-Lived Assets A long-lived asset is reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below its carrying value, as measured by comparing its net book value to the projected undiscounted future cash flows generated by its use. A long-lived asset impairment exists when the carrying value of the asset exceeds its fair value. The amount and timing of the impairment charge for an asset requires the estimation of future cash flows to determine the fair value of the asset. An impaired asset is recorded at its estimated fair value based on a discounted cash flow analysis. Refer to Note 1 5 for further discussion on impairment of long-lived assets. Goodwill and Indefinite-Lived Intangible Assets Accounting Standards Codification (“ASC”) 350, Goodwill and Other Intangible Assets , requires that the Company review the carrying value of goodwill and indefinite-lived intangible assets annually, or if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. The Company evaluates the recoverability of these assets as of October 31 based on the estimated fair value of each of the 13 reporting units and the indefinite-lived intangible assets. See Note 6 for further discussion on goodwill and indefinite-lived intangible assets. Borrowing Expenses Expenses incurred in securing and issuing debt are capitalized and included as a reduction of Long-term borrowings. These amounts are amortized over the life of the related borrowing and the related amortization is included in Interest expense in the Consolidated Statements of Income. Earnings per Common Share Diluted earnings per common share (“EPS”) attributable to IDEX is computed by dividing net income attributable to IDEX by the weighted average number of shares of common stock (basic) plus common stock equivalents outstanding (diluted) during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, restricted stock and performance share units. ASC 260, Earnings per Share , concludes that all outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding shares of restricted stock are participating securities. Accordingly, diluted EPS attributable to IDEX was computed using the two-class method prescribed by ASC 260. Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows: 2021 2020 2019 (In millions) Basic weighted average common shares outstanding 76.0 75.7 75.6 Dilutive effect of stock options, restricted stock and performance share units 0.4 0.7 0.9 Diluted weighted average common shares outstanding 76.4 76.4 76.5 Options to purchase approximately 0.3 million shares of common stock in each of 2021, 2020 and 2019, respectively, were not included in the computation of diluted EPS attributable to IDEX because the effect of their inclusion would have been antidilutive. Share-Based Compensation The Company accounts for share-based payments in accordance with ASC 718, Compensation-Stock Compensation . Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 16 for further discussion on share-based compensation. Depreciation and Amortization Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 2 to 10 years Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 15 years Trade names 5 to 20 years Customer relationships 9 to 20 years Unpatented technology 7 to 20 years Research and Development Expenditures Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales. Total engineering expenses, which include research and development as well as application and support engineering, were $82.9 million, $82.3 million and $92.4 million in 2021, 2020 and 2019, respectively. Research and development expenses, which include costs associated with developing new products and major improvements to existing products, were $50.1 million, $48.2 million and $56.4 million in 2021, 2020 and 2019, respectively . Foreign Currency Translation and Transaction The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date and the income statement amounts have been translated using the average monthly exchange rates for the year. Translation adjustments from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. Foreign currency transaction gains and losses from transactions denominated in a currency other than the functional currency of the subsidiary involved are reported within Other expense - net in the Consolidated Statements of Income. Net losses for the years ending December 31, 2021, 2020 and 2019 were $1.1 million , $3.0 million and $3.3 million, respectively. Income Taxes Income tax expense includes U.S., state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax bases of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and the manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. See Note 13 for further discussion on income taxes. Concentration of Credit Risk The Company is not dependent on a single customer as its largest customer accounted for less than 3% of net sales for all years presented. Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Simplifying the Accounting for Income Taxes , which eliminates the need to analyze whether the following apply in a given period (1) exception to the incremental approach for intraperiod tax allocation, (2) exceptions to accounting for basis differences when there are ownership changes in foreign investments and (3) exceptions in interim period income tax accounting for year-to-date losses that exceed anticipated losses. This ASU is also designed to improve the application of income tax-related guidance and simplify U.S. GAAP for (1) franchise taxes that are partially based on income, (2) transactions with a government that result in a step-up in the tax basis of goodwill, (3) separate financial statements of legal entities that are not subject to tax and (4) enacted changes in tax laws in interim periods. The Company adopted this standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. Recently Issued Accounting Standards In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which adds contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with revenue recognition guidance. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods therein. Early adoption is permitted. Entities should apply the ASU’s provisions prospectively to business combinations occurring on or after the effective date of the amendments. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10, Government Assistance (ASC 832): Disclosures by Business Entities about Government Assistance |
Acquisitions and Divestitures
Acquisitions and Divestitures | 12 Months Ended |
Dec. 31, 2021 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions and Divestitures | Acquisitions and Divestitures All of the Company’s acquisitions of businesses have been accounted for under ASC 805, Business Combinations . Accordingly, the accounts of the acquired companies, after adjustments to reflect the fair values assigned to assets and liabilities, have been included in the Company’s consolidated financial statements from their respective dates of acquisition. The results of operations of the acquired companies have been included in the Company’s consolidated results since the dates of acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on the Company’s consolidated results of operations individually or in the aggregate. 2021 Acquisitions ABEL On March 10, 2021, the Company acquired the stock of ABEL Pumps, L.P. and certain of its affiliates (“ABEL”). ABEL designs and manufactures highly engineered reciprocating positive displacement pumps for a variety of end markets, including mining, marine, power, water, wastewater and other general industries. Headquartered in Büchen, Germany, with sales and service locations in Madrid, Spain, and subsequent to the acquisition with operations in Mansfield, Ohio, ABEL operates in the Company’s Pumps reporting unit within the FMT segment. ABEL was acquired for cash consideration of $106.3 million. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $42.4 million and $46.0 million, respectively. The goodwill is not deductible for tax purposes. The Company made a preliminary allocation of the purchase price for the ABEL acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. As the Company continues to obtain additional information about these assets and liabilities, including intangible asset appraisals, inventory valuation and accrued expenses, and continues to integrate the newly acquired business, the Company will refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company will continue to make required adjustments to the purchase price allocation prior to the completion of the measurement period. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 18.4 Property, plant and equipment 4.0 Goodwill 42.4 Intangible assets 46.0 Deferred income taxes 2.6 Other noncurrent assets 0.1 Total assets acquired 113.5 Current liabilities (7.1) Other noncurrent liabilities (0.1) Net assets acquired $ 106.3 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisition reflects the strategic fit, revenue and earnings growth potential of this business. The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 9.0 15 Customer relationships 30.0 13 Unpatented technology 7.0 11 Acquired intangible assets $ 46.0 Airtech On June 14, 2021, the Company acquired the stock of Airtech Group, Inc., US Valve Corporation and related entities (“Airtech”). Airtech designs and manufactures a wide range of highly-engineered pressure technology products, including vacuum pumps, regenerative blowers, compressor systems and valves for a variety of end markets, including alternative energy, food processing, medical, packaging and transportation. Headquartered in Rutherford, New Jersey, with primary manufacturing operations in Werneck, Germany and Shenzhen, China, Airtech operates in the Company’s Performance Pneumatic Technologies reporting unit within the HST segment. Airtech was acquired for cash consideration of $471.0 million. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $267.6 million and $202.3 million, respectively. The goodwill is not deductible for tax purposes. The Company made a preliminary allocation of the purchase price for the Airtech acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. As the Company continues to obtain additional information about these assets and liabilities, including intangible asset appraisals, inventory valuation and accrued expenses, and continues to integrate the newly acquired business, the Company will refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company will continue to make required adjustments to the purchase price allocation prior to the completion of the measurement period. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 45.3 Property, plant and equipment 4.8 Goodwill 267.6 Intangible assets 202.3 Other noncurrent assets 10.1 Total assets acquired 530.1 Current liabilities (10.1) Deferred income taxes (40.6) Other noncurrent liabilities (8.4) Net assets acquired $ 471.0 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisition reflects the strategic fit, revenue and earnings growth potential of this business. The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 15.4 15 Customer relationships 162.9 13 Unpatented technology 24.0 11 Acquired intangible assets $ 202.3 The Company incurred $6.5 million of acquisition-related transaction costs in 2021. These costs were recorded in Selling, general and administrative expenses and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company also incurred fair value inventory step-up charges of $2.5 million and $9.1 million associated with the acquisitions of ABEL and Airtech, respectively, which were recorded in Cost of sales in the Consolidated Statements of Income for the year ended December 31, 2021. 2020 Acquisitions Flow MD On February 28, 2020, the Company acquired the membership interests of Flow Management Devices, LLC (“Flow MD”), a privately held provider of flow measurement systems that ensure custody transfer accuracy in the oil and gas industry. Flow MD engineers and manufactures small volume provers. Headquartered in Phoenix, Arizona, with operations in Houston, Texas and Pittsburgh, Pennsylvania, Flow MD operates in the Company’s Energy reporting unit within the FMT segment. Flow MD was acquired for cash consideration of $121.2 million. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $60.0 million and $53.0 million, respectively. The goodwill is deductible for tax purposes. The Company finalized the allocation of the purchase price for the Flow MD acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 32.9 Property, plant and equipment 4.2 Goodwill 60.0 Intangible assets 53.0 Other noncurrent assets 1.3 Total assets acquired 151.4 Current liabilities (32.3) Deferred income taxes 2.5 Other noncurrent liabilities (0.4) Net assets acquired $ 121.2 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisition reflects the strategic fit, revenue and earnings growth potential of this business. The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 6.0 15 Customer relationships 31.5 10 Unpatented technology 15.5 20 Acquired intangible assets $ 53.0 Qualtek On November 23, 2020, the Company acquired Qualtek Manufacturing, Inc. (“Qualtek”), a manufacturer of high quality specialty metal components and parts by providing vertically integrated tool and die, metal stamping and metal finishing services. Headquartered in Colorado Springs, Colorado, Qualtek operates in the BAND-IT reporting unit within the FSDP segment. Qualtek was acquired for cash consideration of $1.9 million. The entire purchase price was funded with cash on hand. Goodwill recognized as part of this transaction was $1.1 million. The goodwill recorded for the acquisition reflects the strategic fit, revenue and earnings growth potential of this business. The goodwill is deductible for tax purposes. The Company finalized its allocation of the purchase price for the Qualtek acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. The Company incurred $4.3 million of acquisition-related transaction costs in 2020. These costs were recorded in Selling, general and administrative expenses and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company also incurred fair value inventory step-up charges of $4.1 million and $0.1 million associated with the acquisitions of Flow MD and Qualtek, respectively, which were recorded in Cost of sales in the Consolidated Statements of Income for the year ended December 31, 2020. 2019 Acquisition Velcora On July 18, 2019, the Company acquired the stock of Velcora Holding AB (“Velcora”) and its operating subsidiaries, Roplan and Steridose. Roplan is a global manufacturer of custom mechanical and shaft seals for a variety of end markets including food and beverage, marine, chemical, wastewater and water treatment. Steridose develops engineered hygienic mixers and valves for the global biopharmaceutical industry. Both companies are headquartered in Sweden but also have operations in Ningbo, China; Berkshire, England and Madison, Wisconsin. Roplan and Steridose operate in the HST segment. Velcora was acquired for cash consideration of $87.2 million and the assumption of $51.1 million of debt. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $86.6 million and $48.2 million, respectively. The goodwill is not deductible for tax purposes. The Company finalized the allocation of the purchase price for the Velcora acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 20.2 Property, plant and equipment 1.7 Goodwill 86.6 Intangible assets 48.2 Other noncurrent assets 0.8 Total assets acquired 157.5 Current liabilities (7.6) Long-term borrowings (51.1) Deferred income taxes (11.1) Other noncurrent liabilities (0.5) Net assets acquired $ 87.2 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit, revenue and earnings growth potential of these businesses. The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 7.1 15 Customer relationships 34.7 12 Unpatented technology 6.4 9 Acquired intangible assets $ 48.2 On September 3, 2019, the Company settled the debt assumed in the Velcora acquisition and incurred a loss on early retirement of $0.7 million which was recorded in Other expense - net in the Consolidated Statements of Income for the year ended December 31, 2019. The Company incurred $1.7 million of acquisition-related transaction costs in 2019. These costs were recorded in Selling, general and administrative expenses and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company also incurred a fair value inventory step-up charge of $3.3 million associated with the acquisition of Velcora, which was recorded in Cost of sales in the Consolidated Statements of Income for the year ended December 31, 2019. Divestitures The Company periodically reviews its operations for businesses which may no longer be aligned with its strategic objectives and focuses on core business and customers. Any resulting gain or loss recognized due to divestitures is recorded within Loss (gain) on sale of businesses - net within Selling, general and administrative expenses in the Consolidated Statements of Income. On March 12, 2021, the Company completed the sale of CiDRA Precision Services (“CiDRA”) for $1.0 million in cash, resulting in a pre-tax gain on the sale of $0.5 million. The Company recorded $0.1 million of income tax expense associated with this transaction during the year ended December 31, 2021. The results of CiDRA were reported within the HST segment and generated $0.9 million of revenues in 2021 through the date of sale. The Company concluded that this divestiture did not meet the criteria for reporting the results of CiDRA as discontinued operations. |
Collaborative Investments
Collaborative Investments | 12 Months Ended |
Dec. 31, 2021 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Collaborative Investments | Collaborative Investments On May 12, 2020, a subsidiary of IDEX entered into a joint venture agreement with a third party to form a limited liability company (the “Joint Venture”) that will manufacture and sell high performance elastomer seals for the oil and gas industry to customers within the Kingdom of Saudi Arabia as well as export these high performance elastomer seals outside of the Kingdom of Saudi Arabia. The Joint Venture will be headquartered in Dammam, Saudi Arabia and operates in the Company’s Sealing Solutions reporting unit within the HST segment. During the year ended December 31, 2020, the Company contributed $0.1 million and owns 55% of the share capital while the third party partner contributed $0.1 million and owns 45% of the shar e capital. During the year ended December 31, 2021, the Company contributed an additional $0.6 million . As of December 31, 2021, the Joint Venture has incurred start-up expenses, but has not yet begun manufacturing. Since IDEX controls the entity, IDEX has consolidated the Joint Venture and recorded a noncontrolling interest in its Consolidated Financial Statements. On June 29, 2021, a subsidiary of IDEX funded a $4.2 million convertible promissory note to a start-up company that provides communication technology to improve individual performance and team coordination for firefighters’ responses. The investment aligns with the FSDP segment’s strategic plan to reduce response time and greatly increase life-safety outcomes and is an extension of FSDP’s smart and connected products. The note bears paid-in-kind interest at a rate of 5% per annum and is secured by the Company’s interest in the intellectual property of the start-up company. Unless earlier converted, the principal amount outstanding and the related accrued interest are due upon the earliest of (a) June 28, 2024, (b) a change in control or (c) when declared due and payable by the Company upon an event of default. The note is included in Other noncurrent assets on the Company’s Consolidated Balance Sheets. In addition, the Company recorded $0.1 million of accrued interest in Other noncurrent assets on the Company’s Consolidated Balance Sheets. The Company will measure the allowance for credit losses under the current expected credit loss model. As of December 31, 2021, no allowance for credit losses has been recorded. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Dec. 31, 2021 | |
Additional Financial Information Disclosure [Abstract] | |
Balance Sheet Components | Balance Sheet Components December 31, 2021 2020 (In millions) RECEIVABLES Customers $ 354.9 $ 288.3 Other 8.7 10.9 Total 363.6 299.2 Less allowance for doubtful accounts 7.2 6.1 Total receivables - net $ 356.4 $ 293.1 INVENTORIES Raw materials and components parts $ 229.4 $ 173.2 Work in process 47.4 29.5 Finished goods 93.6 87.2 Total inventories $ 370.4 $ 289.9 PROPERTY, PLANT AND EQUIPMENT Land and improvements $ 39.1 $ 33.7 Buildings and improvements 197.9 192.4 Machinery, equipment and other 467.8 430.4 Office and transportation equipment 96.7 95.6 Construction in progress 30.5 28.7 Total 832.0 780.8 Less accumulated depreciation and amortization 504.7 482.5 Total property, plant and equipment - net $ 327.3 $ 298.3 ACCRUED EXPENSES Payroll and related items $ 91.5 $ 75.2 Management incentive compensation 25.0 15.8 Income taxes payable 17.9 13.4 Insurance 11.0 11.1 Warranty 7.6 7.4 Deferred revenue 49.0 28.4 Lease liability 17.6 16.7 Restructuring 2.8 3.9 Accrued interest 3.6 3.6 Pension and retiree medical obligations 3.5 3.0 Other 30.3 30.3 Total accrued expenses $ 259.8 $ 208.8 OTHER NONCURRENT LIABILITIES Pension and retiree medical obligations $ 82.2 $ 99.4 Transition tax payable 14.1 14.2 Deferred revenue 32.2 30.4 Lease liability 93.4 94.3 Other 25.5 28.5 Total other noncurrent liabilities $ 247.4 $ 266.8 The valuation and qualifying account activity for the years ended December 31, 2021 and 2020 is as follows: 2021 2020 (In millions) ALLOWANCE FOR DOUBTFUL ACCOUNTS Beginning balance January 1 $ 6.1 $ 6.3 Charged to costs and expenses, net of recoveries 1.5 — Utilization (0.9) (0.5) Other adjustments, including acquisitions and currency translation 0.5 0.3 Ending balance December 31 $ 7.2 $ 6.1 |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Disaggregation of Revenue The Company has a comprehensive offering of products, including technologies, built to customers’ specifications that are sold in niche markets throughout the world. The Company disaggregates revenue from contracts with customers by reporting unit and geographical region for each segment as the Company believes it best depicts how the amount, nature, timing and uncertainty of its revenue and cash flows are affected by economic factors. Revenue was attributed to geographical region based on the location of the customer. The following tables present revenue disaggregated by reporting unit and geographical region. Revenue by reporting unit for the years ended December 31, 2021, 2020 and 2019 was as follows: For the Year Ended December 31, 2021 2020 2019 (In millions) Pumps $ 345.1 $ 265.3 $ 331.1 Water (1) 255.3 225.3 239.9 Energy 169.0 200.0 164.8 Valves (1) 121.9 118.6 129.0 Agriculture 107.4 87.1 92.2 Intersegment elimination (0.7) (0.9) (0.5) Fluid & Metering Technologies 998.0 895.4 956.5 Scientific Fluidics & Optics 508.0 415.8 434.6 Sealing Solutions 264.2 207.6 200.5 Performance Pneumatic Technologies (2) 182.2 122.9 133.5 Material Processing Technologies 134.5 120.0 113.6 Micropump 32.9 29.7 32.2 Intersegment elimination (2.8) (2.6) (1.8) Health & Science Technologies 1,119.0 893.4 912.6 Fire & Safety 377.5 376.3 404.0 Dispensing 169.6 98.5 116.2 BAND-IT 100.8 88.1 106.6 Intersegment elimination (0.1) (0.1) (1.3) Fire & Safety/Diversified Products 647.8 562.8 625.5 Total net sales $ 2,764.8 $ 2,351.6 $ 2,494.6 (1) During the third quarter of 2021, the Company merged a business in the Water reporting unit with a business in the Valves reporting unit. Revenue for each reporting unit has been restated to reflect this change for all years presented. (2) This reporting unit was previously named Gast and was renamed Performance Pneumatic Technologies upon the acquisition of Airtech. Prior to 2021, amounts reflect only the Gast business. Revenue by geographical region for the years ended December 31, 2021, 2020 and 2019 was as follows: For the Year Ended December 31, 2021 FMT HST FSDP IDEX (In millions) U.S. $ 532.9 $ 489.7 $ 317.0 $ 1,339.6 North America, excluding U.S. 61.6 23.7 28.5 113.8 Europe 197.2 341.0 161.5 699.7 Asia 143.7 241.8 110.0 495.5 Other (1) 63.3 25.6 30.9 119.8 Intersegment elimination (0.7) (2.8) (0.1) (3.6) Total net sales $ 998.0 $ 1,119.0 $ 647.8 $ 2,764.8 For the Year Ended December 31, 2020 FMT HST FSDP IDEX (In millions) U.S. $ 505.8 $ 387.6 $ 269.9 $ 1,163.3 North America, excluding U.S. 52.8 21.3 23.2 97.3 Europe 174.9 249.8 149.2 573.9 Asia 109.1 221.2 94.2 424.5 Other (1) 53.7 16.1 26.4 96.2 Intersegment elimination (0.9) (2.6) (0.1) (3.6) Total net sales $ 895.4 $ 893.4 $ 562.8 $ 2,351.6 For the Year Ended December 31, 2019 FMT HST FSDP IDEX (In millions) U.S. $ 542.0 $ 411.7 $ 303.6 $ 1,257.3 North America, excluding U.S. 58.3 21.7 26.3 106.3 Europe 170.7 263.5 159.2 593.4 Asia 125.0 201.8 103.4 430.2 Other (1) 61.0 15.7 34.3 111.0 Intersegment elimination (0.5) (1.8) (1.3) (3.6) Total net sales $ 956.5 $ 912.6 $ 625.5 $ 2,494.6 (1) Other includes: South America, Middle East, Australia and Africa. Performance Obligations The Company’s performance obligations are satisfied either at a point in time or over time as work progresses. Revenue from products and services transferred to customers at a point in time approximated 95% of total revenues in each of the years ended December 31, 2021, 2020 and 2019. Revenue from products and services transferred to customers over time approximated 5% of total revenues in each of the years ended December 31, 2021, 2020 and 2019. Contract Balances The timing of revenue recognition, billings and cash collections can result in customer receivables, advance payments or billings in excess of revenue recognized. Customer receivables include both amounts billed and currently due from customers as well as unbilled amounts (contract assets) and are included in Receivables - net on the Consolidated Balance Sheets. Amounts are billed in accordance with contractual terms or as work progresses. Unbilled amounts arise when the timing of billing differs from the timing of revenue recognized, such as when contract provisions require specific milestones to be met before a customer can be billed. Unbilled amounts primarily relate to performance obligations satisfied over time when the cost-to-cost method is utilized and the revenue recognized exceeds the amount billed to the customer as there is not yet a right to invoice in accordance with contractual terms. Unbilled amounts are recorded as a contract asset when the revenue associated with the contract is recognized prior to billing and derecognized when billed in accordance with the terms of the contract. The composition of Customer receivables was as follows: December 31, 2021 December 31, 2020 (In millions) Billed receivables $ 344.0 $ 273.5 Unbilled receivables 10.9 14.8 Total customer receivables $ 354.9 $ 288.3 Advance payments, deposits and billings in excess of revenue recognized are included in Deferred revenue which is classified as current or noncurrent based on the timing of when the Company expects to recognize the revenue. The current portion is included in Accrued expenses and the noncurrent portion is included in Other noncurrent liabilities on the Consolidated Balance Sheets. Advance payments and deposits represent contract liabilities and are recorded when customers remit contractual cash payments in advance of us satisfying performance obligations under contractual arrangements, including those with performance obligations satisfied over time. The Company generally receives advance payments from customers related to maintenance services which are recognized ratably over the service term. The Company also receives deposits from customers on certain orders which the Company recognizes as revenue at a point in time in the future. Billings in excess of revenue recognized represent contract liabilities and primarily relate to performance obligations satisfied over time when the cost-to-cost method is utilized and revenue cannot yet be recognized as the Company has not completed the corresponding performance obligation. Contract liabilities are derecognized when revenue is recognized and the performance obligation is satisfied. The composition of Deferred revenue was as follows: December 31, 2021 December 31, 2020 (In millions) Deferred revenue - current $ 49.0 $ 28.4 Deferred revenue - noncurrent 32.2 30.4 Total deferred revenue $ 81.2 $ 58.8 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill for 2021 and 2020, by reportable business segment, were as follows: FMT HST FSDP Total (In millions) Goodwill $ 599.6 $ 981.6 $ 399.1 $ 1,980.3 Accumulated goodwill impairment losses (20.7) (149.8) (30.1) (200.6) Balance at January 1, 2020 578.9 831.8 369.0 1,779.7 Foreign currency translation 10.4 29.1 13.1 52.6 Acquisitions 60.4 — 1.1 61.5 Acquisition adjustments — 1.8 — 1.8 Balance at December 31, 2020 649.7 862.7 383.2 1,895.6 Foreign currency translation (10.7) (15.7) (11.0) (37.4) Acquisitions 42.4 267.6 — 310.0 Disposition of businesses — (0.1) — (0.1) Acquisition adjustments (0.4) — — (0.4) Balance at December 31, 2021 $ 681.0 $ 1,114.5 $ 372.2 $ 2,167.7 Goodwill represents the purchase price in excess of the net amount assigned to the assets acquired and liabilities assumed and was tested for impairment at each of the Company’s 13 reporting units as of October 31, 2021, the Company’s annual impairment test date. In assessing the fair value of the reporting units, the Company considers both the market approach and the income approach. Under the market approach, the fair value of the reporting unit is determined by the respective trailing 12 month EBITDA and the forward looking 2022 EBITDA (50% each), based on multiples of comparable public companies. The market approach is dependent on a number of significant management assumptions including forecasted EBITDA and selected market multiples. Under the income approach, the fair value of the reporting unit is determined based on the present value of estimated future cash flows. The income approach is dependent on a number of significant management assumptions including estimates of operating results, capital expenditures, net working capital requirements, long-term growth rates and discount rates. Weighting was equally attributed to both the market and the income approaches (50% each) in arriving at the fair value of the reporting units. In 2021 and 2020, there were no events or circumstances that would have required an interim impairment test. The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2021 and 2020: At December 31, 2021 At December 31, 2020 Gross Accumulated Net Weighted Gross Accumulated Net (In millions) (In millions) Amortized intangible assets: Patents $ 3.2 $ (2.0) $ 1.2 10 $ 3.0 $ (1.8) $ 1.2 Trade names 140.9 (72.4) 68.5 15 130.8 (72.7) 58.1 Customer relationships 495.9 (144.2) 351.7 13 318.4 (120.3) 198.1 Unpatented technology 143.8 (58.8) 85.0 13 122.3 (55.1) 67.2 Other — — — — 0.7 (0.6) 0.1 Total amortized intangible assets 783.8 (277.4) 506.4 575.2 (250.5) 324.7 Indefinite-lived intangible assets: Banjo trade name 62.1 — 62.1 62.1 — 62.1 Akron Brass trade name 28.8 — 28.8 28.8 — 28.8 Total intangible assets $ 874.7 $ (277.4) $ 597.3 $ 666.1 $ (250.5) $ 415.6 The Banjo trade name and the Akron Brass trade name are indefinite-lived intangible assets that were also tested for impairment as of October 31, 2021, the Company’s annual impairment test date. These indefinite-lived intangible assets are tested for impairment on an annual basis in accordance with ASC 350 or more frequently if events or changes in circumstances indicate that the assets might be impaired. The Company uses the relief-from-royalty method, a form of the income approach, to determine the fair value of these trade names. The relief-from-royalty method is dependent on a number of significant management assumptions, including estimates of revenues, royalty rates and discount rates. In 2021 and 2020, there were no events or circumstances that would have required an interim impairment test. Refer to Note 15 for discussion on impairment of definite-lived intangibles. Amortization of intangible assets was $56.4 million, $41.8 million and $37.3 million in 2021, 2020 and 2019, respectively. Based on the intangible asset balances as of December 31, 2021, amortization expense is expected to approximate $61.3 million in 2022, $58.1 million in 2023, $53.6 million in 2024, $52.0 million in 2025 and $50.2 million in 2026. |
Borrowings
Borrowings | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings Borrowings at December 31, 2021 and 2020 consisted of the following: 2021 2020 (In millions) 4.20% Senior Notes, repaid in June 2021 $ — $ 350.0 3.20% Senior Notes, due June 2023 100.0 100.0 3.37% Senior Notes, due June 2025 100.0 100.0 3.00% Senior Notes, due May 2030 500.0 500.0 2.625% Senior Notes, due June 2031 500.0 — Other borrowings 0.1 0.2 Total borrowings 1,200.1 1,050.2 Less current portion — 0.1 Less deferred debt issuance costs 8.4 4.8 Less unaccreted debt discount 1.4 0.9 Long-term borrowings $ 1,190.3 $ 1,044.4 Issuance of 2.625% Senior Notes in 2021 On May 28, 2021, the Company completed a public offering of $500.0 million in aggregate principal amount of 2.625% Senior Notes due June 2031 (the “2.625% Senior Notes”). The net proceeds from the offering were approximately $494.7 million, after deducting the issuance discount of $0.6 million, the underwriting commission of $3.3 million and offering expenses of $1.4 million. The net proceeds were used to redeem and repay the $350.0 million aggregate principal amount outstanding of its 4.20% Senior Notes due December 15, 2021 (the “4.20% Senior Notes”) and a $6.7 million make-whole redemption premium, with the remaining balance used for general corporate purposes. The 2.625% Senior Notes bear interest at a rate of 2.625% per annum, which is payable semi-annually in arrears on June 15 and December 15 of each year. The 2.625% Senior Notes mature on June 15, 2031. The 2.625% Senior Notes were issued under an Indenture, dated as of December 6, 2010 (the “Base Indenture”), between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by the Fourth Supplemental Indenture, dated as of May 28, 2021 (the “Supplemental Indenture” and, together with the Base Indenture and other supplements thereto, the “Indenture”), between the Company and the Trustee. The Company may redeem all or a portion of the 2.625% Senior Notes at any time prior to maturity at the redemption prices set forth in the Indenture. The Indenture and the 2.625% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens, enter into certain sale and leaseback transactions and enter into certain mergers, consolidations and transfers of substantially all of the Company’s assets. The terms of the 2.625% Senior Notes also require the Company to make an offer to repurchase the 2.625% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of the principal amount plus accrued and unpaid interest, if any. The Indenture also provides for customary events of default, which include nonpayment, breach of covenants or warranties in the Indenture and certain events of bankruptcy, insolvency or reorganization. Generally, if an event of default occurs, the Trustee or holders of at least 25% of the then outstanding 2.625% Senior Notes may declare the principal amount of all of the 2.625% Senior Notes to be due and payable immediately. On May 17, 2021, the Company provided notice of its election to redeem early, on June 16, 2021, the $350.0 million aggregate principal amount outstanding of its 4.20% Senior Notes at a redemption price of $350.0 million plus a make-whole redemption premium of $6.7 million using proceeds from the Company’s 2.625% Senior Notes. In addition, the Company recognized the remaining $1.3 million of the pre-tax amount included in Accumulated other comprehensive loss in shareholders’ equity related to the interest rate exchange agreement associated with the 4.20% Senior Notes and wrote off the remaining $0.1 million of deferred issuance costs and $0.1 million of the debt issuance discount associated with the 4.20% Senior Notes as well as $0.4 million of deferred taxes for a total loss on early debt redemption of $8.6 million which was recorded within Other expense - net in the Consolidated Statements of Income. Issuance of 3.00% Senior Notes in 2020 On April 29, 2020, the Company completed a public offering of $500.0 million in aggregate principal amount of 3.00% Senior Notes due May 2030 (the “3.00% Senior Notes”). The net proceeds from the offering were approximately $494.4 million, after deducting the issuance discount of $0.9 million, the underwriting commission of $3.3 million and offering expenses of $1.4 million. The net proceeds were used to redeem and repay the $300.0 million aggregate principal amount outstanding of its 4.50% Senior Notes due December 15, 2020 (the “4.50% Senior Notes”) and the related accrued interest and a make-whole redemption premium, with the remaining balance used for general corporate purposes. The 3.00% Senior Notes bear interest at a rate of 3.00% per annum, which is payable semi-annually in arrears on May 1 and November 1 of each year. The 3.00% Senior Notes mature on May 1, 2030. The Company may redeem all or a portion of the 3.00% Senior Notes at any time prior to maturity at the redemption prices set forth in the Indenture governing the 3.00% Senior Notes. The Indenture and 3.00% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale-leaseback transactions and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all of the Company’s assets. The terms of the 3.00% Senior Notes also require the Company to make an offer to repurchase the 3.00% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of the principal amount plus accrued and unpaid interest, if any. The Indenture also provides for customary events of default, which include nonpayment, breach of covenants in the Indenture and certain events of bankruptcy and insolvency. Generally, if an event of default occurs, the Trustee or holders of at least 25% of the then outstanding 3.00% Senior Notes may declare the principal amount of all of the 3.00% Senior Notes to be due and payable immediately. On April 27, 2020, the Company provided notice of its election to redeem early, on May 27, 2020, the $300.0 million aggregate principal amount outstanding of its 4.50% Senior Notes at a redemption price of $300.0 million plus a make-whole redemption premium of $6.8 million and accrued and unpaid interest of $6.1 million using proceeds from the Company’s 3.00% Senior Notes. In addition, the Company recognized the remaining $1.4 million of the pre-tax amount included in Accumulated other comprehensive loss in shareholders’ equity related to the interest rate exchange agreement associated with the 4.50% Senior Notes and wrote off the remaining $0.1 million of deferred issuance costs and $0.1 million of the debt issuance discount associated with the 4.50% Senior Notes for a total loss on early debt redemption of $8.4 million which was recorded within Other expense - net in the Consolidated Statements of Income. Revolving Credit Facility On May 31, 2019, the Company entered into a credit agreement (the “Credit Agreement”) along with certain of its subsidiaries, as borrowers (the “Borrowers”), Bank of America, N.A., as administrative agent, swing line lender and an issuer of letters of credit, with other agents party thereto. The Credit Agreement consists of a revolving credit facility (the “Revolving Facility”) in an aggregate principal amount of $800 million with a final maturity date of May 31, 2024. The maturity date may be extended under certain conditions for an additional one five Proceeds of the Revolving Facility are available for use by the Borrowers for acquisitions, working capital and other general corporate purposes, including refinancing existing debt of the Company and its subsidiaries. The Company may request increases in the lending commitments under the Credit Agreement, but the aggregate lending commitments pursuant to such increases may not exceed $400 million. The Company has the right, subject to certain conditions set forth in the Credit Agreement, to designate certain foreign subsidiaries of the Company as borrowers under the Credit Agreement. In connection with any such designation, the Company is required to guarantee the obligations of any such subsidiaries under the Credit Agreement. Borrowings under the Credit Agreement bear interest at either an alternate base rate or adjusted LIBOR plus, in each case, an applicable margin. Such applicable margin is based on the lower of the Company’s senior, unsecured, long-term debt rating or the Company’s applicable leverage ratio and can range from 0.00% to 1.275%. Interest is payable (a) in the case of base rate loans, quarterly, and (b) in the case of LIBOR loans, on the last day of the applicable interest period selected, or every three months from the effective date of such interest period for interest periods exceeding three months. The Credit Agreement requires payment to the lenders of a facility fee based upon the amount of the lenders’ commitments under the credit facility from time to time, determined based on the lower of the Company’s senior, unsecured long-term debt rating or the Company’s applicable leverage ratio. Voluntary prepayments of any loans and voluntary reductions of the unutilized portion of the commitments under the Credit Agreement are permissible without penalty, subject to break funding payments and minimum notice and minimum reduction amount requirements. The Credit Agreement contains customary affirmative and negative covenants for senior unsecured credit agreements. There are two key financial covenants that the Company is required to maintain in connection with the Credit Agreement and the Senior Notes, excluding the 3.00% Senior Notes which have no financial covenants, a minimum interest coverage ratio of 3.0 to 1 and a maximum leverage ratio of 3.50 to 1, which is the ratio of the Company’s consolidated total debt to its consolidated earnings before interest, income taxes, depreciation and amortization (“EBITDA”), both of which are tested quarterly and in the case of the leverage ratio under the Revolving Facility, there is an option to increase the ratio to 4.00 for 12 months in connection with certain acquisitions. At December 31, 2021, the Company was in compliance with each financial covenant under Credit Agreement and the Senior Notes, excluding the 3.00% Senior Notes which have no financial covenants. While there are no financial covenants relating to the 3.00% Senior Notes, they are subject to cross-default provisions. The negative covenants include restrictions on the Company’s ability to grant liens, enter into transactions resulting in fundamental changes (such as mergers or sales of all or substantially all of the assets of the Company), make certain subsidiary dividends or distributions, engage in materially different lines of businesses and allow subsidiaries to incur certain additional debt. The Credit Agreement also contains customary events of default (subject to grace periods, as appropriate). At December 31, 2021, there was no balance outstanding under the Revolving Facility and $7.2 million of outstanding letters of credit, resulting in a net available borrowing capacity under the Revolving Facility at December 31, 2021 of approximately $792.8 million. In addition, there were no borrowings under the Revolving Facility during the year ended December 31, 2021. Issuance of 3.20% Senior Notes and 3.37% Senior Notes in 2016 On June 13, 2016, the Company completed a private placement of a $100 million aggregate principal amount of 3.20% Senior Notes due June 13, 2023 (the “3.20% Senior Notes”) and a $100 million aggregate principal amount of 3.37% Senior Notes due June 13, 2025 (the “3.37% Senior Notes” and together with the 3.20% Senior Notes, the “2016 Private Placement Notes”) pursuant to a Note Purchase Agreement dated June 13, 2016 (the “Purchase Agreement”). Each series of the 2016 Private Placement Notes bears interest at the stated amount per annum, which is payable semi-annually in arrears on each June 13 th and December 13 th . The 2016 Private Placement Notes are unsecured obligations of the Company and rank pari passu in right of payment with all of the Company’s other unsecured, unsubordinated debt. The Company may at any time prepay all, or any portion of the 2016 Private Placement Notes, provided that such portion is greater than 5% of the aggregate principal amount of the 2016 Private Placement Notes then outstanding. In the event of a prepayment, the Company will pay an amount equal to par plus accrued interest plus a make-whole amount. In addition, the Company may repurchase the 2016 Private Placement Notes by making an offer to all holders of the 2016 Private Placement Notes, subject to certain conditions. The Purchase Agreement contains certain covenants that restrict the Company’s ability to, among other things, transfer or sell assets, incur indebtedness, create liens, transact with affiliates and engage in certain mergers or consolidations or other change of control transactions. In addition, the Company must comply with the leverage ratio and interest coverage ratio described above and the Purchase Agreement also limits the outstanding principal amount of priority debt that may be incurred by the Company to 15% of consolidated assets. The Purchase Agreement provides for customary events of default. In the case of an event of default arising from specified events of bankruptcy or insolvency, all of the outstanding 2016 Private Placement Notes will become due and payable immediately without further action or notice. In the case of payment event of default, any holder of the 2016 Private Placement Notes affected thereby may declare all of the 2016 Private Placement Notes held by it due and payable immediately. In the case of any other event of default, a majority of the holders of the 2016 Private Placement Notes may declare all of the 2016 Private Placement Notes to be due and payable immediately. Total borrowings at December 31, 2021 have scheduled maturities as follows: (In millions) 2022 $ — 2023 100.0 2024 — 2025 100.1 2026 — Thereafter 1,000.0 Total borrowings $ 1,200.1 |
Derivative Instruments
Derivative Instruments | 12 Months Ended |
Dec. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments The Company enters into cash flow hedges from time to time to reduce the exposure to variability in certain expected future cash flows. The types of cash flow hedges the Company enters into include foreign currency exchange contracts designed to minimize the earnings impact on certain intercompany loans as well as interest rate exchange agreements designed to reduce the impact of interest rate changes on future interest expense that effectively convert a portion of floating-rate debt to fixed-rate debt. The effective portion of gains or losses on interest rate exchange agreements is reported in Accumulated other comprehensive loss in shareholders’ equity and reclassified into net income in the same period or periods in which the hedged transaction affects net income. The remaining gain or loss in excess of the cumulative change in the present value of future cash flows or the hedged item, if any, is recognized in net income during the period of change. See Note 17 for the amount of loss reclassified into net income for interest rate contracts for the years ended December 31, 2021, 2020 and 2019. As of December 31, 2021, the Company did not have any interest rate contracts outstanding. In 2010 and 2011, the Company entered into two separate forward starting interest rate exchange agreements in anticipation of the issuance of the 4.50% Senior Notes and the 4.20% Senior Notes. The Company cash settled these two interest rate contracts in 2010 and 2011 for a total of $68.9 million, which was being amortized into interest expense over the 10 year terms of the respective debt instruments. In conjunction with the early redemption of the 4.50% Senior Notes on May 27, 2020, the Company accelerated the recognition of the remaining $1.4 million of the pre-tax amount included in Accumulated other comprehensive loss in shareholders’ equity related to the 4.50% Senior Notes and recorded such as Other expense - net in the Consolidated Statements of Income during the year ended December 31, 2020. In conjunction with the early redemption of the 4.20% Senior Notes on June 16, 2021, the Company accelerated the recognition of the remaining $1.3 million of the pre-tax amount included in Accumulated other comprehensive loss in shareholders’ equity related to the 4.20% Senior Notes and recorded such as Other expense - net in the Consolidated Statements of Income during the year ended December 31, 2021. As of December 31, 2021, there was no balance in Accumulated other comprehensive loss related to the cumulative unrealized gain (loss) on derivatives. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements ASC 820, Fair Value Measurements and Disclosures, defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The standard utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: • Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2: Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. • Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2021 and 2020: Basis of Fair Value Measurements Balance at December 31, 2021 Level 1 Level 2 Level 3 (In millions) Trading securities - mutual funds held in nonqualified SERP (1) $ 11.6 $ 11.6 $ — $ — Available-for-sale securities - equities (2) 45.3 45.3 — — Basis of Fair Value Measurements Balance at December 31, 2020 Level 1 Level 2 Level 3 (In millions) Trading securities - mutual funds held in nonqualified SERP (1) $ 13.6 $ 13.6 $ — $ — (1) The Supplemental Executive Retirement Plan (“SERP”) investment assets are offset by a SERP liability which represents the Company’s obligation to distribute SERP funds to participants. (2) At December 31, 2021, t he securities are included in Other current assets on the Company’s Consolidated Balance Sheets and are available for overnight cash settlement, if necessary, to fund current operations. There were no transfers of assets or liabilities between Level 1 and Level 2 in 2021 or 2020. The carrying values of the Company’s cash and cash equivalents, accounts receivable, marketable securities, accounts payable and accrued expenses approximate fair value because of the short term nature of these instruments. At December 31, 2021 and 2020, the fair value of the outstanding indebtedness described in Footnote 7 based on quoted market prices and current market rates for debt with similar credit risk and maturity was approximately $1,219.9 million and $1,127.6 million, respectively, compared to the carrying value of $1,198.7 million and $1,049.3 million, respectively. These fair value measurements are classified as Level 2 within the fair value hierarchy since they are determined based upon significant inputs observable in the market, including interest rates on recent financing transactions to entities with a credit rating similar to the Company’s rating. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2021 | |
Lessee Disclosure [Abstract] | |
Leases | Leases The Company leases certain office facilities, warehouses, manufacturing plants, equipment (which includes both office and plant equipment) and vehicles under operating leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Certain leases include one or more options to renew. The exercise of lease renewal options is at the Company’s sole discretion. The Company does not include renewal periods in any of the leases’ terms until the renewal is executed as they are generally not reasonably certain of being exercised. The Company does not have any material purchase options. Certain of the Company’s lease agreements have rental payments that are adjusted periodically for inflation or that are based on usage. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Supplemental balance sheet information related to leases as of December 31, 2021 and 2020 was as follows: Balance Sheet Caption December 31, 2021 December 31, 2020 (In millions) Operating leases: Building right-of-use assets - net Other noncurrent assets $ 101.0 $ 100.8 Equipment right-of-use assets - net Other noncurrent assets 6.2 5.8 Total right-of-use assets - net $ 107.2 $ 106.6 Operating leases: Current lease liabilities Accrued expenses $ 17.6 $ 16.7 Noncurrent lease liabilities Other noncurrent liabilities 93.4 94.3 Total lease liabilities $ 111.0 $ 111.0 Refer to Note 15 for discussion on impairment of building right-of-use assets. The components of lease cost for the years ended December 31, 2021, 2020 and 2019 were as follows: 2021 2020 2019 (In millions) Operating lease cost (1) $ 31.5 $ 29.5 $ 23.0 Variable lease cost 2.3 1.9 2.3 Total lease expense $ 33.8 $ 31.4 $ 25.3 (1) Includes short-term leases, which are immaterial. Supplemental cash flow information related to leases for the years ended December 31, 2021, 2020 and 2019 was as follows: 2021 2020 2019 (In millions) Cash paid for amounts included in the measurement of operating lease liabilities $ 31.2 $ 28.7 $ 22.9 Right-of-use assets obtained in exchange for new operating lease liabilities 16.0 40.4 25.9 Other supplemental information related to leases as of December 31, 2021 and 2020 was as follows: Lease Term and Discount Rate December 31, 2021 December 31, 2020 Weighted-average remaining lease term (years): Operating leases - building and equipment 8.50 9.43 Operating leases - vehicles 2.34 2.01 Weighted-average discount rate: Operating leases - building and equipment 3.27 % 3.51 % Operating leases - vehicles 1.08 % 2.05 % The Company uses its incremental borrowing rate to determine the present value of the lease payments. Total lease liabilities at December 31, 2021 have scheduled maturities as follows: Maturity of Lease Liabilities Operating Leases (In millions) 2022 $ 20.1 2023 18.3 2024 15.6 2025 13.3 2026 12.0 Thereafter 48.3 Total lease payments 127.6 Less: Imputed interest (16.6) Present value of lease liabilities $ 111.0 Total lease liabilities at December 31, 2020 had scheduled maturities as follows: Maturity of Lease Liabilities Operating Leases (In millions) 2021 $ 19.7 2022 17.0 2023 13.7 2024 11.7 2025 11.1 Thereafter 57.6 Total lease payments $ 130.8 Less: Imputed interest $ (19.8) Present value of lease liabilities $ 111.0 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Warranty costs are provided for at the time of sale. The warranty provision is based on historical costs and adjusted for specific known claims. A rollforward of the warranty reserve is as follows: 2021 2020 2019 (In millions) Beginning balance at January 1 $ 7.4 $ 5.6 $ 5.3 Provision for warranties 3.4 3.0 3.4 Claim settlements (3.8) (2.7) (3.1) Other adjustments, including acquisitions, divestitures and currency translation 0.6 1.5 — Ending balance at December 31 $ 7.6 $ 7.4 $ 5.6 |
Common and Preferred Stock
Common and Preferred Stock | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Common and Preferred Stock | Common and Preferred Stock On March 17, 2020, the Company’s Board of Directors approved an increase of $500.0 million in the authorized level of repurchases of common stock. This approval is in addition to the prior repurchase authorizations of the Board of Directors of $300.0 million on December 1, 2015. These authorizations have no expiration date. Repurchases under the program will be funded with future cash flow generation or borrowings available under the Revolving Facility. There were no share repurchases during 2021. During 2020, the Company repurchased a total of 0.9 million shares at a cost of $110.3 million. As of December 31, 2021, the amount of share repurchase authorization remaining was $712.0 million. At December 31, 2021 and 2020, the Company had 150 million shares of authorized common stock, with a par value of $.01 per share, and five million shares of authorized preferred stock, with a par value of $.01 per share. No preferred stock was outstanding at December 31, 2021 or 2020. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Pretax income for 2021, 2020 and 2019 was taxed in the following jurisdictions: 2021 2020 2019 (In millions) U.S. $ 350.2 $ 296.3 $ 377.2 Foreign 229.6 174.0 155.7 Total $ 579.8 $ 470.3 $ 532.9 The provision (benefit) for income taxes for 2021, 2020 and 2019 was as follows: 2021 2020 2019 (In millions) Current U.S. $ 64.7 $ 29.5 $ 49.8 State and local 11.0 4.6 9.1 Foreign 60.9 50.2 41.9 Total current 136.6 84.3 100.8 Deferred U.S. (4.1) 10.1 10.1 State and local (1.4) 1.5 (0.1) Foreign (0.6) (3.4) (3.4) Total deferred (6.1) 8.2 6.6 Total provision for income taxes $ 130.5 $ 92.5 $ 107.4 Deferred tax assets (liabilities) at December 31, 2021 and 2020 were: 2021 2020 (In millions) Employee and retiree benefit plans $ 23.6 $ 26.9 Capital loss and other carryforwards 11.9 16.3 Operating lease assets 25.7 24.7 Operating lease liabilities (24.8) (23.9) Depreciation and amortization (222.0) (189.0) Inventories 11.7 8.8 Allowances and accruals 10.3 7.3 Interest rate exchange agreement — 0.7 Other (16.6) (16.9) Total gross deferred tax (liabilities) (180.2) (145.1) Valuation allowance (11.9) (16.3) Total deferred tax (liabilities), net of valuation allowances $ (192.1) $ (161.4) The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2021 and 2020 were: 2021 2020 (In millions) Noncurrent deferred tax asset - Other noncurrent assets $ 4.3 $ 2.5 Noncurrent deferred tax liabilities - Deferred income taxes (196.4) (163.9) Net deferred tax liabilities $ (192.1) $ (161.4) The Company had prepaid income taxes, recorded within Other current assets on the Consolidated Balance Sheets, of $9.1 million and $20.9 million as of December 31, 2021 and 2020, respectively. The provision for income taxes differs from the amount calculated by applying the statutory federal income tax rate to pretax income. The calculated amount and the differences for 2021, 2020 and 2019 are shown in the following table: 2021 2020 2019 (In millions) Pretax income $ 579.8 $ 470.3 $ 532.9 Provision for income taxes: Computed amount at statutory rate of 21% $ 121.8 21.0 % $ 98.8 21.0 % $ 111.9 21.0 % State and local income tax (net of federal tax benefit) 8.0 1.4 % 5.9 1.3 % 8.2 1.5 % Taxes on non-U.S. earnings-net of foreign tax credits 9.2 1.6 % 8.4 1.8 % 6.3 1.2 % Global Intangible Low-Taxed Income 0.4 0.1 % (2.7) (0.6 %) 2.3 0.4 % Foreign-Derived Intangible Income Deduction (7.5) (1.3 %) (4.9) (1.0 %) (5.8) (1.1 %) Share-based payments (3.5) (0.6 %) (9.8) (2.1 %) (11.0) (2.1 %) Other 2.1 0.3 % (3.2) (0.7 %) (4.5) (0.7 %) Total provision for income taxes $ 130.5 22.5 % $ 92.5 19.7 % $ 107.4 20.2 % The Company has $40.6 million and $28.6 million of permanently reinvested earnings of non-U.S. subsidiaries as of December 31, 2021 and 2020, respectively. No deferred U.S. income taxes have been provided on the $40.6 million of earnings that are considered to be permanently reinvested. It should also be noted that the aforementioned earnings will not incur U.S. taxes when ultimately repatriated other than potentially U.S. federal, state and local taxes on foreign exchange gains or losses recognized on the distribution of such earnings. Such distributions could also be subject to additional foreign withholding and foreign income taxes. The amount of unrecognized deferred income tax liabilities on currently permanently reinvested earnings is estimated to be $6.1 million and $4.3 million as of December 31, 2021 and 2020, respectively. During the years ended December 31, 2021, 2020 and 2019, the Company repatriated $116.0 million, $27.0 million and $99.0 million of foreign earnings, respectively. These actual distributions resulted in no incremental income tax expense for the years ended December 31, 2021, 2020 and 2019. These repatriations represent distributions of previously taxed income as well as distributions from liquidating subsidiaries. A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2021, 2020 and 2019 is as follows: 2021 2020 2019 (In millions) Beginning balance January 1 $ 1.1 $ 3.7 $ 4.1 Gross increases for tax positions of prior years 0.1 — — Gross decreases for tax positions of prior years (0.3) — — Settlements (0.2) (2.6) (0.1) Lapse of statute of limitations (0.6) — (0.3) Ending balance December 31 $ 0.1 $ 1.1 $ 3.7 The Company recognizes interest and penalties related to uncertain tax positions in provision for income taxes in the Consolidated Statements of Income. As of December 31, 2021, the Company accrued interest and penalties of less than $0.1 million related to uncertain tax positions. The total amount of unrecognized tax benefits that would affect the Company’s effective tax rate if recognized is $0.1 million, $1.1 million and $3.7 million as of December 31, 2021, 2020 and 2019, respectively. The tax years 2016-2020 remain open to examination by major taxing jurisdictions. Due to the potential for resolution of federal, state and foreign examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized tax benefits balance may change. However, these unrecognized tax benefits are long-term in nature and are not expected to change within the next 12 months. As of December 31, 2021, the Company had non-U.S. and U.S. state net operating loss carryforwards of $0.7 million and $22.5 million, respectively. The entire balance of the non-U.S. net operating losses, the majority of which relates to acquisitions is available to be carried forward indefinitely. The U.S. state net operating loss will expire between 2033 and 2040. There is no valuation allowance as it is more-likely-than-not that the net operating losses will be realized. The Company has U.S. federal, U.S. state and non-U.S. capital loss carryforwards of $11.9 million, $11.9 million and $13.5 million, respectively, with a full valuation allowance against the deferred tax asset. The non-U.S. capital loss can be carried forward indefinitely. The U.S. federal and U.S. state capital loss carryforwards will expire at various dates between 2025 and 2040. |
Business Segments and Geographi
Business Segments and Geographic Information | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Business Segments and Geographic Information | Business Segments and Geographic Information IDEX has three reportable business segments: FMT, HST and FSDP. The FMT segment designs, produces and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors and other fluid-handling pump modules and systems and provides flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agriculture and energy industries. The HST segment designs, produces and distributes a wide range of precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions and precision gear and peristaltic pump technologies. HST serves a variety of end markets, including food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research and defense markets. The FSDP segment designs, produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, other components and systems for the fire and rescue industry, engineered stainless steel banding and clamping devices used in a variety of industrial and commercial applications and precision equipment for dispensing, metering and mixing colorants and paints used in a variety of retail and commercial businesses around the world. Information on the Company’s business segments is presented below based on the nature of the products and services offered. The Company evaluates performance based on several factors, of which sales, operating income and operating margin are the primary financial measures. Intersegment sales are accounted for at fair value as if the sales were to third parties. 2021 2020 2019 (In millions) NET SALES Fluid & Metering Technologies External customers $ 998.0 $ 895.4 $ 956.5 Intersegment sales 0.7 0.9 0.5 Total segment sales 998.7 896.3 957.0 Health & Science Technologies External customers 1,119.0 893.4 912.6 Intersegment sales 2.8 2.6 1.8 Total segment sales 1,121.8 896.0 914.4 Fire & Safety/Diversified Products External customers 647.8 562.8 625.5 Intersegment sales 0.1 0.1 1.3 Total segment sales 647.9 562.9 626.8 Intersegment eliminations (3.6) (3.6) (3.6) Total net sales $ 2,764.8 $ 2,351.6 $ 2,494.6 OPERATING INCOME (LOSS) (1) Fluid & Metering Technologies $ 259.3 $ 235.0 $ 285.2 Health & Science Technologies 288.9 206.4 200.2 Fire & Safety/Diversified Products 169.3 144.2 165.3 Corporate office and other (80.5) (64.9) (71.7) Total operating income 637.0 520.7 579.0 Interest expense 41.0 44.8 44.3 Other expense - net 16.2 5.6 1.8 Income before income taxes $ 579.8 $ 470.3 $ 532.9 2021 2020 2019 (In millions) ASSETS Fluid & Metering Technologies $ 1,458.8 $ 1,387.0 $ 1,150.7 Health & Science Technologies 2,138.3 1,576.1 1,507.1 Fire & Safety/Diversified Products 892.5 891.9 825.4 Corporate office and other 427.6 559.4 330.7 Total assets $ 4,917.2 $ 4,414.4 $ 3,813.9 DEPRECIATION AND AMORTIZATION (2) Fluid & Metering Technologies $ 30.5 $ 25.9 $ 22.2 Health & Science Technologies 56.7 41.8 39.7 Fire & Safety/Diversified Products 15.3 15.2 14.3 Corporate office and other 0.5 0.6 0.7 Total depreciation and amortization $ 103.0 $ 83.5 $ 76.9 CAPITAL EXPENDITURES Fluid & Metering Technologies $ 21.0 $ 11.9 $ 17.3 Health & Science Technologies 41.5 27.7 22.0 Fire & Safety/Diversified Products 9.5 8.9 9.8 Corporate office and other 0.7 3.1 1.8 Total capital expenditures $ 72.7 $ 51.6 $ 50.9 (1) Segment operating income (loss) excludes net unallocated corporate operating expenses. (2) Excludes amortization of debt issuance expenses. Information about the Company’s long-lived assets in different geographical regions for the years ended December 31, 2021, 2020 and 2019 is shown below. 2021 2020 2019 (In millions) LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT U.S. $ 188.3 $ 169.2 $ 165.7 North America, excluding U.S. 5.4 5.0 3.8 Europe 98.9 100.0 88.1 Asia 34.5 24.0 22.5 Other 0.2 0.1 0.2 Total long-lived assets - net $ 327.3 $ 298.3 $ 280.3 |
Restructuring Expenses and Asse
Restructuring Expenses and Asset Impairments | 12 Months Ended |
Dec. 31, 2021 | |
Restructuring Costs and Asset Impairment Charges [Abstract] | |
Restructuring Expenses and Asset Impairments | Restructuring Expenses and Asset Impairments During 2021, 2020 and 2019, the Company incurred restructuring expenses and asset impairments of $9.3 million, $11.8 million and $21.0 million, respectively. These costs were incurred to facilitate long-term sustainable growth through cost reduction actions, consisting of employee reductions, facility rationalization, contract termination costs and asset impairments. Restructuring costs include severance benefits, exit costs and asset impairments and are included in Restructuring expenses and asset impairments in the Consolidated Statements of Income. Severance costs primarily consist of severance benefits through payroll continuation, COBRA subsidies, outplacement services, conditional separation costs and employer tax liabilities, while exit costs primarily consist of lease exit and contract termination costs. 2021 Initiative During the year ended December 31, 2021, the Company incurred severance costs related to employee reductions. In addition, the Company consolidated certain facilities within the FMT segment which resulted in asset impairments of $0.8 million related to property, plant and equipment that was not relocated to the new locations. Pre-tax restructuring expenses and asset impairments by segment for the 2021 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 3.7 $ — $ 0.8 $ 4.5 Health & Science Technologies 1.7 — — 1.7 Fire & Safety/Diversified Products 0.5 — — 0.5 Corporate/Other 2.6 — — 2.6 Total restructuring costs $ 8.5 $ — $ 0.8 $ 9.3 2020 Initiative During the year ended December 31, 2020, the Company incurred severance costs related to employee reductions and exit costs related to early lease terminations. In addition, in the fourth quarter of 2020, the Company consolidated certain facilities within the FMT segment, which resulted in an impairment charge of $2.5 million. The Company also relocated its corporate office, which resulted in an impairment charge of $0.6 million. Pre-tax restructuring expenses and asset impairments by segment for the 2020 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 2.9 $ 0.2 $ 2.5 $ 5.6 Health & Science Technologies 2.7 — — 2.7 Fire & Safety/Diversified Products 2.5 — — 2.5 Corporate/Other 0.4 — 0.6 1.0 Total restructuring costs $ 8.5 $ 0.2 $ 3.1 $ 11.8 2019 Initiative During the year ended December 31, 2019, the Company incurred severance costs related to employee reductions and exit costs related to early lease terminations. In addition, in the second quarter of 2019, the Company began to evaluate strategic alternatives for one of its businesses in the HST segment. Prior to making a final decision on the options that were presented for this business, the business was informed of the loss of its largest customer. As a result, the Company accelerated its restructuring activities for this business and a decision was made to wind down the business over time. This event required an interim impairment test be performed on the long-lived tangible and intangible assets of the business, which resulted in an impairment charge of $9.7 million. The Company also consolidated one of its facilities into the Optics Center of Excellence in Rochester, New York, which resulted in an impairment charge of $0.4 million related to a building right-of-use asset. Pre-tax restructuring expenses and asset impairments by segment for the 2019 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 2.9 $ — $ — $ 2.9 Health & Science Technologies 3.0 1.0 10.2 14.2 Fire & Safety/Diversified Products 1.3 — — 1.3 Corporate/Other 2.6 — — 2.6 Total restructuring costs $ 9.8 $ 1.0 $ 10.2 $ 21.0 Restructuring accruals reflected in Accrued expenses in the Company’s Consolidated Balance Sheets are as follows: Restructuring (In millions) Balance at January 1, 2020 $ 6.1 Restructuring expenses (1) 8.8 Payments, utilization and other (11.0) Balance at December 31, 2020 3.9 Restructuring expenses (2) 8.5 Payments, utilization and other (9.6) Balance at December 31, 2021 $ 2.8 (1) Excludes $2.9 million of asset impairments related to property, plant and equipment and right-of-use assets. (2) Excludes $0.8 million of asset impairments related to property, plant and equipment. |
Share-Based Compensation
Share-Based Compensation | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Share-Based Compensation | Share-Based Compensation The Company maintains two share-based compensation plans for executives, non-employee directors and certain key employees that authorize the granting of stock options, restricted stock, performance share units and other types of awards consistent with the purpose of the plans. The number of shares authorized for issuance under the Company’s plans as of December 31, 2021 totaled 15.6 million, of which 2.4 million shares were available for future issuance. The Company’s policy is to recognize compensation cost on a straight-line basis, assuming forfeitures, over the requisite service period for the entire award. The Company typically grants equity awards annually at its regularly scheduled first quarter meeting of the Board of Directors based on the recommendation from the Compensation Committee. Stock Options Stock options granted under the Company’s plans are generally non-qualified and are granted with an exercise price equal to the market price of the Company’s stock on the date of grant. The fair value of each option grant is estimated on the date of the grant using the Binomial lattice option pricing model (for options granted before March 2021) or the Black Scholes valuation model (for options granted after February 2021). The adoption of the Black Scholes model in 2021 was driven by a historical review of option exercise history, which more closely aligned with the methodology of the Black Scholes model. The majority of the options issued to employees vest ratably over four years, with vesting beginning one year from the date of grant, and generally expire 10 years from the date of grant. Weighted average option fair values and assumptions for the periods specified are as follows: Years Ended December 31, 2021 2020 2019 Weighted average fair value of grants $38.88 $34.22 $35.15 Dividend yield 1.01% 1.15% 1.18% Volatility 23.78% 22.04% 24.77% Risk-free interest rate 0.12% - 1.54% 1.39% - 1.66% 2.53% - 3.04% Expected life (in years) 5.70 5.80 5.87 The assumptions are as follows: • The Company estimated volatility using its historical share price performance over the contractual term of the option (for the Binomial lattice option pricing model) or over the expected life of the option (for the Black Scholes valuation model). • The Company uses historical data to estimate the expected life of the option. The expected life assumption for options granted before March 2021 is an output of the Binomial lattice option pricing model, which incorporates vesting provisions, rate of voluntary exercise and rate of post-vesting termination over the contractual life of the option to define expected employee behavior. The expected life assumption for options granted after March 2021 is based on IDEX’s own exercise and cancellation history, adjusted for current vesting schedules. • The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option (for the Binomial lattice option pricing model) or commensurate with the expected life of the option (for the Black Scholes valuation model). For options granted before March 2021, the Company presents the range of risk-free one-year forward rates, derived from the U.S. treasury yield curve, utilized in the Binomial lattice option pricing model. For options granted after March 2021, the Company presents the spot rate used in the Black Scholes valuation model. • The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the option. A summary of the Company’s stock option activity as of December 31, 2021, and changes during the year ended December 31, 2021 is presented as follows: Shares Weighted Weighted-Average Aggregate (Dollars in millions except weighted average price) Stock Options Outstanding at January 1, 2021 963,726 $ 125.70 6.94 $ 70.8 Granted 279,785 198.29 Exercised (186,897) 105.22 Forfeited/Expired (48,028) 168.36 Outstanding at December 31, 2021 1,008,586 $ 147.60 6.97 $ 89.5 Vested and expected to vest at December 31, 2021 967,228 $ 145.97 6.90 $ 87.4 Exercisable at December 31, 2021 444,057 $ 108.60 5.22 $ 56.7 The intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock as of the end of the period and the grant price. The total intrinsic value of options exercised in 2021, 2020 and 2019 was $21.4 million, $41.3 million and $49.5 million, respectively. In 2021, 2020 and 2019, cash received from options exercised was $19.7 million, $44.6 million and $38.8 million, respectively, while the actual tax benefit realized for the tax deductions from stock options exercised totaled $4.5 million, $8.7 million and $10.4 million, respectively. Total compensation cost for stock options is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.5 $ 0.5 $ 0.5 Selling, general and administrative expenses 8.0 7.6 8.7 Total expense before income taxes 8.5 8.1 9.2 Income tax benefit (0.8) (0.9) (1.2) Total expense after income taxes $ 7.7 $ 7.2 $ 8.0 As of December 31, 2021, there was $9.7 million of total unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.2 years. Restricted Stock Restricted stock awards generally cliff vest after three years for employees and non-employee directors. Unvested restricted stock carries dividend and voting rights and the sale of the shares is restricted prior to the date of vesting. Dividends are paid on restricted stock awards and their fair value is equal to the market price of the Company’s stock at the date of the grant. A summary of the Company’s restricted stock activity as of December 31, 2021, and changes during the year ending December 31, 2021 is as follows: Restricted Stock Shares Weighted-Average Unvested at January 1, 2021 111,300 $ 147.13 Granted 39,530 206.53 Vested (34,680) 140.73 Forfeited (8,675) 170.22 Unvested at December 31, 2021 107,475 $ 169.58 Total compensation cost for restricted stock is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.4 $ 0.3 $ 0.3 Selling, general and administrative expenses 5.1 3.9 4.5 Total expense before income taxes 5.5 4.2 4.8 Income tax benefit (1.1) (0.9) (0.9) Total expense after income taxes $ 4.4 $ 3.3 $ 3.9 As of December 31, 2021, there was $6.8 million of total unrecognized compensation cost related to restricted stock that is expected to be recognized over a weighted-average period of 1.0 year. Cash-Settled Restricted Stock The Company also maintains a cash-settled share based compensation plan for certain employees. Cash-settled restricted stock awards generally cliff vest after three years. Cash-settled restricted stock awards are recorded at fair value on a quarterly basis using the market price of the Company’s stock on the last day of the quarter. Dividend equivalents are paid on certain cash-settled restricted stock awards. A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2021, and changes during the year ending December 31, 2021 is as follows: Cash-Settled Restricted Stock Shares Weighted-Average Unvested at January 1, 2021 63,940 $ 199.20 Granted 22,385 198.85 Vested (22,921) 199.78 Forfeited (5,455) 236.32 Unvested at December 31, 2021 57,949 $ 236.32 Total compensation cost for cash-settled restricted stock is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.7 $ 0.9 $ 1.2 Selling, general and administrative expenses 4.3 3.7 4.1 Total expense before income taxes (1) 5.0 4.6 5.3 Income tax benefit (0.4) (0.4) (0.5) Total expense after income taxes $ 4.6 $ 4.2 $ 4.8 (1) The 2020 and 2019 amounts were previously included in Share-based compensation expense on the Consolidated Statements of Cash Flows. These amounts have been reclassified to Accrued expenses and Other-net such that the amounts presented in Share-based compensation expense on the Consolidated Statements of Cash Flows relate solely to non-cash awards for all years presented. There was no change to the reported amount of net cash flows provided by operating activities for either 2020 or 2019 as a result of the reclassification. At December 31, 2021 and 2020, the Company has accrued $5.9 million and $5.4 million, respectively, for cash-settled restricted stock in Accrued expenses in the Consolidated Balance Sheets and has accrued $2.8 million and $2.9 million, respectively, for cash-settled restricted stock in Other non-current liabilities in the Consolidated Balance Sheets. Performance Share Units Beginning in 2013, the Company granted performance share units to selected key employees that may be earned based on IDEX total shareholder return over the three-year period following the date of grant. Performance share units are expected to be made annually and are paid out at the end of a three th percentile of the peer group. Performance share units earn dividend equivalents for the award period, which will be paid to participants with the award payout at the end of the period based on the actual number of performance share units that are earned. Payments made at the end of the award period will be in the form of stock for performance share units and will be in cash for dividend equivalents. The Company’s performance share units are market condition awards, have been assessed at fair value on the date of grant using a Monte Carlo simulation model and are expensed ratably over the three-year term of the awards. The Company granted 29,020, 42,690 and 56,860 performance share units in 2021, 2020 and 2019, respectively. Weighted average performance share unit fair values and assumptions for the period specified are as follows: Years Ended December 31, 2021 2020 2019 Weighted average fair value of grants $247.49 $224.14 $207.26 Dividend yield —% —% —% Volatility 28.60% 19.50% 19.11% Risk-free interest rate 0.33% 1.30% 2.49% Expected life (in years) 2.93 2.94 2.83 The assumptions are as follows: • The Company estimated volatility using its historical share price performance over the remaining performance period as of the grant date. • The Company uses a Monte Carlo simulation model that uses an expected life commensurate with the performance period. As a result, the expected life of the performance share units was assumed to be the period from the grant date to the end of the performance period. • The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with a term commensurate with the remaining performance period. • Total Shareholder Return is determined assuming that dividends are reinvested in the issuing entity over the performance period, which is mathematically equivalent to utilizing a 0% dividend yield. A summary of the Company’s performance share unit activity as of December 31, 2021, and changes during the year ending December 31, 2021, is as follows: Performance Share Units Shares Weighted-Average Unvested at January 1, 2021 58,695 $ 218.16 Granted 29,020 247.49 Vested (29,840) 212.46 Forfeited (5,850) 212.44 Unvested at December 31, 2021 52,025 $ 236.75 Based on the Company’s relative total shareholder return rank during the three year period ended December 31, 2021, the Company achieved a 143% payout factor and issued 42,688 common shares in February 2022 for awards that vested in 2021. Total compensation cost for performance share units is as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ — $ — $ — Selling, general and administrative expenses 6.4 2.6 8.4 Total expense before income taxes 6.4 2.6 8.4 Income tax benefit (0.3) (0.2) (0.6) Total expense after income taxes $ 6.1 $ 2.4 $ 7.8 As of December 31, 2021, there was $4.7 million of total unrecognized compensation cost related to performance shares that is expected to be recognized over a weighted-average period of 0.8 years. |
Other Comprehensive (Loss) Inco
Other Comprehensive (Loss) Income | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Other Comprehensive Income (Loss) | Other Comprehensive (Loss) Income The components of Other comprehensive (loss) income are as follows: For the Year Ended December 31, 2021 For the Year Ended December 31, 2020 Pre-tax Tax Net of tax Pre-tax Tax Net of tax (In millions) Cumulative translation adjustment $ (75.6) $ — $ (75.6) $ 107.8 $ — $ 107.8 Pension and other postretirement adjustments Net gain (loss) arising during the year 12.0 (2.9) 9.1 (1.5) 0.1 (1.4) Amortization and settlement loss, net of 10.3 (2.4) 7.9 2.9 (0.1) 2.8 Pension and other postretirement adjustments 22.3 (5.3) 17.0 1.4 — 1.4 Reclassification adjustments for derivatives 3.3 (0.8) 2.5 6.0 (1.4) 4.6 Total other comprehensive (loss) income $ (50.0) $ (6.1) $ (56.1) $ 115.2 $ (1.4) $ 113.8 For the Year Ended December 31, 2019 Pre-tax Tax Net of tax (In millions) Cumulative translation adjustment $ 0.1 $ — $ 0.1 Pension and other postretirement adjustments Net (loss) gain arising during the year (7.4) 2.4 (5.0) Amortization/recognition of settlement loss 2.8 (0.9) 1.9 Pension and other postretirement adjustments (4.6) 1.5 (3.1) Reclassification adjustments for derivatives 6.3 (1.4) 4.9 Total other comprehensive income (loss) $ 1.8 $ 0.1 $ 1.9 The amounts reclassified from accumulated other comprehensive (loss) income to net income are summarized as follows: For the Year Ended December 31, 2021 2020 2019 Income Statement Caption (In millions) Pension and other postretirement plans: Amortization of service cost $ 1.8 $ 2.9 $ 2.9 Other expense - net Settlement loss recognized 10.5 — (0.1) Other expense - net Curtailment gain recognized (2.0) — — Other expense - net Total before tax 10.3 2.9 2.8 Provision for income taxes (2.4) (0.1) (0.9) Total net of tax $ 7.9 $ 2.8 $ 1.9 Derivatives: Reclassification adjustments $ 3.3 $ 6.0 $ 6.3 Interest expense, Other expense - net Total before tax 3.3 6.0 6.3 Provision for income taxes (0.8) (1.4) (1.4) Total net of tax $ 2.5 $ 4.6 $ 4.9 |
Retirement Benefits
Retirement Benefits | 12 Months Ended |
Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |
Retirement Benefits | Retirement BenefitsThe Company sponsors several qualified and nonqualified defined benefit and defined contribution pension plans as well as other post-retirement plans for its employees. The Company uses a measurement date of December 31 for its defined benefit pension plans and post-retirement medical plans. The Company employs the measurement date provisions of ASC 715, Compensation-Retirement Benefits , which require the measurement date of plan assets and liabilities to coincide with the sponsor’s year end. Effective September 30, 2019, the IDEX Corporation Retirement Plan (“Plan”), a U.S. defined benefit plan, was amended to freeze the accrual of retirement benefits for all participants. This action impacted fewer than 60 participants, as the Plan had been closed to new entrants as of December 31, 2004 and frozen as of December 31, 2005 for all but certain older, longer service participants. Subsequent to the freeze, termination of the Plan was approved in November 2019. In addition, the Company recorded a settlement charge of $0.7 million in Other expense - net in the Consolidated Statements of Income for the year ended December 31, 2019. Participants were notified in February 2020 and the Plan was terminated in May 2020. As a result of the termination, the settlement threshold was reached in early 2020 and the Company recorded a settlement charge of $0.9 million in Other expense - net in the Consolidated Statements of Income for the year ended December 31, 2020. The settlement also triggered the remeasurement of net periodic benefit cost resulting in a reduction of $1.0 million to Other expense - net in the Consolidated Statements of Income for the year ended December 31, 2020 as a result of significant decreases in discount rates and strong asset performance in 2020. During the year ended December 31, 2021, the Company settled its remaining obligations under the U.S. pension plan through a combination of lump-sum payments to eligible participants who elected them, and through the purchase of annuities from Legal and General, an A rated third-party insurer. The Company recognized a net loss of $9.7 million, which was recorded within Other expense - net. The net loss consisted of $10.7 million related to previously deferred pension related costs, partially offset by $1.0 million related to an increase in plan assets remaining after the settlement. As of December 31, 2021, the Plan had surplus plan assets of approximately $10.2 million, representing cash equivalents held in a trust. These plan assets are included in Other current assets on the Company’s Consolidated Balance Sheets and will be used to fund the Company’s other retirement benefit plans over the next twelve months. The following table provides a reconciliation of the changes in the benefit obligations and fair value of plan assets over the two-year period ended December 31, 2021 and a statement of the funded status at December 31 for both years. Pension Benefits Other Benefits 2021 2020 2021 2020 U.S. Non-U.S. U.S. Non-U.S. (In millions) CHANGE IN BENEFIT OBLIGATION Obligation at January 1 $ 94.0 $ 115.7 $ 95.9 $ 102.0 $ 24.2 $ 23.3 Service cost 0.1 2.0 0.1 2.2 0.7 0.6 Interest cost 0.3 0.7 1.3 1.1 0.4 0.6 Plan amendments — (0.5) 0.2 — — (2.9) Benefits paid (3.3) (3.0) (4.0) (2.6) (0.7) (0.7) Actuarial loss (gain) (1.9) (5.3) 6.5 7.3 (0.8) 3.2 Currency translation — (6.0) — 8.9 — 0.1 Settlements (78.6) — (6.0) (3.8) — — Curtailments — — — — (0.2) — Other — 0.7 — 0.6 — — Obligation at December 31 $ 10.6 $ 104.3 $ 94.0 $ 115.7 $ 23.6 $ 24.2 CHANGE IN PLAN ASSETS Fair value of plan assets at January 1 $ 100.0 $ 42.2 $ 93.4 $ 39.3 $ — $ — Actual return on plan assets (0.5) 4.2 16.2 3.6 — — Employer contributions 0.4 2.9 0.4 2.4 0.7 0.7 Benefits paid (3.3) (3.0) (4.0) (2.6) (0.7) (0.7) Currency translation — (0.9) — 2.7 — — Settlements (78.6) — (6.0) (3.8) — — Acquisition/Divestiture — — — — — — Other (1.0) 0.7 — 0.6 — — Fair value of plan assets at December 31 $ 17.0 $ 46.1 $ 100.0 $ 42.2 $ — $ — Funded status at December 31 $ 6.4 $ (58.2) $ 6.0 $ (73.5) $ (23.6) $ (24.2) COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS Other current assets $ 10.2 $ — $ — $ — $ — $ — Other noncurrent assets — 0.1 10.7 — — — Current liabilities (0.8) (1.5) (0.5) (1.5) (1.2) (1.0) Other noncurrent liabilities (3.0) (56.8) (4.2) (72.0) (22.4) (23.2) Net asset (liability) at December 31 $ 6.4 $ (58.2) $ 6.0 $ (73.5) $ (23.6) $ (24.2) The pension benefits actuarial gain in 2021 was primarily driven by the increase in the discount rates from 2020 to 2021. The U.S. actuarial gain was partially offset by an updated projection scale assumption. The non-U.S. actuarial gain was primarily driven by the increase in the discount rates, asset gains and the updated mortality assumptions in Switzerland. The other benefits actuarial gain in 2021 was primarily driven by the increase in the discount rates from 2020 to 2021 and gains from updated participant data, partially offset by updated claims and contributions experience. The accumulated benefit obligation (“ABO”) for all defined benefit pension plans was $110.7 million and $204.4 million at December 31, 2021 and 2020, respectively. The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Other Benefits 2021 2020 2021 2020 2021 2020 Discount rate 2.52 % 2.14 % 1.25 % 0.95 % 2.70 % 2.20 % Rate of compensation increase — % — % 2.31 % 2.32 % — % — % Cash balance interest credit rate — % 4.00 % 1.00 % 1.00 % — % — % The pretax amounts recognized in Accumulated other comprehensive loss on the Consolidated Balance Sheets as of December 31, 2021 and 2020 were as follows: Pension Benefits Other Benefits 2021 2020 2021 2020 U.S. Non-U.S. U.S. Non-U.S. (In millions) Prior service cost (credit) $ 0.1 $ (0.5) $ 0.2 $ (0.1) $ (0.5) $ (2.9) Net loss (gain) 2.1 12.6 13.4 24.5 (3.0) (2.3) Total $ 2.2 $ 12.1 $ 13.6 $ 24.4 $ (3.5) $ (5.2) The components of the net periodic (benefit) cost for the plans in 2021, 2020 and 2019 are as follows: Pension Benefits 2021 2020 2019 U.S. Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In millions) Service cost $ 0.1 $ 2.0 $ 0.1 $ 2.2 $ 0.6 $ 1.8 Interest cost 0.3 0.7 1.3 1.1 2.8 1.5 Expected return on plan assets (0.9) (1.0) (3.8) (1.2) (3.3) (1.0) Settlement loss recognized 10.5 — 0.9 (0.4) 0.7 — Special termination benefit recognized — — — — 0.3 — Net amortization 0.4 2.1 1.2 1.7 1.6 1.1 Net periodic cost (benefit) $ 10.4 $ 3.8 $ (0.3) $ 3.4 $ 2.7 $ 3.4 Other Benefits 2021 2020 2019 (In millions) Service cost $ 0.7 $ 0.6 $ 0.6 Interest cost 0.4 0.6 0.8 Curtailment gain recognized (2.0) — — Net amortization (0.6) (0.5) (0.6) Net periodic (benefit) cost $ (1.5) $ 0.7 $ 0.8 The Company recognizes the service cost component in both Selling, general and administrative expenses and Cost of sales in the Consolidated Statements of Income depending on the functional area of the underlying employees included in the plans. The assumptions used in determining the net periodic cost (benefit) were as follows: U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Discount rate 2.14 % Various* 4.11%/2.99%** 0.95 % 1.33 % 2.07 % Expected return on plan assets 2.40 % 4.00 % 4.00 % 2.41 % 3.00 % 3.12 % Rate of compensation increase — % — % 4.00 % 2.32 % 2.29 % 2.13 % *For the IDEX Corporation Retirement Plan, a discount rate of 3.07% was used to determine the net periodic (benefit) cost for the period January 1, 2020 through March 31, 2020, a discount rate of 2.97% was used to determine the net periodic (benefit) cost for the period April 1, 2020 through June 30, 2020, a discount rate of 2.41% was used to determine the net periodic (benefit) cost for the period July 1, 2020 through September 30, 2020 and a discount rate of 2.36% was used to determine the net periodic (benefit) cost for the period October 1, 2020 through December 31, 2020 as a result of the quarterly remeasurements that occurred in conjunction with the termination of the Plan. For the Pulsafeeder, Inc. Pension Plan for Hourly Employees at Rochester, New York, a discount rate of 3.21% was used to determine the net periodic (benefit) cost for the period January 1, 2020 through June 30, 2020 and a discount rate of 2.62% was used to determine the net periodic (benefit) cost for the period July 1, 2020 through December 31, 2020 as a result of the remeasurement that occurred in conjunction with the ratification of the collective bargaining agreement. **A discount rate of 4.11% was used to determine the net periodic benefit cost for the period January 1, 2019 through August 31, 2019 and a discount rate of 2.99% was used to determine the net periodic benefit cost for the period September 1, 2019 through December 31, 2019 as a result of the remeasurement that occurred in conjunction with the decision to freeze the Plan. Other Benefits 2021 2020 2019 Discount rate 2.20 % 3.09 % 4.11 % Expected return on plan assets — % — % — % Rate of compensation increase — % 4.00 % 4.00 % The pretax change recognized in Accumulated other comprehensive loss on the Consolidated Balance Sheet in 2021 is as follows: Pension Benefits Other U.S. Non-U.S. (In millions) Net gain (loss) in current year $ 0.5 $ 8.5 $ 1.0 Prior service cost — 0.5 — Amortization of prior service cost (credit) 0.1 — (2.4) Amortization of net loss (gain) 10.8 2.1 (0.3) Exchange rate effect on amounts in other comprehensive income — 1.5 — Total $ 11.4 $ 12.6 $ (1.7) The discount rates for the Company’s plans are derived by matching the plan’s cash flows to a yield curve that provides the equivalent yields on zero-coupon bonds for each maturity. The discount rate selected is the rate that produces the same present value of cash flows. In selecting the expected rate of return on plan assets, the Company considers the historical returns and expected returns on plan assets. The expected returns are evaluated using asset return class, variance and correlation assumptions based on the plan’s target asset allocation and current market conditions. Prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10% of the greater of the benefit obligation or the market value of assets are amortized over the average remaining service period of active participants. Costs of defined contribution plans were $12.8 million, $12.5 million and $12.4 million for 2021, 2020 and 2019, respectively. The Company, through its subsidiaries, participates in certain multi-employer pension plans covering approximately 212 participants under U.S. collective bargaining agreements. None of these plans are considered individually significant to the Company as contributions to these plans totaled $1.0 million, $1.1 million, and $1.1 million for 2021, 2020 and 2019, respectively. For measurement purposes, a 5.45% weighted average annual rate of increase in the per capita cost of covered health care benefits was assumed for 2021. The rate was assumed to decrease gradually each year to a rate of 4.45% for 2040, and remain at that level thereafter. Plan Assets The Company’s pension plan weighted average asset allocations at December 31, 2021 and 2020, by asset category, were as follows: U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Equity securities 4 % 7 % 18 % 17 % Fixed income securities 33 % 65 % 22 % 24 % Cash/Commingled Funds/Other (1) 63 % 28 % 60 % 59 % Total 100 % 100 % 100 % 100 % The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2021 and 2020 is summarized as follows: Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2021 (In millions) Equity U.S. Large Cap $ 0.3 $ 0.3 $ — $ — U.S. Small / Mid Cap 4.6 — 4.6 — International 4.2 1.0 3.2 — Fixed Income U.S. Intermediate 1.9 — 1.9 — U.S. Long Term 5.4 — 5.4 — U.S. High Yield 0.7 — 0.7 — International 7.5 0.3 7.2 — Other Commingled Funds (1) 23.7 — — 23.7 Cash and Equivalents 12.1 11.0 1.1 — Other 2.7 — 2.7 — $ 63.1 $ 12.6 $ 26.8 $ 23.7 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2020 (In millions) Equity U.S. Large Cap $ 3.7 $ 3.7 $ — $ — U.S. Small / Mid Cap 0.4 — 0.4 — International 10.4 4.4 6.0 — Fixed Income U.S. Intermediate 14.3 — 14.3 — U.S. Long Term 51.9 — 51.9 — U.S. High Yield 0.3 — 0.3 — International 8.4 0.3 8.1 — Other Commingled Funds (1) 20.7 — — 20.7 Cash and Equivalents 28.5 27.8 0.7 — Other 3.5 — 3.5 — $ 142.1 $ 36.2 $ 85.2 $ 20.7 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. Equities that are valued using quoted prices are valued at the published market prices. Equities in a common collective trust or a registered investment company that are valued using significant other observable inputs are valued at the net asset value (“NAV”) provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund minus its liabilities. Fixed income securities that are valued using significant other observable inputs are valued at prices obtained from independent financial service industry-recognized vendors. Investment Policies and Strategies The investment objective of the U.S. plan, consistent with prudent standards for preservation of capital and maintenance of liquidity, is to earn the highest possible total rate of return consistent with the plan’s tolerance for risk. The general asset allocation guidelines for plan assets are that “equities” will constitute 10% and “fixed income” obligations, including cash, will constitute 90% of the market value of total fund assets. The investment objective of the UK plan, consistent with prudent standards for preservation of capital and maintenance of liquidity, is to earn a target return of UK Gilts plus approximately 3.1% per year. The general asset allocation guidelines for plan assets are that “equities” will constitute from 60% to 65% of the market value of total fund assets with a target of 62%, and “fixed income” obligations, including cash, will constitute from 35% to 40% with a target of 38%. The UK plan also has a framework in place such that if the funding position (which is monitored daily) improves to a certain level, the asset allocation will switch out of equities into fixed income assets in order to lower the level of risk of the investments. The term “equities” includes common stock, while the term “fixed income” includes obligations with contractual payments and a specific maturity date. The Company, through the use of a professional independent advisor, will monitor the asset allocation daily and maintain an asset allocation that closely replicates the designated targets. Diversification of assets is employed to ensure that adverse performance of one security or security class does not have an undue detrimental impact on the portfolio as a whole. Diversification is interpreted to include diversification by type, characteristic and number of investments as well as by investment style of designated investment fund managers. No restrictions are placed on the selection of individual investments by the investment fund managers. The total fund performance and the performance of the investment fund managers is reviewed on a regular basis using an appointed professional independent advisor. As of December 31, 2021, there were no shares of the Company’s stock held in plan assets. Cash Flows The Company expects to contribute approximately $4.0 million to its defined benefit plans and $1.2 million to its other postretirement benefit plans in 2022. The Company also expects to contribute approximately $15.1 million to its defined contribution plan and $10.2 million to its 401(k) savings plan in 2022 using both the $10.2 million of surplus plan assets described above and cash on hand. Estimated Future Benefit Payments The future estimated benefit payments for the next five years and the five years thereafter are as follows: 2022 — $6.4 million; 2023 — $6.0 million; 2024 — $6.0 million; 2025 — $6.3 million; 2026 — $6.3 million; 2027 to 2031 — $31.8 million. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events As previously announced, on November 23, 2021, the Company entered into a definitive agreement to acquire Nexsight, LLC and its businesses Envirosight, WinCan, MyTana and Pipeline Renewal Technologies (“Nexsight”) for cash consideration of $120.0 million, subject to customary post-closing adjustments. Nexsight is based in Randolph, New Jersey. Nexsight will complement and create synergies with the Company’s existing iPEK and ADS business units that design and create sewer crawlers, inspection and monitoring systems and software applications that allow teams to identify, anticipate and correct wastewater system issues remotely. Nexsight will be part of the Company’s Water reporting unit within the FMT segment. The Company expects to close the transaction by the end of the first quarter of 2022, subject to regulatory approval and customary closing conditions. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, allowance for credit losses, inventory valuation, recoverability of long-lived assets, valuation of goodwill and intangible assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions. |
Revenue Recognition | Revenue Recognition The Company accounts for a contract with a customer when it has approval from both parties, the rights and payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company determines the appropriate revenue recognition by analyzing the terms and conditions of the contract. Revenue is recognized when control of products or services is transferred to a customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring the products or providing the services. Control is transferred to customers when performance obligations within a contract are satisfied. A performance obligation is a promise to transfer a distinct product or service to a customer. For contracts that require complex design, manufacturing and installation activities, certain performance obligations may not be separately identifiable and, therefore, not distinct. As a result, the entire contract is accounted for as a single performance obligation. For contracts that include distinct products or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct products or services. Certain contracts have multiple performance obligations for which the Company allocates the transaction price to each performance obligation using an estimate of the standalone selling price of each distinct product or service and recognizes as revenue when, or as, the performance obligation is satisfied. For product sales, each product sold to a customer generally represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the standalone selling price. In certain cases, the Company may be required to estimate the standalone selling price using the expected cost plus margin approach, under which it forecasts the expected costs of satisfying a performance obligation and then adds an appropriate margin for the distinct product or service. The Company’s performance obligations are satisfied at either a point in time or over time as work progresses. Revenue recognized at a point in time is approximately 95% while revenue recognized over time is approximately 5%. For performance obligations satisfied at a point in time, generally revenue recognition occurs with the transfer of control of the asset, which is in line with shipping terms. For performance obligations satisfied over time, revenue is recognized as work is performed based on the relationship between actual costs incurred to date for each contract and the total estimated costs for such contract at completion of the performance obligation (i.e. the cost-to-cost method) or ratably over the contract term for service revenue. The Company defines service revenue as revenue from activities that are not associated with the design, development or manufacture of a product or the delivery of a software license. When accounting for over-time contracts, the Company uses an input measure to determine the extent of progress towards completion of the performance obligation. The Company believes this measure of progress best depicts the transfer of control to the customer which occurs as the Company incurs costs on its contracts. Incurred cost represents work performed, which corresponds with the transfer of control to the customer. Contract costs include labor, material and overhead. Contract estimates are based on various assumptions to project the outcome of future events. These assumptions include labor productivity and availability; the complexity of the work to be performed; the cost and availability of materials; the performance of subcontractors; and the availability and timing of funding from the customer. Revenues, including estimated fees or profits, are recorded proportionally as costs are incurred. As a significant change in one or more of these estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its estimates regularly. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised. Such revisions to costs and income are recognized in the period in which the revisions are determined as a cumulative catch-up adjustment. The impact of the adjustment on profit recorded to date on a contract is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, the Company recognizes provisions for estimated losses on incomplete contracts in the period in which such losses are determined. The Company records allowances for discounts and product returns at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties (primarily assurance-type) and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company. Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred. |
Advertising Costs | Advertising Costs Advertising costs of $10.7 million , $9.9 million and $15.7 million for 2021, 2020 and 2019, respectively, are expensed as incurred within Selling, general and administrative expenses. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of 3 months or less to be cash and cash equivalents. |
Marketable Securities | Marketable Securities The Company holds investments in marketable securities, which are recorded in Other current assets in the Consolidated Balance Sheets. These investments are recorded at fair value, with gains and losses, dividends and interest income included in Other expense - net in the Consolidated Statements of Income. See Note 9 |
Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at face amount less an allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts for expected losses as a result of customers’ inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time |
Inventories | Inventories The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor and overhead, is determined on a first in, first out basis. The Company makes adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolete, zero usage or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets A long-lived asset is reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below its carrying value, as measured by comparing its net book value to the projected undiscounted future cash flows generated by its use. A long-lived asset impairment exists when the carrying value of the asset exceeds its fair value. The amount and timing of the impairment charge for an asset requires the estimation of future cash flows to determine the fair value of the asset. An impaired asset is recorded at its estimated fair value based on a discounted cash flow analysis. Refer to Note 1 5 for further discussion on impairment of long-lived assets. |
Goodwill and Indefinite-Lived Intangible Assets | Goodwill and Indefinite-Lived Intangible Assets Accounting Standards Codification (“ASC”) 350, Goodwill and Other Intangible Assets , requires that the Company review the carrying value of goodwill and indefinite-lived intangible assets annually, or if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. The Company evaluates the recoverability of these assets as of October 31 based on the estimated fair value of each of the 13 reporting units and the indefinite-lived intangible assets. See Note 6 for further discussion on goodwill and indefinite-lived intangible assets. |
Borrowing Expenses | Borrowing Expenses Expenses incurred in securing and issuing debt are capitalized and included as a reduction of Long-term borrowings. These amounts are amortized over the life of the related borrowing and the related amortization is included in Interest expense in the Consolidated Statements of Income. |
Earnings per Common Share | Earnings per Common Share Diluted earnings per common share (“EPS”) attributable to IDEX is computed by dividing net income attributable to IDEX by the weighted average number of shares of common stock (basic) plus common stock equivalents outstanding (diluted) during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, restricted stock and performance share units. ASC 260, Earnings per Share , concludes that all outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding shares of restricted stock are participating securities. Accordingly, diluted EPS attributable to IDEX was computed using the two-class method prescribed by ASC 260. |
Share-Based Compensation | Share-Based Compensation The Company accounts for share-based payments in accordance with ASC 718, Compensation-Stock Compensation . Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 16 for further discussion on share-based compensation. |
Depreciation and Amortization | Depreciation and Amortization Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 2 to 10 years Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 15 years Trade names 5 to 20 years Customer relationships 9 to 20 years Unpatented technology 7 to 20 years |
Research and Development Expenditures | Research and Development Expenditures Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales. |
Foreign Currency Translation and Transaction | Foreign Currency Translation and TransactionThe functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date and the income statement amounts have been translated using the average monthly exchange rates for the year. Translation adjustments from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. Foreign currency transaction gains and losses from transactions denominated in a currency other than the functional currency of the subsidiary involved are reported within Other expense - net in the Consolidated Statements of Income. |
Income Taxes | Income TaxesIncome tax expense includes U.S., state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax bases of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and the manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. |
Concentration of Credit Risk | Concentration of Credit Risk The Company is not dependent on a single customer as its largest customer accounted for less than 3% of net sales for all years presented. |
Recently Adopted Accounting Standards and Recently Issued Accounting Standards | Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Simplifying the Accounting for Income Taxes , which eliminates the need to analyze whether the following apply in a given period (1) exception to the incremental approach for intraperiod tax allocation, (2) exceptions to accounting for basis differences when there are ownership changes in foreign investments and (3) exceptions in interim period income tax accounting for year-to-date losses that exceed anticipated losses. This ASU is also designed to improve the application of income tax-related guidance and simplify U.S. GAAP for (1) franchise taxes that are partially based on income, (2) transactions with a government that result in a step-up in the tax basis of goodwill, (3) separate financial statements of legal entities that are not subject to tax and (4) enacted changes in tax laws in interim periods. The Company adopted this standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. Recently Issued Accounting Standards In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which adds contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with revenue recognition guidance. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods therein. Early adoption is permitted. Entities should apply the ASU’s provisions prospectively to business combinations occurring on or after the effective date of the amendments. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10, Government Assistance (ASC 832): Disclosures by Business Entities about Government Assistance |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares | Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows: 2021 2020 2019 (In millions) Basic weighted average common shares outstanding 76.0 75.7 75.6 Dilutive effect of stock options, restricted stock and performance share units 0.4 0.7 0.9 Diluted weighted average common shares outstanding 76.4 76.4 76.5 |
Property and Equipment at Cost, Depreciation and Amortization Estimated Useful Lives | Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 2 to 10 years |
Schedule of Identifiable Intangible Assets, Useful Lives | Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 15 years Trade names 5 to 20 years Customer relationships 9 to 20 years Unpatented technology 7 to 20 years |
Acquisitions and Divestitures (
Acquisitions and Divestitures (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Allocation of Acquisition Costs To Assets Acquired and Liabilities Assumed | The preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 18.4 Property, plant and equipment 4.0 Goodwill 42.4 Intangible assets 46.0 Deferred income taxes 2.6 Other noncurrent assets 0.1 Total assets acquired 113.5 Current liabilities (7.1) Other noncurrent liabilities (0.1) Net assets acquired $ 106.3 The preliminary allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 45.3 Property, plant and equipment 4.8 Goodwill 267.6 Intangible assets 202.3 Other noncurrent assets 10.1 Total assets acquired 530.1 Current liabilities (10.1) Deferred income taxes (40.6) Other noncurrent liabilities (8.4) Net assets acquired $ 471.0 (In millions) Total Current assets, net of cash acquired $ 32.9 Property, plant and equipment 4.2 Goodwill 60.0 Intangible assets 53.0 Other noncurrent assets 1.3 Total assets acquired 151.4 Current liabilities (32.3) Deferred income taxes 2.5 Other noncurrent liabilities (0.4) Net assets acquired $ 121.2 The final allocation of the purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at the acquisition date, is as follows: (In millions) Total Current assets, net of cash acquired $ 20.2 Property, plant and equipment 1.7 Goodwill 86.6 Intangible assets 48.2 Other noncurrent assets 0.8 Total assets acquired 157.5 Current liabilities (7.6) Long-term borrowings (51.1) Deferred income taxes (11.1) Other noncurrent liabilities (0.5) Net assets acquired $ 87.2 |
Acquired Intangible Assets and Weighted Average Amortization Periods | The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 9.0 15 Customer relationships 30.0 13 Unpatented technology 7.0 11 Acquired intangible assets $ 46.0 The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 15.4 15 Customer relationships 162.9 13 Unpatented technology 24.0 11 Acquired intangible assets $ 202.3 The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 6.0 15 Customer relationships 31.5 10 Unpatented technology 15.5 20 Acquired intangible assets $ 53.0 Qualtek On November 23, 2020, the Company acquired Qualtek Manufacturing, Inc. (“Qualtek”), a manufacturer of high quality specialty metal components and parts by providing vertically integrated tool and die, metal stamping and metal finishing services. Headquartered in Colorado Springs, Colorado, Qualtek operates in the BAND-IT reporting unit within the FSDP segment. Qualtek was acquired for cash consideration of $1.9 million. The entire purchase price was funded with cash on hand. Goodwill recognized as part of this transaction was $1.1 million. The goodwill recorded for the acquisition reflects the strategic fit, revenue and earnings growth potential of this business. The goodwill is deductible for tax purposes. The Company finalized its allocation of the purchase price for the Qualtek acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. The acquired intangible assets and weighted average amortization periods are as follows: (In millions, except weighted average life) Total Weighted Average Life Trade names $ 7.1 15 Customer relationships 34.7 12 Unpatented technology 6.4 9 Acquired intangible assets $ 48.2 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Additional Financial Information Disclosure [Abstract] | |
Balance Sheet Components | December 31, 2021 2020 (In millions) RECEIVABLES Customers $ 354.9 $ 288.3 Other 8.7 10.9 Total 363.6 299.2 Less allowance for doubtful accounts 7.2 6.1 Total receivables - net $ 356.4 $ 293.1 INVENTORIES Raw materials and components parts $ 229.4 $ 173.2 Work in process 47.4 29.5 Finished goods 93.6 87.2 Total inventories $ 370.4 $ 289.9 PROPERTY, PLANT AND EQUIPMENT Land and improvements $ 39.1 $ 33.7 Buildings and improvements 197.9 192.4 Machinery, equipment and other 467.8 430.4 Office and transportation equipment 96.7 95.6 Construction in progress 30.5 28.7 Total 832.0 780.8 Less accumulated depreciation and amortization 504.7 482.5 Total property, plant and equipment - net $ 327.3 $ 298.3 ACCRUED EXPENSES Payroll and related items $ 91.5 $ 75.2 Management incentive compensation 25.0 15.8 Income taxes payable 17.9 13.4 Insurance 11.0 11.1 Warranty 7.6 7.4 Deferred revenue 49.0 28.4 Lease liability 17.6 16.7 Restructuring 2.8 3.9 Accrued interest 3.6 3.6 Pension and retiree medical obligations 3.5 3.0 Other 30.3 30.3 Total accrued expenses $ 259.8 $ 208.8 OTHER NONCURRENT LIABILITIES Pension and retiree medical obligations $ 82.2 $ 99.4 Transition tax payable 14.1 14.2 Deferred revenue 32.2 30.4 Lease liability 93.4 94.3 Other 25.5 28.5 Total other noncurrent liabilities $ 247.4 $ 266.8 |
Accounts Receivable, Allowance for Credit Loss | The valuation and qualifying account activity for the years ended December 31, 2021 and 2020 is as follows: 2021 2020 (In millions) ALLOWANCE FOR DOUBTFUL ACCOUNTS Beginning balance January 1 $ 6.1 $ 6.3 Charged to costs and expenses, net of recoveries 1.5 — Utilization (0.9) (0.5) Other adjustments, including acquisitions and currency translation 0.5 0.3 Ending balance December 31 $ 7.2 $ 6.1 |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | Revenue by reporting unit for the years ended December 31, 2021, 2020 and 2019 was as follows: For the Year Ended December 31, 2021 2020 2019 (In millions) Pumps $ 345.1 $ 265.3 $ 331.1 Water (1) 255.3 225.3 239.9 Energy 169.0 200.0 164.8 Valves (1) 121.9 118.6 129.0 Agriculture 107.4 87.1 92.2 Intersegment elimination (0.7) (0.9) (0.5) Fluid & Metering Technologies 998.0 895.4 956.5 Scientific Fluidics & Optics 508.0 415.8 434.6 Sealing Solutions 264.2 207.6 200.5 Performance Pneumatic Technologies (2) 182.2 122.9 133.5 Material Processing Technologies 134.5 120.0 113.6 Micropump 32.9 29.7 32.2 Intersegment elimination (2.8) (2.6) (1.8) Health & Science Technologies 1,119.0 893.4 912.6 Fire & Safety 377.5 376.3 404.0 Dispensing 169.6 98.5 116.2 BAND-IT 100.8 88.1 106.6 Intersegment elimination (0.1) (0.1) (1.3) Fire & Safety/Diversified Products 647.8 562.8 625.5 Total net sales $ 2,764.8 $ 2,351.6 $ 2,494.6 (1) During the third quarter of 2021, the Company merged a business in the Water reporting unit with a business in the Valves reporting unit. Revenue for each reporting unit has been restated to reflect this change for all years presented. (2) This reporting unit was previously named Gast and was renamed Performance Pneumatic Technologies upon the acquisition of Airtech. Prior to 2021, amounts reflect only the Gast business. |
Schedule of External Net Sales Disaggregated by Geography | Revenue by geographical region for the years ended December 31, 2021, 2020 and 2019 was as follows: For the Year Ended December 31, 2021 FMT HST FSDP IDEX (In millions) U.S. $ 532.9 $ 489.7 $ 317.0 $ 1,339.6 North America, excluding U.S. 61.6 23.7 28.5 113.8 Europe 197.2 341.0 161.5 699.7 Asia 143.7 241.8 110.0 495.5 Other (1) 63.3 25.6 30.9 119.8 Intersegment elimination (0.7) (2.8) (0.1) (3.6) Total net sales $ 998.0 $ 1,119.0 $ 647.8 $ 2,764.8 For the Year Ended December 31, 2020 FMT HST FSDP IDEX (In millions) U.S. $ 505.8 $ 387.6 $ 269.9 $ 1,163.3 North America, excluding U.S. 52.8 21.3 23.2 97.3 Europe 174.9 249.8 149.2 573.9 Asia 109.1 221.2 94.2 424.5 Other (1) 53.7 16.1 26.4 96.2 Intersegment elimination (0.9) (2.6) (0.1) (3.6) Total net sales $ 895.4 $ 893.4 $ 562.8 $ 2,351.6 For the Year Ended December 31, 2019 FMT HST FSDP IDEX (In millions) U.S. $ 542.0 $ 411.7 $ 303.6 $ 1,257.3 North America, excluding U.S. 58.3 21.7 26.3 106.3 Europe 170.7 263.5 159.2 593.4 Asia 125.0 201.8 103.4 430.2 Other (1) 61.0 15.7 34.3 111.0 Intersegment elimination (0.5) (1.8) (1.3) (3.6) Total net sales $ 956.5 $ 912.6 $ 625.5 $ 2,494.6 (1) Other includes: South America, Middle East, Australia and Africa. |
Schedule of Contract with Customer, Asset and Liability | The composition of Customer receivables was as follows: December 31, 2021 December 31, 2020 (In millions) Billed receivables $ 344.0 $ 273.5 Unbilled receivables 10.9 14.8 Total customer receivables $ 354.9 $ 288.3 |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | The composition of Deferred revenue was as follows: December 31, 2021 December 31, 2020 (In millions) Deferred revenue - current $ 49.0 $ 28.4 Deferred revenue - noncurrent 32.2 30.4 Total deferred revenue $ 81.2 $ 58.8 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Changes in the Carrying Amount of Goodwill | The changes in the carrying amount of goodwill for 2021 and 2020, by reportable business segment, were as follows: FMT HST FSDP Total (In millions) Goodwill $ 599.6 $ 981.6 $ 399.1 $ 1,980.3 Accumulated goodwill impairment losses (20.7) (149.8) (30.1) (200.6) Balance at January 1, 2020 578.9 831.8 369.0 1,779.7 Foreign currency translation 10.4 29.1 13.1 52.6 Acquisitions 60.4 — 1.1 61.5 Acquisition adjustments — 1.8 — 1.8 Balance at December 31, 2020 649.7 862.7 383.2 1,895.6 Foreign currency translation (10.7) (15.7) (11.0) (37.4) Acquisitions 42.4 267.6 — 310.0 Disposition of businesses — (0.1) — (0.1) Acquisition adjustments (0.4) — — (0.4) Balance at December 31, 2021 $ 681.0 $ 1,114.5 $ 372.2 $ 2,167.7 |
Schedule of Gross Carrying Value and Accumulated Amortization For Each Major Class of Intangible Asset | The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2021 and 2020: At December 31, 2021 At December 31, 2020 Gross Accumulated Net Weighted Gross Accumulated Net (In millions) (In millions) Amortized intangible assets: Patents $ 3.2 $ (2.0) $ 1.2 10 $ 3.0 $ (1.8) $ 1.2 Trade names 140.9 (72.4) 68.5 15 130.8 (72.7) 58.1 Customer relationships 495.9 (144.2) 351.7 13 318.4 (120.3) 198.1 Unpatented technology 143.8 (58.8) 85.0 13 122.3 (55.1) 67.2 Other — — — — 0.7 (0.6) 0.1 Total amortized intangible assets 783.8 (277.4) 506.4 575.2 (250.5) 324.7 Indefinite-lived intangible assets: Banjo trade name 62.1 — 62.1 62.1 — 62.1 Akron Brass trade name 28.8 — 28.8 28.8 — 28.8 Total intangible assets $ 874.7 $ (277.4) $ 597.3 $ 666.1 $ (250.5) $ 415.6 |
Borrowings (Tables)
Borrowings (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Borrowings | Borrowings at December 31, 2021 and 2020 consisted of the following: 2021 2020 (In millions) 4.20% Senior Notes, repaid in June 2021 $ — $ 350.0 3.20% Senior Notes, due June 2023 100.0 100.0 3.37% Senior Notes, due June 2025 100.0 100.0 3.00% Senior Notes, due May 2030 500.0 500.0 2.625% Senior Notes, due June 2031 500.0 — Other borrowings 0.1 0.2 Total borrowings 1,200.1 1,050.2 Less current portion — 0.1 Less deferred debt issuance costs 8.4 4.8 Less unaccreted debt discount 1.4 0.9 Long-term borrowings $ 1,190.3 $ 1,044.4 |
Schedule of Maturities of Borrowings | Total borrowings at December 31, 2021 have scheduled maturities as follows: (In millions) 2022 $ — 2023 100.0 2024 — 2025 100.1 2026 — Thereafter 1,000.0 Total borrowings $ 1,200.1 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Company's Financial Assets (Liabilities) at Fair Value on Recurring Basis | The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2021 and 2020: Basis of Fair Value Measurements Balance at December 31, 2021 Level 1 Level 2 Level 3 (In millions) Trading securities - mutual funds held in nonqualified SERP (1) $ 11.6 $ 11.6 $ — $ — Available-for-sale securities - equities (2) 45.3 45.3 — — Basis of Fair Value Measurements Balance at December 31, 2020 Level 1 Level 2 Level 3 (In millions) Trading securities - mutual funds held in nonqualified SERP (1) $ 13.6 $ 13.6 $ — $ — (1) The Supplemental Executive Retirement Plan (“SERP”) investment assets are offset by a SERP liability which represents the Company’s obligation to distribute SERP funds to participants. (2) At December 31, 2021, t |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Lessee Disclosure [Abstract] | |
Supplemental Balance Sheet Disclosures | Supplemental balance sheet information related to leases as of December 31, 2021 and 2020 was as follows: Balance Sheet Caption December 31, 2021 December 31, 2020 (In millions) Operating leases: Building right-of-use assets - net Other noncurrent assets $ 101.0 $ 100.8 Equipment right-of-use assets - net Other noncurrent assets 6.2 5.8 Total right-of-use assets - net $ 107.2 $ 106.6 Operating leases: Current lease liabilities Accrued expenses $ 17.6 $ 16.7 Noncurrent lease liabilities Other noncurrent liabilities 93.4 94.3 Total lease liabilities $ 111.0 $ 111.0 |
Schedule of Lease, Cost | The components of lease cost for the years ended December 31, 2021, 2020 and 2019 were as follows: 2021 2020 2019 (In millions) Operating lease cost (1) $ 31.5 $ 29.5 $ 23.0 Variable lease cost 2.3 1.9 2.3 Total lease expense $ 33.8 $ 31.4 $ 25.3 (1) Includes short-term leases, which are immaterial. |
Schedule of Cash Flow, Supplemental Disclosures | Supplemental cash flow information related to leases for the years ended December 31, 2021, 2020 and 2019 was as follows: 2021 2020 2019 (In millions) Cash paid for amounts included in the measurement of operating lease liabilities $ 31.2 $ 28.7 $ 22.9 Right-of-use assets obtained in exchange for new operating lease liabilities 16.0 40.4 25.9 Other supplemental information related to leases as of December 31, 2021 and 2020 was as follows: Lease Term and Discount Rate December 31, 2021 December 31, 2020 Weighted-average remaining lease term (years): Operating leases - building and equipment 8.50 9.43 Operating leases - vehicles 2.34 2.01 Weighted-average discount rate: Operating leases - building and equipment 3.27 % 3.51 % Operating leases - vehicles 1.08 % 2.05 % |
Schedule of Operating Lease, Liability, Maturity | Total lease liabilities at December 31, 2021 have scheduled maturities as follows: Maturity of Lease Liabilities Operating Leases (In millions) 2022 $ 20.1 2023 18.3 2024 15.6 2025 13.3 2026 12.0 Thereafter 48.3 Total lease payments 127.6 Less: Imputed interest (16.6) Present value of lease liabilities $ 111.0 Total lease liabilities at December 31, 2020 had scheduled maturities as follows: Maturity of Lease Liabilities Operating Leases (In millions) 2021 $ 19.7 2022 17.0 2023 13.7 2024 11.7 2025 11.1 Thereafter 57.6 Total lease payments $ 130.8 Less: Imputed interest $ (19.8) Present value of lease liabilities $ 111.0 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Roll Forward of the Warranty Reserve | A rollforward of the warranty reserve is as follows: 2021 2020 2019 (In millions) Beginning balance at January 1 $ 7.4 $ 5.6 $ 5.3 Provision for warranties 3.4 3.0 3.4 Claim settlements (3.8) (2.7) (3.1) Other adjustments, including acquisitions, divestitures and currency translation 0.6 1.5 — Ending balance at December 31 $ 7.6 $ 7.4 $ 5.6 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Before Income Tax | Pretax income for 2021, 2020 and 2019 was taxed in the following jurisdictions: 2021 2020 2019 (In millions) U.S. $ 350.2 $ 296.3 $ 377.2 Foreign 229.6 174.0 155.7 Total $ 579.8 $ 470.3 $ 532.9 |
Schedule of Components of Income Tax | The provision (benefit) for income taxes for 2021, 2020 and 2019 was as follows: 2021 2020 2019 (In millions) Current U.S. $ 64.7 $ 29.5 $ 49.8 State and local 11.0 4.6 9.1 Foreign 60.9 50.2 41.9 Total current 136.6 84.3 100.8 Deferred U.S. (4.1) 10.1 10.1 State and local (1.4) 1.5 (0.1) Foreign (0.6) (3.4) (3.4) Total deferred (6.1) 8.2 6.6 Total provision for income taxes $ 130.5 $ 92.5 $ 107.4 |
Schedule of Deferred Tax Assets and Liabilities | Deferred tax assets (liabilities) at December 31, 2021 and 2020 were: 2021 2020 (In millions) Employee and retiree benefit plans $ 23.6 $ 26.9 Capital loss and other carryforwards 11.9 16.3 Operating lease assets 25.7 24.7 Operating lease liabilities (24.8) (23.9) Depreciation and amortization (222.0) (189.0) Inventories 11.7 8.8 Allowances and accruals 10.3 7.3 Interest rate exchange agreement — 0.7 Other (16.6) (16.9) Total gross deferred tax (liabilities) (180.2) (145.1) Valuation allowance (11.9) (16.3) Total deferred tax (liabilities), net of valuation allowances $ (192.1) $ (161.4) |
Schedule of Deferred Tax Assets (Liabilities) Recognized In Balance Sheets | The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2021 and 2020 were: 2021 2020 (In millions) Noncurrent deferred tax asset - Other noncurrent assets $ 4.3 $ 2.5 Noncurrent deferred tax liabilities - Deferred income taxes (196.4) (163.9) Net deferred tax liabilities $ (192.1) $ (161.4) |
Schedule of Effective Income Tax Rate Reconciliation | The provision for income taxes differs from the amount calculated by applying the statutory federal income tax rate to pretax income. The calculated amount and the differences for 2021, 2020 and 2019 are shown in the following table: 2021 2020 2019 (In millions) Pretax income $ 579.8 $ 470.3 $ 532.9 Provision for income taxes: Computed amount at statutory rate of 21% $ 121.8 21.0 % $ 98.8 21.0 % $ 111.9 21.0 % State and local income tax (net of federal tax benefit) 8.0 1.4 % 5.9 1.3 % 8.2 1.5 % Taxes on non-U.S. earnings-net of foreign tax credits 9.2 1.6 % 8.4 1.8 % 6.3 1.2 % Global Intangible Low-Taxed Income 0.4 0.1 % (2.7) (0.6 %) 2.3 0.4 % Foreign-Derived Intangible Income Deduction (7.5) (1.3 %) (4.9) (1.0 %) (5.8) (1.1 %) Share-based payments (3.5) (0.6 %) (9.8) (2.1 %) (11.0) (2.1 %) Other 2.1 0.3 % (3.2) (0.7 %) (4.5) (0.7 %) Total provision for income taxes $ 130.5 22.5 % $ 92.5 19.7 % $ 107.4 20.2 % |
Schedule of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2021, 2020 and 2019 is as follows: 2021 2020 2019 (In millions) Beginning balance January 1 $ 1.1 $ 3.7 $ 4.1 Gross increases for tax positions of prior years 0.1 — — Gross decreases for tax positions of prior years (0.3) — — Settlements (0.2) (2.6) (0.1) Lapse of statute of limitations (0.6) — (0.3) Ending balance December 31 $ 0.1 $ 1.1 $ 3.7 |
Business Segments and Geograp_2
Business Segments and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Information on Company's Business Segments | Information on the Company’s business segments is presented below based on the nature of the products and services offered. The Company evaluates performance based on several factors, of which sales, operating income and operating margin are the primary financial measures. Intersegment sales are accounted for at fair value as if the sales were to third parties. 2021 2020 2019 (In millions) NET SALES Fluid & Metering Technologies External customers $ 998.0 $ 895.4 $ 956.5 Intersegment sales 0.7 0.9 0.5 Total segment sales 998.7 896.3 957.0 Health & Science Technologies External customers 1,119.0 893.4 912.6 Intersegment sales 2.8 2.6 1.8 Total segment sales 1,121.8 896.0 914.4 Fire & Safety/Diversified Products External customers 647.8 562.8 625.5 Intersegment sales 0.1 0.1 1.3 Total segment sales 647.9 562.9 626.8 Intersegment eliminations (3.6) (3.6) (3.6) Total net sales $ 2,764.8 $ 2,351.6 $ 2,494.6 OPERATING INCOME (LOSS) (1) Fluid & Metering Technologies $ 259.3 $ 235.0 $ 285.2 Health & Science Technologies 288.9 206.4 200.2 Fire & Safety/Diversified Products 169.3 144.2 165.3 Corporate office and other (80.5) (64.9) (71.7) Total operating income 637.0 520.7 579.0 Interest expense 41.0 44.8 44.3 Other expense - net 16.2 5.6 1.8 Income before income taxes $ 579.8 $ 470.3 $ 532.9 2021 2020 2019 (In millions) ASSETS Fluid & Metering Technologies $ 1,458.8 $ 1,387.0 $ 1,150.7 Health & Science Technologies 2,138.3 1,576.1 1,507.1 Fire & Safety/Diversified Products 892.5 891.9 825.4 Corporate office and other 427.6 559.4 330.7 Total assets $ 4,917.2 $ 4,414.4 $ 3,813.9 DEPRECIATION AND AMORTIZATION (2) Fluid & Metering Technologies $ 30.5 $ 25.9 $ 22.2 Health & Science Technologies 56.7 41.8 39.7 Fire & Safety/Diversified Products 15.3 15.2 14.3 Corporate office and other 0.5 0.6 0.7 Total depreciation and amortization $ 103.0 $ 83.5 $ 76.9 CAPITAL EXPENDITURES Fluid & Metering Technologies $ 21.0 $ 11.9 $ 17.3 Health & Science Technologies 41.5 27.7 22.0 Fire & Safety/Diversified Products 9.5 8.9 9.8 Corporate office and other 0.7 3.1 1.8 Total capital expenditures $ 72.7 $ 51.6 $ 50.9 (1) Segment operating income (loss) excludes net unallocated corporate operating expenses. (2) Excludes amortization of debt issuance expenses. |
Schedule of Sales From External Customers and Long-Lived Assets | Information about the Company’s long-lived assets in different geographical regions for the years ended December 31, 2021, 2020 and 2019 is shown below. 2021 2020 2019 (In millions) LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT U.S. $ 188.3 $ 169.2 $ 165.7 North America, excluding U.S. 5.4 5.0 3.8 Europe 98.9 100.0 88.1 Asia 34.5 24.0 22.5 Other 0.2 0.1 0.2 Total long-lived assets - net $ 327.3 $ 298.3 $ 280.3 |
Restructuring Expenses and As_2
Restructuring Expenses and Asset Impairments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Restructuring Costs and Asset Impairment Charges [Abstract] | |
Schedule of Pre-Tax Restructuring Expenses by Segment | Pre-tax restructuring expenses and asset impairments by segment for the 2021 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 3.7 $ — $ 0.8 $ 4.5 Health & Science Technologies 1.7 — — 1.7 Fire & Safety/Diversified Products 0.5 — — 0.5 Corporate/Other 2.6 — — 2.6 Total restructuring costs $ 8.5 $ — $ 0.8 $ 9.3 Pre-tax restructuring expenses and asset impairments by segment for the 2020 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 2.9 $ 0.2 $ 2.5 $ 5.6 Health & Science Technologies 2.7 — — 2.7 Fire & Safety/Diversified Products 2.5 — — 2.5 Corporate/Other 0.4 — 0.6 1.0 Total restructuring costs $ 8.5 $ 0.2 $ 3.1 $ 11.8 Pre-tax restructuring expenses and asset impairments by segment for the 2019 initiative were as follows: Severance Costs Exit Costs Asset Impairments Total (In millions) Fluid & Metering Technologies $ 2.9 $ — $ — $ 2.9 Health & Science Technologies 3.0 1.0 10.2 14.2 Fire & Safety/Diversified Products 1.3 — — 1.3 Corporate/Other 2.6 — — 2.6 Total restructuring costs $ 9.8 $ 1.0 $ 10.2 $ 21.0 |
Schedule of Restructuring Accruals Expenses | Restructuring accruals reflected in Accrued expenses in the Company’s Consolidated Balance Sheets are as follows: Restructuring (In millions) Balance at January 1, 2020 $ 6.1 Restructuring expenses (1) 8.8 Payments, utilization and other (11.0) Balance at December 31, 2020 3.9 Restructuring expenses (2) 8.5 Payments, utilization and other (9.6) Balance at December 31, 2021 $ 2.8 (1) Excludes $2.9 million of asset impairments related to property, plant and equipment and right-of-use assets. (2) Excludes $0.8 million of asset impairments related to property, plant and equipment. |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Weighted Average Option Fair Values and Assumptions | Weighted average option fair values and assumptions for the periods specified are as follows: Years Ended December 31, 2021 2020 2019 Weighted average fair value of grants $38.88 $34.22 $35.15 Dividend yield 1.01% 1.15% 1.18% Volatility 23.78% 22.04% 24.77% Risk-free interest rate 0.12% - 1.54% 1.39% - 1.66% 2.53% - 3.04% Expected life (in years) 5.70 5.80 5.87 |
Schedule of Stock Option Activity | A summary of the Company’s stock option activity as of December 31, 2021, and changes during the year ended December 31, 2021 is presented as follows: Shares Weighted Weighted-Average Aggregate (Dollars in millions except weighted average price) Stock Options Outstanding at January 1, 2021 963,726 $ 125.70 6.94 $ 70.8 Granted 279,785 198.29 Exercised (186,897) 105.22 Forfeited/Expired (48,028) 168.36 Outstanding at December 31, 2021 1,008,586 $ 147.60 6.97 $ 89.5 Vested and expected to vest at December 31, 2021 967,228 $ 145.97 6.90 $ 87.4 Exercisable at December 31, 2021 444,057 $ 108.60 5.22 $ 56.7 |
Schedule of Compensation Cost for Stock Options | Total compensation cost for stock options is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.5 $ 0.5 $ 0.5 Selling, general and administrative expenses 8.0 7.6 8.7 Total expense before income taxes 8.5 8.1 9.2 Income tax benefit (0.8) (0.9) (1.2) Total expense after income taxes $ 7.7 $ 7.2 $ 8.0 |
Schedule of Restricted Stock Activity | A summary of the Company’s restricted stock activity as of December 31, 2021, and changes during the year ending December 31, 2021 is as follows: Restricted Stock Shares Weighted-Average Unvested at January 1, 2021 111,300 $ 147.13 Granted 39,530 206.53 Vested (34,680) 140.73 Forfeited (8,675) 170.22 Unvested at December 31, 2021 107,475 $ 169.58 |
Schedule of Compensation Cost for Restricted Stock | Total compensation cost for restricted stock is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.4 $ 0.3 $ 0.3 Selling, general and administrative expenses 5.1 3.9 4.5 Total expense before income taxes 5.5 4.2 4.8 Income tax benefit (1.1) (0.9) (0.9) Total expense after income taxes $ 4.4 $ 3.3 $ 3.9 |
Schedule of Unvested Cash-settled Restricted Stock Activity | A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2021, and changes during the year ending December 31, 2021 is as follows: Cash-Settled Restricted Stock Shares Weighted-Average Unvested at January 1, 2021 63,940 $ 199.20 Granted 22,385 198.85 Vested (22,921) 199.78 Forfeited (5,455) 236.32 Unvested at December 31, 2021 57,949 $ 236.32 |
Schedule of Compensation Cost for Unvested Cash-settled Restricted Stock | Total compensation cost for cash-settled restricted stock is recorded in the Consolidated Statements of Income as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ 0.7 $ 0.9 $ 1.2 Selling, general and administrative expenses 4.3 3.7 4.1 Total expense before income taxes (1) 5.0 4.6 5.3 Income tax benefit (0.4) (0.4) (0.5) Total expense after income taxes $ 4.6 $ 4.2 $ 4.8 (1) The 2020 and 2019 amounts were previously included in Share-based compensation expense on the Consolidated Statements of Cash Flows. These amounts have been reclassified to Accrued expenses and Other-net such that the amounts presented in Share-based compensation expense on the Consolidated Statements of Cash Flows relate solely to non-cash awards for all years presented. There was no change to the reported amount of net cash flows provided by operating activities for either 2020 or 2019 as a result of the reclassification. |
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions | Weighted average performance share unit fair values and assumptions for the period specified are as follows: Years Ended December 31, 2021 2020 2019 Weighted average fair value of grants $247.49 $224.14 $207.26 Dividend yield —% —% —% Volatility 28.60% 19.50% 19.11% Risk-free interest rate 0.33% 1.30% 2.49% Expected life (in years) 2.93 2.94 2.83 |
Schedule of Performance Shares Units Activity | A summary of the Company’s performance share unit activity as of December 31, 2021, and changes during the year ending December 31, 2021, is as follows: Performance Share Units Shares Weighted-Average Unvested at January 1, 2021 58,695 $ 218.16 Granted 29,020 247.49 Vested (29,840) 212.46 Forfeited (5,850) 212.44 Unvested at December 31, 2021 52,025 $ 236.75 |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Total compensation cost for performance share units is as follows: Years Ended December 31, 2021 2020 2019 (In millions) Cost of goods sold $ — $ — $ — Selling, general and administrative expenses 6.4 2.6 8.4 Total expense before income taxes 6.4 2.6 8.4 Income tax benefit (0.3) (0.2) (0.6) Total expense after income taxes $ 6.1 $ 2.4 $ 7.8 |
Other Comprehensive (Loss) In_2
Other Comprehensive (Loss) Income (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The components of Other comprehensive (loss) income are as follows: For the Year Ended December 31, 2021 For the Year Ended December 31, 2020 Pre-tax Tax Net of tax Pre-tax Tax Net of tax (In millions) Cumulative translation adjustment $ (75.6) $ — $ (75.6) $ 107.8 $ — $ 107.8 Pension and other postretirement adjustments Net gain (loss) arising during the year 12.0 (2.9) 9.1 (1.5) 0.1 (1.4) Amortization and settlement loss, net of 10.3 (2.4) 7.9 2.9 (0.1) 2.8 Pension and other postretirement adjustments 22.3 (5.3) 17.0 1.4 — 1.4 Reclassification adjustments for derivatives 3.3 (0.8) 2.5 6.0 (1.4) 4.6 Total other comprehensive (loss) income $ (50.0) $ (6.1) $ (56.1) $ 115.2 $ (1.4) $ 113.8 For the Year Ended December 31, 2019 Pre-tax Tax Net of tax (In millions) Cumulative translation adjustment $ 0.1 $ — $ 0.1 Pension and other postretirement adjustments Net (loss) gain arising during the year (7.4) 2.4 (5.0) Amortization/recognition of settlement loss 2.8 (0.9) 1.9 Pension and other postretirement adjustments (4.6) 1.5 (3.1) Reclassification adjustments for derivatives 6.3 (1.4) 4.9 Total other comprehensive income (loss) $ 1.8 $ 0.1 $ 1.9 |
Reclassification out of Accumulated Other Comprehensive Income | mounts reclassified from accumulated other comprehensive (loss) income to net income are summarized as follows: For the Year Ended December 31, 2021 2020 2019 Income Statement Caption (In millions) Pension and other postretirement plans: Amortization of service cost $ 1.8 $ 2.9 $ 2.9 Other expense - net Settlement loss recognized 10.5 — (0.1) Other expense - net Curtailment gain recognized (2.0) — — Other expense - net Total before tax 10.3 2.9 2.8 Provision for income taxes (2.4) (0.1) (0.9) Total net of tax $ 7.9 $ 2.8 $ 1.9 Derivatives: Reclassification adjustments $ 3.3 $ 6.0 $ 6.3 Interest expense, Other expense - net Total before tax 3.3 6.0 6.3 Provision for income taxes (0.8) (1.4) (1.4) Total net of tax $ 2.5 $ 4.6 $ 4.9 |
Retirement Benefits (Tables)
Retirement Benefits (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |
Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets | The following table provides a reconciliation of the changes in the benefit obligations and fair value of plan assets over the two-year period ended December 31, 2021 and a statement of the funded status at December 31 for both years. Pension Benefits Other Benefits 2021 2020 2021 2020 U.S. Non-U.S. U.S. Non-U.S. (In millions) CHANGE IN BENEFIT OBLIGATION Obligation at January 1 $ 94.0 $ 115.7 $ 95.9 $ 102.0 $ 24.2 $ 23.3 Service cost 0.1 2.0 0.1 2.2 0.7 0.6 Interest cost 0.3 0.7 1.3 1.1 0.4 0.6 Plan amendments — (0.5) 0.2 — — (2.9) Benefits paid (3.3) (3.0) (4.0) (2.6) (0.7) (0.7) Actuarial loss (gain) (1.9) (5.3) 6.5 7.3 (0.8) 3.2 Currency translation — (6.0) — 8.9 — 0.1 Settlements (78.6) — (6.0) (3.8) — — Curtailments — — — — (0.2) — Other — 0.7 — 0.6 — — Obligation at December 31 $ 10.6 $ 104.3 $ 94.0 $ 115.7 $ 23.6 $ 24.2 CHANGE IN PLAN ASSETS Fair value of plan assets at January 1 $ 100.0 $ 42.2 $ 93.4 $ 39.3 $ — $ — Actual return on plan assets (0.5) 4.2 16.2 3.6 — — Employer contributions 0.4 2.9 0.4 2.4 0.7 0.7 Benefits paid (3.3) (3.0) (4.0) (2.6) (0.7) (0.7) Currency translation — (0.9) — 2.7 — — Settlements (78.6) — (6.0) (3.8) — — Acquisition/Divestiture — — — — — — Other (1.0) 0.7 — 0.6 — — Fair value of plan assets at December 31 $ 17.0 $ 46.1 $ 100.0 $ 42.2 $ — $ — Funded status at December 31 $ 6.4 $ (58.2) $ 6.0 $ (73.5) $ (23.6) $ (24.2) COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS Other current assets $ 10.2 $ — $ — $ — $ — $ — Other noncurrent assets — 0.1 10.7 — — — Current liabilities (0.8) (1.5) (0.5) (1.5) (1.2) (1.0) Other noncurrent liabilities (3.0) (56.8) (4.2) (72.0) (22.4) (23.2) Net asset (liability) at December 31 $ 6.4 $ (58.2) $ 6.0 $ (73.5) $ (23.6) $ (24.2) |
Weighted Average Assumptions Used in Measurement of Benefit Obligation | The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Other Benefits 2021 2020 2021 2020 2021 2020 Discount rate 2.52 % 2.14 % 1.25 % 0.95 % 2.70 % 2.20 % Rate of compensation increase — % — % 2.31 % 2.32 % — % — % Cash balance interest credit rate — % 4.00 % 1.00 % 1.00 % — % — % U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Discount rate 2.14 % Various* 4.11%/2.99%** 0.95 % 1.33 % 2.07 % Expected return on plan assets 2.40 % 4.00 % 4.00 % 2.41 % 3.00 % 3.12 % Rate of compensation increase — % — % 4.00 % 2.32 % 2.29 % 2.13 % *For the IDEX Corporation Retirement Plan, a discount rate of 3.07% was used to determine the net periodic (benefit) cost for the period January 1, 2020 through March 31, 2020, a discount rate of 2.97% was used to determine the net periodic (benefit) cost for the period April 1, 2020 through June 30, 2020, a discount rate of 2.41% was used to determine the net periodic (benefit) cost for the period July 1, 2020 through September 30, 2020 and a discount rate of 2.36% was used to determine the net periodic (benefit) cost for the period October 1, 2020 through December 31, 2020 as a result of the quarterly remeasurements that occurred in conjunction with the termination of the Plan. For the Pulsafeeder, Inc. Pension Plan for Hourly Employees at Rochester, New York, a discount rate of 3.21% was used to determine the net periodic (benefit) cost for the period January 1, 2020 through June 30, 2020 and a discount rate of 2.62% was used to determine the net periodic (benefit) cost for the period July 1, 2020 through December 31, 2020 as a result of the remeasurement that occurred in conjunction with the ratification of the collective bargaining agreement. **A discount rate of 4.11% was used to determine the net periodic benefit cost for the period January 1, 2019 through August 31, 2019 and a discount rate of 2.99% was used to determine the net periodic benefit cost for the period September 1, 2019 through December 31, 2019 as a result of the remeasurement that occurred in conjunction with the decision to freeze the Plan. Other Benefits 2021 2020 2019 Discount rate 2.20 % 3.09 % 4.11 % Expected return on plan assets — % — % — % Rate of compensation increase — % 4.00 % 4.00 % |
Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss) | The pretax amounts recognized in Accumulated other comprehensive loss on the Consolidated Balance Sheets as of December 31, 2021 and 2020 were as follows: Pension Benefits Other Benefits 2021 2020 2021 2020 U.S. Non-U.S. U.S. Non-U.S. (In millions) Prior service cost (credit) $ 0.1 $ (0.5) $ 0.2 $ (0.1) $ (0.5) $ (2.9) Net loss (gain) 2.1 12.6 13.4 24.5 (3.0) (2.3) Total $ 2.2 $ 12.1 $ 13.6 $ 24.4 $ (3.5) $ (5.2) The pretax change recognized in Accumulated other comprehensive loss on the Consolidated Balance Sheet in 2021 is as follows: Pension Benefits Other U.S. Non-U.S. (In millions) Net gain (loss) in current year $ 0.5 $ 8.5 $ 1.0 Prior service cost — 0.5 — Amortization of prior service cost (credit) 0.1 — (2.4) Amortization of net loss (gain) 10.8 2.1 (0.3) Exchange rate effect on amounts in other comprehensive income — 1.5 — Total $ 11.4 $ 12.6 $ (1.7) |
Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans | The components of the net periodic (benefit) cost for the plans in 2021, 2020 and 2019 are as follows: Pension Benefits 2021 2020 2019 U.S. Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In millions) Service cost $ 0.1 $ 2.0 $ 0.1 $ 2.2 $ 0.6 $ 1.8 Interest cost 0.3 0.7 1.3 1.1 2.8 1.5 Expected return on plan assets (0.9) (1.0) (3.8) (1.2) (3.3) (1.0) Settlement loss recognized 10.5 — 0.9 (0.4) 0.7 — Special termination benefit recognized — — — — 0.3 — Net amortization 0.4 2.1 1.2 1.7 1.6 1.1 Net periodic cost (benefit) $ 10.4 $ 3.8 $ (0.3) $ 3.4 $ 2.7 $ 3.4 Other Benefits 2021 2020 2019 (In millions) Service cost $ 0.7 $ 0.6 $ 0.6 Interest cost 0.4 0.6 0.8 Curtailment gain recognized (2.0) — — Net amortization (0.6) (0.5) (0.6) Net periodic (benefit) cost $ (1.5) $ 0.7 $ 0.8 The Company recognizes the service cost component in both Selling, general and administrative expenses and Cost of sales in the Consolidated Statements of Income depending on the functional area of the underlying employees included in the plans. |
Summary of Basis Used to Measure Defined Benefit Plans' Assets at Fair Value | The Company’s pension plan weighted average asset allocations at December 31, 2021 and 2020, by asset category, were as follows: U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Equity securities 4 % 7 % 18 % 17 % Fixed income securities 33 % 65 % 22 % 24 % Cash/Commingled Funds/Other (1) 63 % 28 % 60 % 59 % Total 100 % 100 % 100 % 100 % The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2021 and 2020 is summarized as follows: Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2021 (In millions) Equity U.S. Large Cap $ 0.3 $ 0.3 $ — $ — U.S. Small / Mid Cap 4.6 — 4.6 — International 4.2 1.0 3.2 — Fixed Income U.S. Intermediate 1.9 — 1.9 — U.S. Long Term 5.4 — 5.4 — U.S. High Yield 0.7 — 0.7 — International 7.5 0.3 7.2 — Other Commingled Funds (1) 23.7 — — 23.7 Cash and Equivalents 12.1 11.0 1.1 — Other 2.7 — 2.7 — $ 63.1 $ 12.6 $ 26.8 $ 23.7 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2020 (In millions) Equity U.S. Large Cap $ 3.7 $ 3.7 $ — $ — U.S. Small / Mid Cap 0.4 — 0.4 — International 10.4 4.4 6.0 — Fixed Income U.S. Intermediate 14.3 — 14.3 — U.S. Long Term 51.9 — 51.9 — U.S. High Yield 0.3 — 0.3 — International 8.4 0.3 8.1 — Other Commingled Funds (1) 20.7 — — 20.7 Cash and Equivalents 28.5 27.8 0.7 — Other 3.5 — 3.5 — $ 142.1 $ 36.2 $ 85.2 $ 20.7 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. |
Significant Accounting Polici_4
Significant Accounting Policies - Business (Details) | 12 Months Ended |
Dec. 31, 2021segment | |
Accounting Policies [Abstract] | |
Number of reportable segments | 3 |
Significant Accounting Polici_5
Significant Accounting Policies - Revenue Recogition (Details) - Revenue from Contract with Customer - Product Concentration Risk | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Transferred at Point in Time | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Percentage of concentration risk (less than) | 95.00% | 95.00% | 95.00% |
Transferred over Time | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Percentage of concentration risk (less than) | 5.00% | 5.00% | 5.00% |
Significant Accounting Polici_6
Significant Accounting Policies - Advertising Costs (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Advertising costs | $ 10.7 | $ 9.9 | $ 15.7 |
Significant Accounting Polici_7
Significant Accounting Policies - Goodwill and Indefinite-Lived Intangible Assets (Details) - unit | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Number of reporting units | 13 | 13 |
Significant Accounting Polici_8
Significant Accounting Policies - Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares Outstanding (Details) - shares shares in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Basic weighted average common shares outstanding (in shares) | 76 | 75.7 | 75.6 |
Dilutive effect of stock options, restricted stock and performance share units (in shares) | 0.4 | 0.7 | 0.9 |
Diluted weighted average common shares outstanding (in shares) | 76.4 | 76.4 | 76.5 |
Significant Accounting Polici_9
Significant Accounting Policies - Earnings per Common Share (Details) - shares shares in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Option to purchase common stock shares not included in the computation of diluted EPS (in shares) | 0.3 | 0.3 | 0.3 |
Significant Accounting Polic_10
Significant Accounting Policies - Property and Equipment at Cost Depreciation and Amortization Estimated Useful Lives (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Land improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 8 years |
Land improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 12 years |
Buildings and improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 8 years |
Buildings and improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 30 years |
Machinery, equipment and other | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 3 years |
Machinery, equipment and other | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 12 years |
Office and transportation equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 2 years |
Office and transportation equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 10 years |
Significant Accounting Polic_11
Significant Accounting Policies - Intangible Asset Depreciation and Amortization Estimated Useful Lives (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Patents | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 10 years |
Patents | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 5 years |
Patents | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 15 years |
Trade names | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 15 years |
Trade names | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 5 years |
Trade names | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Customer relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 13 years |
Customer relationships | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 9 years |
Customer relationships | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Unpatented technology | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 13 years |
Unpatented technology | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 7 years |
Unpatented technology | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Significant Accounting Polic_12
Significant Accounting Policies - Research and Development Expenditures (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Engineering expense | $ 82.9 | $ 82.3 | $ 92.4 |
Research and development expense | $ 50.1 | $ 48.2 | $ 56.4 |
Significant Accounting Polic_13
Significant Accounting Policies - Foreign Currency (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Foreign currency transaction (gain) loss | $ 1.1 | $ 3 | $ 3.3 |
Significant Accounting Polic_14
Significant Accounting Policies - Concentration of Credit Risk (Details) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Revenue from Contract with Customer | Customer Concentration Risk | Largest Customer | |||
Concentration Risk [Line Items] | |||
Percentage of concentration risk (less than) | 3.00% | 3.00% | 3.00% |
Acquisitions and Divestitures -
Acquisitions and Divestitures - Acquisitions (Details) - USD ($) $ in Thousands | Nov. 23, 2021 | Jun. 14, 2021 | Mar. 10, 2021 | Nov. 23, 2020 | Feb. 28, 2020 | Sep. 03, 2019 | Jul. 18, 2019 | Jul. 23, 2018 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Business Acquisition [Line Items] | |||||||||||
Goodwill | $ 2,167,700 | $ 1,895,600 | $ 1,779,700 | ||||||||
Debt acquired with acquisition of business | 0 | 0 | 51,100 | ||||||||
Selling, general and administrative expenses | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Acquisition-related transaction costs | 6,500 | 4,300 | 1,700 | ||||||||
Cost of goods sold | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Adjustment, inventory | $ 3,300 | ||||||||||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 106,300 | ||||||||||
Goodwill | 42,400 | ||||||||||
Intangible assets | $ 46,000 | ||||||||||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | Cost of goods sold | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Adjustment, inventory | 2,500 | ||||||||||
Airtech Group, Inc. (Airtech) | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 471,000 | ||||||||||
Goodwill | 267,600 | ||||||||||
Intangible assets | $ 202,300 | ||||||||||
Airtech Group, Inc. (Airtech) | Cost of goods sold | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Adjustment, inventory | $ 9,100 | ||||||||||
Nexsight, LLC | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 120,000 | ||||||||||
Qualtek | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 1,900 | ||||||||||
Goodwill | 1,100 | ||||||||||
Goodwill, expected tax deductible amount | $ 1,100 | ||||||||||
Qualtek | Cost of goods sold | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Adjustment, inventory | 100 | ||||||||||
Flow MD | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Goodwill | $ 60,000 | ||||||||||
Intangible assets | 53,000 | ||||||||||
Flow MD | Cost of goods sold | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Adjustment, inventory | $ 4,100 | ||||||||||
Velcora Holding AB | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 87,200 | ||||||||||
Goodwill | $ 86,600 | ||||||||||
Intangible assets | 48,200 | ||||||||||
Debt acquired with acquisition of business | $ 51,100 | ||||||||||
Gain (loss) on extinguishment of debt | $ (700) | ||||||||||
FLI | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Aggregate purchase price, cash paid | $ 121,200 |
Acquisitions and Divestitures_2
Acquisitions and Divestitures - Allocation of Acquisition Costs to Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Jun. 14, 2021 | Mar. 10, 2021 | Dec. 31, 2020 | Feb. 28, 2020 | Dec. 31, 2019 | Jul. 18, 2019 |
Business Acquisition [Line Items] | |||||||
Goodwill | $ 2,167,700 | $ 1,895,600 | $ 1,779,700 | ||||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | |||||||
Business Acquisition [Line Items] | |||||||
Current assets, net of cash acquired | $ 18,400 | ||||||
Property, plant and equipment | 4,000 | ||||||
Goodwill | 42,400 | ||||||
Intangible assets | 46,000 | ||||||
Deferred income taxes | 2,600 | ||||||
Other noncurrent assets | 100 | ||||||
Total assets acquired | 113,500 | ||||||
Current liabilities | (7,100) | ||||||
Other noncurrent liabilities | (100) | ||||||
Net assets acquired | $ 106,300 | ||||||
Airtech Group, Inc. (Airtech) | |||||||
Business Acquisition [Line Items] | |||||||
Current assets, net of cash acquired | $ 45,300 | ||||||
Property, plant and equipment | 4,800 | ||||||
Goodwill | 267,600 | ||||||
Intangible assets | 202,300 | ||||||
Other noncurrent assets | 10,100 | ||||||
Total assets acquired | 530,100 | ||||||
Current liabilities | (10,100) | ||||||
Deferred income taxes | (40,600) | ||||||
Other noncurrent liabilities | (8,400) | ||||||
Net assets acquired | $ 471,000 | ||||||
Flow MD | |||||||
Business Acquisition [Line Items] | |||||||
Current assets, net of cash acquired | $ 32,900 | ||||||
Property, plant and equipment | 4,200 | ||||||
Goodwill | 60,000 | ||||||
Intangible assets | 53,000 | ||||||
Other noncurrent assets | 1,300 | ||||||
Total assets acquired | 151,400 | ||||||
Current liabilities | (32,300) | ||||||
Deferred income taxes | 2,500 | ||||||
Other noncurrent liabilities | (400) | ||||||
Net assets acquired | $ 121,200 | ||||||
Velcora Holding AB | |||||||
Business Acquisition [Line Items] | |||||||
Current assets, net of cash acquired | $ 20,200 | ||||||
Property, plant and equipment | 1,700 | ||||||
Goodwill | 86,600 | ||||||
Intangible assets | 48,200 | ||||||
Other noncurrent assets | 800 | ||||||
Total assets acquired | 157,500 | ||||||
Current liabilities | (7,600) | ||||||
Long-term borrowings | (51,100) | ||||||
Deferred income taxes | (11,100) | ||||||
Other noncurrent liabilities | (500) | ||||||
Net assets acquired | $ 87,200 |
Acquisitions and Divestitures_3
Acquisitions and Divestitures - Acquired Intangible Assets and Weighted Average Amortization Periods (Details) - USD ($) $ in Millions | Jun. 14, 2021 | Mar. 10, 2021 | Feb. 28, 2020 | Jul. 18, 2019 |
Abel Pumps, L.P. and certain of its affiliates (ABEL) | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 46 | |||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | Trade names | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 9 | |||
Weighted Average Life | 15 years | |||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | Customer relationships | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 30 | |||
Weighted Average Life | 13 years | |||
Abel Pumps, L.P. and certain of its affiliates (ABEL) | Unpatented technology | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 7 | |||
Weighted Average Life | 11 years | |||
Airtech Group, Inc. (Airtech) | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 202.3 | |||
Airtech Group, Inc. (Airtech) | Trade names | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 15.4 | |||
Weighted Average Life | 15 years | |||
Airtech Group, Inc. (Airtech) | Customer relationships | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 162.9 | |||
Weighted Average Life | 13 years | |||
Airtech Group, Inc. (Airtech) | Unpatented technology | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 24 | |||
Weighted Average Life | 11 years | |||
Flow MD | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 53 | |||
Flow MD | Trade names | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 6 | |||
Weighted Average Life | 15 years | |||
Flow MD | Customer relationships | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 31.5 | |||
Weighted Average Life | 10 years | |||
Flow MD | Unpatented technology | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 15.5 | |||
Weighted Average Life | 20 years | |||
Velcora Holding AB | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 48.2 | |||
Velcora Holding AB | Trade names | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 7.1 | |||
Weighted Average Life | 15 years | |||
Velcora Holding AB | Customer relationships | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 34.7 | |||
Weighted Average Life | 12 years | |||
Velcora Holding AB | Unpatented technology | ||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||
Total | $ 6.4 | |||
Weighted Average Life | 9 years |
Acquisitions and Divestitures_4
Acquisitions and Divestitures - Divestitures (Details) - USD ($) $ in Millions | Mar. 12, 2021 | Dec. 28, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Income tax benefit | $ 130.5 | $ 92.5 | $ 107.4 | ||
CiDRA Precision Services | Disposed of by Sale | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Proceeds from sale of business | $ 1 | ||||
Gain (loss) on sale of businesses | 0.5 | ||||
Income tax benefit | $ 0.1 | ||||
Revenue | $ 0.9 | ||||
Avery Hardoll | Disposed of by Sale | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Proceeds from sale of business | $ 0.5 | ||||
Gain (loss) on sale of businesses | (0.4) | ||||
Income tax benefit | $ (0.3) | ||||
Revenue | $ 1.2 |
Collaborative Investments (Deta
Collaborative Investments (Details) - USD ($) | Jun. 29, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Net Investment Income [Line Items] | |||||
Contribution to joint venture | $ 100,000 | $ 600,000 | |||
Note receivable from collaborative partner | 4,200,000 | $ 0 | $ 0 | ||
Other Noncurrent Assets | |||||
Net Investment Income [Line Items] | |||||
Interest receivable | $ 100,000 | ||||
Convertible Promissory Note | |||||
Net Investment Income [Line Items] | |||||
Note receivable from collaborative partner | $ 4,200,000 | ||||
Account receivable, weighted average interest rate | 5.00% | ||||
Accounts receivable, allowance for credit loss | $ 0 | ||||
Elastomer Seals Joint Venture | |||||
Net Investment Income [Line Items] | |||||
Ownership percentage by parent | 55.00% | 55.00% | |||
Ownership percentage by noncontrolling owners | 45.00% | 45.00% | |||
Elastomer Seals Joint Venture Partner | |||||
Net Investment Income [Line Items] | |||||
Contribution to joint venture | $ 100,000 |
Balance Sheet Components - Comp
Balance Sheet Components - Components (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
RECEIVABLES | ||
Customers | $ 354.9 | $ 288.3 |
Other | 8.7 | 10.9 |
Total | 363.6 | 299.2 |
Less allowance for doubtful accounts | 7.2 | 6.1 |
Total receivables - net | 356.4 | 293.1 |
INVENTORIES | ||
Raw materials and components parts | 229.4 | 173.2 |
Work in process | 47.4 | 29.5 |
Finished goods | 93.6 | 87.2 |
Total inventories | 370.4 | 289.9 |
PROPERTY, PLANT AND EQUIPMENT | ||
Land and improvements | 39.1 | 33.7 |
Buildings and improvements | 197.9 | 192.4 |
Machinery, equipment and other | 467.8 | 430.4 |
Office and transportation equipment | 96.7 | 95.6 |
Construction in progress | 30.5 | 28.7 |
Total | 832 | 780.8 |
Less accumulated depreciation and amortization | 504.7 | 482.5 |
Total property, plant and equipment - net | 327.3 | 298.3 |
ACCRUED EXPENSES | ||
Payroll and related items | 91.5 | 75.2 |
Management incentive compensation | 25 | 15.8 |
Income taxes payable | 17.9 | 13.4 |
Insurance | 11 | 11.1 |
Warranty | 7.6 | 7.4 |
Deferred revenue | 49 | 28.4 |
Lease liability | 17.6 | 16.7 |
Restructuring | 2.8 | 3.9 |
Accrued interest | 3.6 | 3.6 |
Pension and retiree medical obligations | 3.5 | 3 |
Other | 30.3 | 30.3 |
Total accrued expenses | 259.8 | 208.8 |
OTHER NONCURRENT LIABILITIES | ||
Pension and retiree medical obligations | 82.2 | 99.4 |
Transition tax payable | 14.1 | 14.2 |
Deferred revenue | 32.2 | 30.4 |
Lease liability | 93.4 | 94.3 |
Other | 25.5 | 28.5 |
Total other noncurrent liabilities | $ 247.4 | $ 266.8 |
Balance Sheet Components - Valu
Balance Sheet Components - Valuation And Qualifying Accounts (Details) - ALLOWANCE FOR DOUBTFUL ACCOUNTS - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | ||
Beginning balance January 1 | $ 6.1 | $ 6.3 |
Charged to costs and expenses, net of recoveries | 1.5 | 0 |
Utilization | (0.9) | (0.5) |
Other adjustments, including acquisitions and currency translation | 0.5 | 0.3 |
Ending balance December 31 | $ 7.2 | $ 6.1 |
Revenue - Revenue by Reporting
Revenue - Revenue by Reporting Unit (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 2,764.8 | $ 2,351.6 | $ 2,494.6 |
Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (3.6) | (3.6) | (3.6) |
FMT | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 998 | 895.4 | 956.5 |
FMT | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (0.7) | (0.9) | (0.5) |
FMT | Pumps | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 345.1 | 265.3 | 331.1 |
FMT | Water | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 255.3 | 225.3 | 239.9 |
FMT | Energy | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 169 | 200 | 164.8 |
FMT | Valves | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 121.9 | 118.6 | 129 |
FMT | Agriculture | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 107.4 | 87.1 | 92.2 |
HST | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 1,119 | 893.4 | 912.6 |
HST | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (2.8) | (2.6) | (1.8) |
HST | Scientific Fluidics & Optics | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 508 | 415.8 | 434.6 |
HST | Sealing Solutions | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 264.2 | 207.6 | 200.5 |
HST | Performance Pneumatic Technologies | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 182.2 | 122.9 | 133.5 |
HST | Material Processing Technologies | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 134.5 | 120 | 113.6 |
HST | Micropump | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 32.9 | 29.7 | 32.2 |
FSDP | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 647.8 | 562.8 | 625.5 |
FSDP | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (0.1) | (0.1) | (1.3) |
FSDP | Fire & Safety | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 377.5 | 376.3 | 404 |
FSDP | Dispensing | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 169.6 | 98.5 | 116.2 |
FSDP | BAND-IT | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 100.8 | $ 88.1 | $ 106.6 |
Revenue - Revenue by Geography
Revenue - Revenue by Geography (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 2,764.8 | $ 2,351.6 | $ 2,494.6 |
Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (3.6) | (3.6) | (3.6) |
U.S. Plans | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 1,339.6 | 1,163.3 | 1,257.3 |
North America, excluding U.S. | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 113.8 | 97.3 | 106.3 |
Europe | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 699.7 | 573.9 | 593.4 |
Asia | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 495.5 | 424.5 | 430.2 |
Other | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 119.8 | 96.2 | 111 |
FMT | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 998 | 895.4 | 956.5 |
FMT | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (0.7) | (0.9) | (0.5) |
FMT | U.S. Plans | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 532.9 | 505.8 | 542 |
FMT | North America, excluding U.S. | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 61.6 | 52.8 | 58.3 |
FMT | Europe | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 197.2 | 174.9 | 170.7 |
FMT | Asia | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 143.7 | 109.1 | 125 |
FMT | Other | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 63.3 | 53.7 | 61 |
HST | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 1,119 | 893.4 | 912.6 |
HST | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (2.8) | (2.6) | (1.8) |
HST | U.S. Plans | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 489.7 | 387.6 | 411.7 |
HST | North America, excluding U.S. | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 23.7 | 21.3 | 21.7 |
HST | Europe | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 341 | 249.8 | 263.5 |
HST | Asia | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 241.8 | 221.2 | 201.8 |
HST | Other | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 25.6 | 16.1 | 15.7 |
FSDP | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 647.8 | 562.8 | 625.5 |
FSDP | Intersegment elimination | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | (0.1) | (0.1) | (1.3) |
FSDP | U.S. Plans | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 317 | 269.9 | 303.6 |
FSDP | North America, excluding U.S. | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 28.5 | 23.2 | 26.3 |
FSDP | Europe | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 161.5 | 149.2 | 159.2 |
FSDP | Asia | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 110 | 94.2 | 103.4 |
FSDP | Other | Operating Segments | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 30.9 | $ 26.4 | $ 34.3 |
Revenue - Receivables (Details)
Revenue - Receivables (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total customer receivables | $ 354.9 | $ 288.3 |
Unbilled receivables | 10.9 | 14.8 |
Billed receivables | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total customer receivables | $ 344 | $ 273.5 |
Revenue - Deferred Revenue (Det
Revenue - Deferred Revenue (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Revenue from Contract with Customer [Abstract] | ||
Deferred revenue - current | $ 49 | $ 28.4 |
Deferred revenue | 32.2 | 30.4 |
Total deferred revenue | $ 81.2 | $ 58.8 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - Revenue from Contract with Customer - Product Concentration Risk | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Transferred at Point in Time | |||
Disaggregation of Revenue [Line Items] | |||
Revenue from products and services transferred to customers | 95.00% | 95.00% | 95.00% |
Transferred over Time | |||
Disaggregation of Revenue [Line Items] | |||
Revenue from products and services transferred to customers | 5.00% | 5.00% | 5.00% |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | $ 1,980.3 | ||
Accumulated goodwill impairment losses | (200.6) | ||
Goodwill | |||
Beginning Balance | $ 1,895.6 | $ 1,779.7 | |
Foreign currency translation | (37.4) | 52.6 | |
Acquisitions | 310 | 61.5 | |
Disposition of businesses | (0.1) | ||
Acquisition adjustments | (0.4) | 1.8 | |
Ending Balance | 2,167.7 | 1,895.6 | |
FMT | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 599.6 | ||
Accumulated goodwill impairment losses | (20.7) | ||
Goodwill | |||
Beginning Balance | 649.7 | 578.9 | |
Foreign currency translation | (10.7) | 10.4 | |
Acquisitions | 42.4 | 60.4 | |
Disposition of businesses | 0 | ||
Acquisition adjustments | (0.4) | 0 | |
Ending Balance | 681 | 649.7 | |
HST | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 981.6 | ||
Accumulated goodwill impairment losses | (149.8) | ||
Goodwill | |||
Beginning Balance | 862.7 | 831.8 | |
Foreign currency translation | (15.7) | 29.1 | |
Acquisitions | 267.6 | 0 | |
Disposition of businesses | (0.1) | ||
Acquisition adjustments | 0 | 1.8 | |
Ending Balance | 1,114.5 | 862.7 | |
FSDP | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 399.1 | ||
Accumulated goodwill impairment losses | $ (30.1) | ||
Goodwill | |||
Beginning Balance | 383.2 | 369 | |
Foreign currency translation | (11) | 13.1 | |
Acquisitions | 0 | 1.1 | |
Disposition of businesses | 0 | ||
Acquisition adjustments | 0 | 0 | |
Ending Balance | $ 372.2 | $ 383.2 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Narrative (Details) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021USD ($)unit | Dec. 31, 2020USD ($)unit | Dec. 31, 2019USD ($) | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Number of reporting units | unit | 13 | 13 | |
Amortization of intangible assets | $ 56.4 | $ 41.8 | $ 37.3 |
Expected amortization expense, year one | 61.3 | ||
Expected amortization expense, year two | 58.1 | ||
Expected amortization expense, year three | 53.6 | ||
Expected amortization expense, year four | 52 | ||
Expected amortization expense, year five | $ 50.2 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Schedule of Gross Carrying Value and Accumulated Amortization for Each Major Class of Intangible Asset (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 783.8 | $ 575.2 |
Intangible assets - Gross Carrying Amount | 874.7 | 666.1 |
Accumulated Amortization | (277.4) | (250.5) |
Amortized intangible assets - Net | 506.4 | 324.7 |
Intangible assets - Net | 597.3 | 415.6 |
Banjo trade name | ||
Goodwill And Intangible Assets [Line Items] | ||
Indefinite lived intangible assets | 62.1 | 62.1 |
Akron Brass trade name | ||
Goodwill And Intangible Assets [Line Items] | ||
Indefinite lived intangible assets | 28.8 | 28.8 |
Patents | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | 3.2 | 3 |
Accumulated Amortization | (2) | (1.8) |
Amortized intangible assets - Net | $ 1.2 | 1.2 |
Amortized intangible assets - Weighted Average Life | 10 years | |
Trade names | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 140.9 | 130.8 |
Accumulated Amortization | (72.4) | (72.7) |
Amortized intangible assets - Net | $ 68.5 | 58.1 |
Amortized intangible assets - Weighted Average Life | 15 years | |
Customer relationships | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 495.9 | 318.4 |
Accumulated Amortization | (144.2) | (120.3) |
Amortized intangible assets - Net | $ 351.7 | 198.1 |
Amortized intangible assets - Weighted Average Life | 13 years | |
Unpatented technology | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 143.8 | 122.3 |
Accumulated Amortization | (58.8) | (55.1) |
Amortized intangible assets - Net | $ 85 | 67.2 |
Amortized intangible assets - Weighted Average Life | 13 years | |
Other | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 0 | 0.7 |
Accumulated Amortization | 0 | (0.6) |
Amortized intangible assets - Net | $ 0 | $ 0.1 |
Borrowings - Schedule of Borrow
Borrowings - Schedule of Borrowings (Details) - USD ($) | Dec. 31, 2021 | May 28, 2021 | Dec. 31, 2020 | Apr. 29, 2020 | Jun. 13, 2016 |
Debt Instrument [Line Items] | |||||
Total borrowings | $ 1,200,100,000 | $ 1,050,200,000 | |||
Less current portion | 0 | 100,000 | |||
Less deferred debt issuance costs | 8,400,000 | 4,800,000 | |||
Less unaccreted debt discount | 1,400,000 | 900,000 | |||
Long-term borrowings | $ 1,190,300,000 | 1,044,400,000 | |||
Senior Notes | 4.20% Senior Notes, repaid in June 2021 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 4.20% | ||||
Total borrowings | $ 0 | 350,000,000 | |||
Senior Notes | 3.20% Senior Notes, due June 2023 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 3.20% | 3.20% | |||
Total borrowings | $ 100,000,000 | 100,000,000 | |||
Senior Notes | 3.37% Senior Notes, due June 2025 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 3.37% | 3.37% | |||
Total borrowings | $ 100,000,000 | 100,000,000 | |||
Senior Notes | 3.00% Senior Notes, due May 2030 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 3.00% | ||||
Total borrowings | $ 500,000,000 | 500,000,000 | $ 500,000,000 | ||
Less unaccreted debt discount | $ 900,000 | ||||
Senior Notes | 2.625% Senior Notes, due 2031 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 2.625% | ||||
Less unaccreted debt discount | $ 600,000 | ||||
Long-term Debt | $ 500,000,000 | 0 | |||
Other Borrowings | |||||
Debt Instrument [Line Items] | |||||
Total borrowings | $ 100,000 | $ 200,000 |
Borrowings - Narrative (Details
Borrowings - Narrative (Details) | Jun. 16, 2021USD ($) | May 28, 2021USD ($) | May 17, 2021USD ($) | May 27, 2020USD ($) | Apr. 29, 2020USD ($) | Jun. 23, 2015USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | May 31, 2019USD ($) | Jun. 13, 2016USD ($) |
Line of Credit Facility [Line Items] | |||||||||||
Less unaccreted debt discount | $ 1,400,000 | $ 900,000 | |||||||||
Interest | 36,000,000 | 35,200,000 | $ 36,700,000 | ||||||||
Credit facility, term | 5 years | ||||||||||
Balance outstanding | $ 1,200,100,000 | 1,050,200,000 | |||||||||
For 12 Months in Connection with Certain Acquisitions | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Leverage ratio | 4 | ||||||||||
Line of Credit | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Current borrowing capacity | $ 700,000,000 | ||||||||||
Revolving facility, extension term | 1 year | ||||||||||
Revolving Credit Facility | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Current borrowing capacity | $ 800,000,000 | ||||||||||
Aggregate lending commitments | $ 400,000,000 | ||||||||||
Minimum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Required percent for prepayment amount of aggregate principal amount | 5.00% | ||||||||||
Minimum | Revolving Credit Facility | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Applicable leverage ratio | 0.00% | ||||||||||
Maximum | Revolving Credit Facility | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Applicable leverage ratio | 1.275% | ||||||||||
Revolving Credit Facility | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Balance outstanding | $ 0 | ||||||||||
Outstanding letters of credit | 7,200,000 | ||||||||||
Revolving facility, amount available to borrow | $ 792,800,000 | ||||||||||
Revolving Credit Facility | Minimum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Interest coverage ratio | 3 | ||||||||||
Revolving Credit Facility | Maximum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Leverage ratio | 3.50 | ||||||||||
Senior Notes | Maximum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Limitation of outstanding principal of higher preference debt as percent of consolidated assets | 15.00% | ||||||||||
Senior Notes | 4.20% Senior Notes, repaid in June 2021 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 4.20% | ||||||||||
Extinguishment of debt | $ 350,000,000 | $ 350,000,000 | |||||||||
Redemption premium | 6,700,000 | 6,700,000 | |||||||||
Amount to be recognized from hedged transactions within 12 months, approximate | $ 1,300,000 | ||||||||||
Write off of deferred debt issuance cost | 100,000 | ||||||||||
Write off of deferred debt remaining discount | 100,000 | ||||||||||
Write-off deferred taxes | $ 400,000 | ||||||||||
Gain (loss) on extinguishment of debt | $ 8,600,000 | ||||||||||
Balance outstanding | $ 0 | 350,000,000 | |||||||||
Senior Notes | 3.00% Senior Notes, due May 2030 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 3.00% | ||||||||||
Proceeds from debt | $ 494,400,000 | ||||||||||
Less unaccreted debt discount | 900,000 | ||||||||||
Underwriting commission | (3,300,000) | ||||||||||
Offering expenses | $ (1,400,000) | ||||||||||
Redemption price, percentage | 101.00% | ||||||||||
Balance outstanding | $ 500,000,000 | $ 500,000,000 | 500,000,000 | ||||||||
Senior Notes | 3.00% Senior Notes, due May 2030 | Minimum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Percent of outstanding amount owned for decision making | 25.00% | ||||||||||
Senior Notes | 2.625% Senior Notes, due 2031 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 2.625% | ||||||||||
Debt instrument face amount | 500,000,000 | ||||||||||
Proceeds from debt | 494,700,000 | ||||||||||
Less unaccreted debt discount | 600,000 | ||||||||||
Underwriting commission | 3,300,000 | ||||||||||
Offering expenses | $ 1,400,000 | ||||||||||
Redemption price, percentage | 101.00% | ||||||||||
Senior Notes | 2.625% Senior Notes, due 2031 | Minimum | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Percent of notes held | 25.00% | ||||||||||
Senior Notes | 3.20% Senior Notes, due June 2023 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 3.20% | 3.20% | |||||||||
Debt instrument face amount | $ 100,000,000 | ||||||||||
Balance outstanding | $ 100,000,000 | 100,000,000 | |||||||||
Senior Notes | 3.37% Senior Notes, due June 2025 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 3.37% | 3.37% | |||||||||
Debt instrument face amount | $ 100,000,000 | ||||||||||
Balance outstanding | $ 100,000,000 | 100,000,000 | |||||||||
Senior Notes | 4.50% Senior Notes, due December 2020 | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Stated interest rate | 4.50% | ||||||||||
Extinguishment of debt | $ 300,000,000 | $ 300,000,000 | |||||||||
Redemption premium | 6,800,000 | ||||||||||
Amount to be recognized from hedged transactions within 12 months, approximate | 1,400,000 | ||||||||||
Write off of deferred debt issuance cost | 100,000 | ||||||||||
Write off of deferred debt remaining discount | 100,000 | ||||||||||
Gain (loss) on extinguishment of debt | $ 8,400,000 | ||||||||||
Interest | $ 6,100,000 | ||||||||||
Letters of Credit | Line of Credit | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Current borrowing capacity | $ 75,000,000 | ||||||||||
Swing line Loans | Line of Credit | |||||||||||
Line of Credit Facility [Line Items] | |||||||||||
Current borrowing capacity | $ 50,000,000 |
Borrowings - Schedule of Maturi
Borrowings - Schedule of Maturities of Borrowings (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Disclosure [Abstract] | ||
2022 | $ 0 | |
2023 | 100 | |
2024 | 0 | |
2025 | 100.1 | |
2026 | 0 | |
Thereafter | 1,000 | |
Total borrowings | $ 1,200.1 | $ 1,050.2 |
Derivative Instruments (Details
Derivative Instruments (Details) $ in Millions | Jun. 16, 2021USD ($) | May 27, 2020USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2011USD ($)instrument |
Derivative [Line Items] | ||||||
Amortization of interest expense | $ 1.7 | $ 1.7 | $ 1.4 | |||
Non-cash interest expense associated with forward starting swaps | $ 3.3 | $ 6 | $ 6.3 | |||
Senior Notes | 4.50% Senior Notes, due December 2020 | ||||||
Derivative [Line Items] | ||||||
Interest rate on senior notes | 4.50% | |||||
Amount to be recognized from hedged transactions within 12 months, approximate | $ (1.4) | |||||
Senior Notes | 4.20% Senior Notes, repaid in June 2021 | ||||||
Derivative [Line Items] | ||||||
Interest rate on senior notes | 4.20% | |||||
Amount to be recognized from hedged transactions within 12 months, approximate | $ (1.3) | |||||
Interest Rate Contract | ||||||
Derivative [Line Items] | ||||||
Derivative, number of instruments held | instrument | 2 | |||||
Interest Rate Exchange Agreement Expiring Two Thousand Ten and Eleven | ||||||
Derivative [Line Items] | ||||||
Amortization of interest expense | $ 68.9 | |||||
Term of amortized interest expense, years | 10 years |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Company Financial Assets and Liabilities at Fair Value on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities - equities | $ 45.3 | |
Mutual Fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trading | 11.6 | $ 13.6 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities - equities | 45.3 | |
Level 1 | Mutual Fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trading | 11.6 | 13.6 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities - equities | 0 | |
Level 2 | Mutual Fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trading | 0 | 0 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities - equities | 0 | |
Level 3 | Mutual Fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trading | $ 0 | $ 0 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Transfers of assets between Level 1 and Level 2 | $ 0 | $ 0 |
Transfers of assets between Level 2 and Level 1 | 0 | 0 |
Transfers of liabilities between Level 1 and Level 2 | 0 | 0 |
Transfers of liabilities between Level 2 and Level 1 | 0 | 0 |
Estimate of Fair Value Measurement | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Carrying value of our revolving facility and senior debt | 1,219,900,000 | 1,127,600,000 |
Reported Value Measurement | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Carrying value of our revolving facility and senior debt | $ 1,198,700,000 | $ 1,049,300,000 |
Leases - Narrative (Details)
Leases - Narrative (Details) | Dec. 31, 2021option |
Leases [Abstract] | |
Options for renewal | 1 |
Leases - Balance Sheet Composit
Leases - Balance Sheet Composition (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Operating leases: | ||
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other noncurrent assets | Other noncurrent assets |
Operating lease, right-of-use asset | $ 107.2 | $ 106.6 |
Operating leases: | ||
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Accrued expenses | Accrued expenses |
Current lease liabilities | $ 17.6 | $ 16.7 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | Other noncurrent liabilities | Other noncurrent liabilities |
Noncurrent lease liabilities | $ 93.4 | $ 94.3 |
Total lease liabilities | 111 | 111 |
Building | ||
Operating leases: | ||
Operating lease, right-of-use asset | 101 | 100.8 |
Equipment | ||
Operating leases: | ||
Operating lease, right-of-use asset | $ 6.2 | $ 5.8 |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | |||
Operating lease cost | $ 31.5 | $ 29.5 | $ 23 |
Variable lease cost | 2.3 | 1.9 | 2.3 |
Total lease expense | $ 33.8 | $ 31.4 | $ 25.3 |
Leases - Supplemental Informati
Leases - Supplemental Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Lessee, Lease, Description [Line Items] | |||
Cash paid for amounts included in the measurement of operating lease liabilities | $ 31.2 | $ 28.7 | $ 22.9 |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ 16 | $ 40.4 | $ 25.9 |
Building and Equipment | |||
Weighted-average remaining lease term (years): | |||
Operating leases - building and equipment | 8 years 6 months | 9 years 5 months 4 days | |
Weighted-average discount rate: | |||
Operating leases - vehicles | 3.27% | 3.51% | |
Vehicles | |||
Weighted-average remaining lease term (years): | |||
Operating leases - building and equipment | 2 years 4 months 2 days | 2 years 3 days | |
Weighted-average discount rate: | |||
Operating leases - vehicles | 1.08% | 2.05% |
Leases - Lease Liability Future
Leases - Lease Liability Future Payments (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
2022 | $ 20.1 | $ 19.7 |
2023 | 18.3 | 17 |
2024 | 15.6 | 13.7 |
2025 | 13.3 | 11.7 |
2026 | 12 | 11.1 |
Thereafter | 48.3 | 57.6 |
Total lease payments | 127.6 | 130.8 |
Less: Imputed interest | (16.6) | (19.8) |
Present value of lease liabilities | $ 111 | $ 111 |
Leases - Future Minimum Operati
Leases - Future Minimum Operating Lease Payments (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
2021 | $ 20.1 | $ 19.7 |
2022 | 18.3 | 17 |
2023 | 15.6 | 13.7 |
2024 | 13.3 | 11.7 |
2025 | 12 | 11.1 |
Thereafter | 48.3 | 57.6 |
Total lease payments | 127.6 | 130.8 |
Less: Imputed interest | (16.6) | (19.8) |
Present value of lease liabilities | $ 111 | $ 111 |
Commitments and Contingencies_2
Commitments and Contingencies (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | |||
Beginning balance at January 1 | $ 7.4 | $ 5.6 | $ 5.3 |
Provision for warranties | 3.4 | 3 | 3.4 |
Claim settlements | (3.8) | (2.7) | (3.1) |
Other adjustments, including acquisitions, divestitures and currency translation | 0.6 | 1.5 | 0 |
Ending balance at December 31 | 7.6 | $ 7.4 | $ 5.6 |
Damages sought | $ 1 |
Common and Preferred Stock (Det
Common and Preferred Stock (Details) - USD ($) | Mar. 17, 2020 | Dec. 01, 2015 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Equity [Abstract] | |||||
Increase in share repurchase authorized amount | $ 500,000,000 | $ 300,000,000 | |||
Purchase of common stock (in shares) | 0 | 876,423 | 388,953 | ||
Repurchase of common stock | $ 110,300,000 | $ 54,700,000 | |||
Remaining authorized repurchase amount | $ 712,000,000 | ||||
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 | |||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 | |||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||
Preferred stock, shares issued (in shares) | 0 | 0 |
Income Taxes - Schedule Of Inco
Income Taxes - Schedule Of Income Before Income Tax (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
U.S. | $ 350.2 | $ 296.3 | $ 377.2 |
Foreign | 229.6 | 174 | 155.7 |
Income before income taxes | $ 579.8 | $ 470.3 | $ 532.9 |
Income Taxes - Provision Benefi
Income Taxes - Provision Benefit for Income Taxes (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Current | |||
U.S. | $ 64.7 | $ 29.5 | $ 49.8 |
State and local | 11 | 4.6 | 9.1 |
Foreign | 60.9 | 50.2 | 41.9 |
Total current | 136.6 | 84.3 | 100.8 |
Deferred | |||
U.S. | (4.1) | 10.1 | 10.1 |
State and local | (1.4) | 1.5 | (0.1) |
Foreign | (0.6) | (3.4) | (3.4) |
Total deferred | (6.1) | 8.2 | 6.6 |
Total provision for income taxes | $ 130.5 | $ 92.5 | $ 107.4 |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets Liabilities (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | ||
Employee and retiree benefit plans | $ 23.6 | $ 26.9 |
Capital loss and other carryforwards | 11.9 | 16.3 |
Operating lease assets | 25.7 | 24.7 |
Operating lease liabilities | (24.8) | (23.9) |
Depreciation and amortization | (222) | (189) |
Inventories | 11.7 | 8.8 |
Allowances and accruals | 10.3 | 7.3 |
Interest rate exchange agreement | 0 | 0.7 |
Other | (16.6) | (16.9) |
Total gross deferred tax (liabilities) | (180.2) | (145.1) |
Valuation allowance | (11.9) | (16.3) |
Total deferred tax (liabilities), net of valuation allowances | $ (192.1) | $ (161.4) |
Income Taxes - Deferred Tax A_2
Income Taxes - Deferred Tax Assets and Liabilities Recognized in Company's Consolidated Balance Sheets (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | ||
Noncurrent deferred tax asset - Other noncurrent assets | $ 4.3 | $ 2.5 |
Noncurrent deferred tax liabilities - Deferred income taxes | (196.4) | (163.9) |
Total deferred tax (liabilities), net of valuation allowances | $ (192.1) | $ (161.4) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Line Items] | |||
Permanently reinvested earnings of non-U.S. subsidiaries | $ 40,600,000 | $ 28,600,000 | |
Unrecognized deferred income tax liabilities on currently permanently reinvested earnings | 6,100,000 | 4,300,000 | |
Foreign earnings repatriated | 116,000,000 | 27,000,000 | $ 99,000,000 |
Incremental income tax expense (benefit) | 0 | 0 | 0 |
Accrued interest related to uncertain tax positions | 100,000 | ||
Accrued penalties related to uncertain tax positions | 100,000 | ||
Unrecognized tax benefits that would affect our effective tax rate | 100,000 | 1,100,000 | $ 3,700,000 |
Net operating loss carryforwards for non-U.S. | 700,000 | ||
Capital loss and other carryforwards | 11,900,000 | 16,300,000 | |
Foreign tax credit carryover for U.S. federal purposes | 6,600,000 | ||
Federal | |||
Income Tax Disclosure [Line Items] | |||
Capital loss and other carryforwards | 11,900,000 | ||
State and Local | |||
Income Tax Disclosure [Line Items] | |||
Net operating loss carryforwards | 22,500,000 | ||
Capital loss and other carryforwards | 11,900,000 | ||
Foreign | |||
Income Tax Disclosure [Line Items] | |||
Capital loss and other carryforwards | 13,500,000 | ||
Other current assets | |||
Income Tax Disclosure [Line Items] | |||
Prepaid taxes | $ 9,100,000 | $ 20,900,000 |
Income Taxes - Computed Amount
Income Taxes - Computed Amount and Differences in Provision for Income Taxes (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Pretax income | $ 579.8 | $ 470.3 | $ 532.9 |
Computed amount at statutory rate of 21% | 121.8 | 98.8 | 111.9 |
State and local income tax (net of federal tax benefit) | 8 | 5.9 | 8.2 |
Taxes on non-U.S. earnings-net of foreign tax credits | 9.2 | 8.4 | 6.3 |
Global Intangible Low-Taxed Income | 0.4 | (2.7) | 2.3 |
Foreign-Derived Intangible Income Deduction | (7.5) | (4.9) | (5.8) |
Share-based payments | (3.5) | (9.8) | (11) |
Other | 2.1 | (3.2) | (4.5) |
Total provision for income taxes | $ 130.5 | $ 92.5 | $ 107.4 |
Computed amount at statutory rate of 21% | 21.00% | 21.00% | 21.00% |
State and local income tax (net of federal tax benefit) | 1.40% | 1.30% | 1.50% |
Taxes on non-U.S. earnings-net of foreign tax credits | 1.60% | 1.80% | 1.20% |
Global Intangible Low-Taxed Income | 0.10% | (0.60%) | 0.40% |
Foreign-Derived Intangible Income Deduction | (1.30%) | (1.00%) | (1.10%) |
Share-based payments | (0.60%) | (2.10%) | (2.10%) |
Other | 0.30% | (0.70%) | (0.70%) |
Total provision for income taxes | 22.50% | 19.70% | 20.20% |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Beginning balance January 1 | $ 1.1 | $ 3.7 | $ 4.1 |
Gross increases for tax positions of prior years | 0.1 | 0 | 0 |
Gross decreases for tax positions of prior years | (0.3) | 0 | 0 |
Settlements | (0.2) | (2.6) | (0.1) |
Lapse of statute of limitations | (0.6) | 0 | (0.3) |
Ending balance December 31 | $ 0.1 | $ 1.1 | $ 3.7 |
Business Segments and Geograp_3
Business Segments and Geographic Information - Narrative (Details) | 12 Months Ended |
Dec. 31, 2021segment | |
Segment Reporting [Abstract] | |
Number of reportable business segments | 3 |
Business Segments and Geograp_4
Business Segments and Geographic Information - Schedule of Information on Company's Business Segments (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | |||
Total net sales | $ 2,764.8 | $ 2,351.6 | $ 2,494.6 |
Total operating income | 637 | 520.7 | 579 |
Interest expense | 41 | 44.8 | 44.3 |
Other expense - net | 16.2 | 5.6 | 1.8 |
Income before income taxes | 579.8 | 470.3 | 532.9 |
Total assets | 4,917.2 | 4,414.4 | 3,813.9 |
Depreciation and Amortization | 103 | 83.5 | 76.9 |
Total capital expenditures | 72.7 | 51.6 | 50.9 |
Intersegment elimination | |||
Segment Reporting Information [Line Items] | |||
Total net sales | (3.6) | (3.6) | (3.6) |
Corporate office and other | |||
Segment Reporting Information [Line Items] | |||
Total operating income | (80.5) | (64.9) | (71.7) |
Total assets | 427.6 | 559.4 | 330.7 |
Depreciation and Amortization | 0.5 | 0.6 | 0.7 |
Total capital expenditures | 0.7 | 3.1 | 1.8 |
FMT | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 998 | 895.4 | 956.5 |
Total operating income | 259.3 | 235 | 285.2 |
Total assets | 1,458.8 | 1,387 | 1,150.7 |
Depreciation and Amortization | 30.5 | 25.9 | 22.2 |
Total capital expenditures | 21 | 11.9 | 17.3 |
FMT | Intersegment elimination | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 0.7 | 0.9 | 0.5 |
FMT | Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 998.7 | 896.3 | 957 |
HST | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 1,119 | 893.4 | 912.6 |
Total operating income | 288.9 | 206.4 | 200.2 |
Total assets | 2,138.3 | 1,576.1 | 1,507.1 |
Depreciation and Amortization | 56.7 | 41.8 | 39.7 |
Total capital expenditures | 41.5 | 27.7 | 22 |
HST | Intersegment elimination | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 2.8 | 2.6 | 1.8 |
HST | Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 1,121.8 | 896 | 914.4 |
FSDP | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 647.8 | 562.8 | 625.5 |
Total operating income | 169.3 | 144.2 | 165.3 |
Total assets | 892.5 | 891.9 | 825.4 |
Depreciation and Amortization | 15.3 | 15.2 | 14.3 |
Total capital expenditures | 9.5 | 8.9 | 9.8 |
FSDP | Intersegment elimination | |||
Segment Reporting Information [Line Items] | |||
Total net sales | 0.1 | 0.1 | 1.3 |
FSDP | Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Total net sales | $ 647.9 | $ 562.9 | $ 626.8 |
Business Segments and Geograp_5
Business Segments and Geographic Information - Schedule of Sales from External Customers and Long Lived Assets (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | $ 327.3 | $ 298.3 | $ 280.3 |
U.S. Plans | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | 188.3 | 169.2 | 165.7 |
North America, excluding U.S. | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | 5.4 | 5 | 3.8 |
Europe | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | 98.9 | 100 | 88.1 |
Asia | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | 34.5 | 24 | 22.5 |
Other | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets - net | $ 0.2 | $ 0.1 | $ 0.2 |
Restructuring Expenses and As_3
Restructuring Expenses and Asset Impairments - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2019 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Restructuring Cost and Reserve [Line Items] | ||||||
Restructuring expenses and asset impairments | $ 9.3 | $ 11.8 | $ 21 | |||
Asset impairments | 0.8 | 3.1 | 10.2 | |||
Restructuring accrual | $ 3.9 | $ 6.1 | 2.8 | 3.9 | $ 6.1 | |
Property, plant and equipment | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Asset impairment charges | $ 0.8 | $ 2.9 | ||||
FMT | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Asset impairments | 2.5 | |||||
FMT | Corporate Office | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Asset impairments | $ 0.6 | |||||
HST | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Operating lease, impairment | $ 0.4 | |||||
Asset impairment charges | $ 9.7 |
Restructuring Expenses and As_4
Restructuring Expenses and Asset Impairments - Schedule of Pre-Tax Restructuring Expenses by Segment (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | $ 9.3 | $ 11.8 | $ 21 |
Severance Costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 8.5 | 8.5 | 9.8 |
Exit Costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0.2 | 1 |
Asset Impairment | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0.8 | 3.1 | 10.2 |
Operating Segments | FMT | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 4.5 | 5.6 | 2.9 |
Operating Segments | HST | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 1.7 | 2.7 | 14.2 |
Operating Segments | FSDP | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0.5 | 2.5 | 1.3 |
Operating Segments | Severance Costs | FMT | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 3.7 | 2.9 | 2.9 |
Operating Segments | Severance Costs | HST | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 1.7 | 2.7 | 3 |
Operating Segments | Severance Costs | FSDP | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0.5 | 2.5 | 1.3 |
Operating Segments | Exit Costs | FMT | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0.2 | 0 |
Operating Segments | Exit Costs | HST | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0 | 1 |
Operating Segments | Exit Costs | FSDP | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0 | 0 |
Operating Segments | Asset Impairment | FMT | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0.8 | 2.5 | 0 |
Operating Segments | Asset Impairment | HST | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0 | 10.2 |
Operating Segments | Asset Impairment | FSDP | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0 | 0 |
Corporate office and other | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 2.6 | 1 | 2.6 |
Corporate office and other | Severance Costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 2.6 | 0.4 | 2.6 |
Corporate office and other | Exit Costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | 0 | 0 | 0 |
Corporate office and other | Asset Impairment | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring costs | $ 0 | $ 0.6 | $ 0 |
Restructuring Expenses and As_5
Restructuring Expenses and Asset Impairments - Schedule of Restructuring Accruals Expenses (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Restructuring Reserve [Roll Forward] | ||
Beginning balance | $ 3.9 | $ 6.1 |
Restructuring expenses(2) | 8.5 | 8.8 |
Payments, utilization and other | (9.6) | (11) |
Ending balance | 2.8 | 3.9 |
Property, plant and equipment | ||
Restructuring Cost and Reserve [Line Items] | ||
Asset impairment charges | $ 0.8 | $ 2.9 |
Share-Based Compensation - Narr
Share-Based Compensation - Narrative (Details) $ in Millions | 12 Months Ended | |||
Dec. 31, 2021USD ($)share-based_compensation_planshares | Dec. 31, 2020USD ($)shares | Dec. 31, 2019USD ($)shares | Feb. 28, 2022shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of share-based compensation plans (in shares) | share-based_compensation_plan | 2 | |||
Number of shares authorized (in shares) | shares | 15,600,000 | |||
Number of shares available for future issuance (in shares) | shares | 2,400,000 | |||
Proceeds from stock option exercises | $ 19.7 | $ 44.6 | $ 38.8 | |
Stock Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock option exercisable life | 10 years | |||
Total intrinsic value of options exercised | $ 21.4 | 41.3 | 49.5 | |
Proceeds from stock option exercises | 19.7 | 44.6 | 38.8 | |
Tax benefit realized for the tax deductions from stock options exercised | 4.5 | 8.7 | $ 10.4 | |
Total unrecognized compensation cost | $ 9.7 | |||
Weighted-average period of total unrecognized compensation cost, in years | 1 year 2 months 12 days | |||
Stock Option | Employees | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 4 years | |||
Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Total unrecognized compensation cost | $ 6.8 | |||
Weighted-average period of total unrecognized compensation cost, in years | 1 year | |||
Unvested shares, granted (in shares) | shares | 39,530 | |||
Cash-settled Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Share based compensation, accrued expenses | $ 5.9 | 5.4 | ||
Share based compensation, other noncurrent liabilities | $ 2.8 | $ 2.9 | ||
Unvested shares, granted (in shares) | shares | 22,385 | |||
Performance Shares Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total unrecognized compensation cost | $ 4.7 | |||
Weighted-average period of total unrecognized compensation cost, in years | 9 months 18 days | |||
Award requisite service period | 3 years | |||
Unvested shares, granted (in shares) | shares | 29,020 | 42,690 | 56,860 | |
Payout factor, percent | 143.00% | |||
Performance Shares Units | Forecast | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares issued (in shares) | shares | 42,688 | |||
Performance Shares Units | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Target award | 0.00% | |||
Performance Shares Units | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Target award | 250.00% | |||
Target payout | 100.00% |
Share-Based Compensation - Sche
Share-Based Compensation - Schedule of Weighted Average Option Fair Values and Assumptions (Details) - Stock Option - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average fair value of grants (in dollars per share) | $ 38.88 | $ 34.22 | $ 35.15 |
Dividend yield | 1.01% | 1.15% | 1.18% |
Volatility | 23.78% | 22.04% | 24.77% |
Risk-free interest rate, minimum | 0.12% | 1.39% | 2.53% |
Risk-free interest rate, maximum | 1.54% | 1.66% | 3.04% |
Expected life (in years) | 5 years 8 months 12 days | 5 years 9 months 18 days | 5 years 10 months 13 days |
Share-Based Compensation - Stoc
Share-Based Compensation - Stock Options Activity (Details) - Stock Option - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Shares | ||
Outstanding at January 1, 2019 (in shares) | 963,726 | |
Granted (in shares) | 279,785 | |
Exercised (in shares) | (186,897) | |
Forfeited (in shares) | (48,028) | |
Outstanding at December 31, 2019 (in shares) | 1,008,586 | 963,726 |
Vested and expected to vest at December 31, 2019 (in shares) | 967,228 | |
Exercisable at December 31, 2019 (in shares) | 444,057 | |
Weighted Average Price | ||
Outstanding at January 1, 2019 (in dollars per share) | $ 125.70 | |
Granted (in dollars per share) | 198.29 | |
Exercised (in dollars per share) | 105.22 | |
Forfeited (in dollars per share) | 168.36 | |
Outstanding at December 31, 2019 (in dollars per share) | 147.60 | $ 125.70 |
Vested and expected to vest at December 31, 2019 (in dollars per share) | 145.97 | |
Exercisable at December 31, 2019 (in dollars per share) | $ 108.60 | |
Weighted-Average Remaining Contractual Term | ||
Weighted-Average Remaining Contractual Term | 6 years 11 months 19 days | 6 years 11 months 8 days |
Vested and expected to vest at December 31, 2019 | 6 years 10 months 24 days | |
Exercisable at December 31, 2019 | 5 years 2 months 19 days | |
Aggregate Intrinsic Value | ||
Outstanding, intrinsic value | $ 89,500,000 | $ 70,800,000 |
Vested and expected to vest at December 31, 2019 | 87,400,000 | |
Exercisable at December 31, 2019 | $ 56,700,000 |
Share-Based Compensation - Sc_2
Share-Based Compensation - Schedule of Compensation Cost for Stock Options (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 20.4 | $ 14.8 | $ 22.1 |
Stock Option | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | 8.5 | 8.1 | 9.2 |
Income tax benefit | (0.8) | (0.9) | (1.2) |
Total expense after income taxes | 7.7 | 7.2 | 8 |
Stock Option | Cost of goods sold | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | 0.5 | 0.5 | 0.5 |
Stock Option | Selling, general and administrative expenses | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 8 | $ 7.6 | $ 8.7 |
Share-Based Compensation - Rest
Share-Based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock | 12 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Shares | |
Beginning balance (in shares) | shares | 111,300 |
Granted (in shares) | shares | 39,530 |
Vested (in shares) | shares | (34,680) |
Forfeited (in shares) | shares | (8,675) |
Ending balance (in shares) | shares | 107,475 |
Weighted-Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 147.13 |
Granted (in dollars per share) | $ / shares | 206.53 |
Vested (in dollars per share) | $ / shares | 140.73 |
Forfeited (in dollars per share) | $ / shares | 170.22 |
Ending balance (in dollars per share) | $ / shares | $ 169.58 |
Share-Based Compensation - Sc_3
Share-Based Compensation - Schedule of Compensation Cost for Restricted Stock Units (Details) - Restricted Stock - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 5.5 | $ 4.2 | $ 4.8 |
Income tax benefit | (1.1) | (0.9) | (0.9) |
Total expense after income taxes | 4.4 | 3.3 | 3.9 |
Cost of goods sold | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | 0.4 | 0.3 | 0.3 |
Selling, general and administrative expenses | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 5.1 | $ 3.9 | $ 4.5 |
Share-Based Compensation Share-
Share-Based Compensation Share-Based Compensation - Cash-settled Restricted Stock Activity (Details) - Cash-settled Restricted Stock | 12 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Shares | |
Beginning balance (in shares) | shares | 63,940 |
Granted (in shares) | shares | 22,385 |
Vested (in shares) | shares | (22,921) |
Forfeited (in shares) | shares | (5,455) |
Ending balance (in shares) | shares | 57,949 |
Weighted-Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 199.20 |
Granted (in dollars per share) | $ / shares | 198.85 |
Vested (in dollars per share) | $ / shares | 199.78 |
Forfeited (in dollars per share) | $ / shares | 236.32 |
Ending balance (in dollars per share) | $ / shares | $ 236.32 |
Share-Based Compensation - Sc_4
Share-Based Compensation - Schedule of Compensation Cost for Cash-settled Restricted Stock (Details) - Cash-settled Restricted Stock - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 5 | $ 4.6 | $ 5.3 |
Income tax benefit | (0.4) | (0.4) | (0.5) |
Total expense after income taxes | 4.6 | 4.2 | 4.8 |
Cost of goods sold | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | 0.7 | 0.9 | 1.2 |
Selling, general and administrative expenses | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 4.3 | $ 3.7 | $ 4.1 |
Share-Based Compensation - Sc_5
Share-Based Compensation - Schedule of Weighted Average Performance Share Units Fair Values and Assumptions (Details) - Performance Shares Units - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average fair value of grants (in dollars per share) | $ 247.49 | $ 224.14 | $ 207.26 |
Dividend yield | 0.00% | 0.00% | 0.00% |
Volatility | 28.60% | 19.50% | 19.11% |
Risk-free interest rate | 0.33% | 1.30% | 2.49% |
Expected life (in years) | 2 years 11 months 4 days | 2 years 11 months 8 days | 2 years 9 months 29 days |
Share-Based Compensation - Perf
Share-Based Compensation - Performance Share Unit Activity (Details) - Performance Shares Units - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Shares | |||
Beginning balance (in shares) | 58,695 | ||
Granted (in shares) | 29,020 | 42,690 | 56,860 |
Vested (in shares) | (29,840) | ||
Forfeited (in shares) | (5,850) | ||
Ending balance (in shares) | 52,025 | 58,695 | |
Weighted-Average Grant Date Fair Value | |||
Beginning balance (in dollars per share) | $ 218.16 | ||
Granted (in dollars per share) | 247.49 | ||
Vested (in dollars per share) | 212.46 | ||
Forfeited (in dollars per share) | 212.44 | ||
Ending balance (in dollars per share) | $ 236.75 | $ 218.16 |
Share-Based Compensation - Sc_6
Share-Based Compensation - Schedule of Compensation Cost for Performance Share Units (Details) - Performance Shares Units - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 6.4 | $ 2.6 | $ 8.4 |
Income tax benefit | (0.3) | (0.2) | (0.6) |
Total expense after income taxes | 6.1 | 2.4 | 7.8 |
Cost of goods sold | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | 0 | 0 | 0 |
Selling, general and administrative expenses | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total expense before income taxes | $ 6.4 | $ 2.6 | $ 8.4 |
Other Comprehensive (Loss) In_3
Other Comprehensive (Loss) Income - Components of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Pre-tax | |||
Other comprehensive income (loss), pre-tax | $ (50) | $ 115.2 | $ 1.8 |
Tax | |||
Total other comprehensive income (loss), tax | (6.1) | (1.4) | 0.1 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Total other comprehensive income (loss), net of tax | (56.1) | 113.8 | 1.9 |
Cumulative translation adjustment | |||
Pre-tax | |||
Other comprehensive income (loss) before reclassifications, before tax | 0.1 | ||
Other comprehensive income (loss), pre-tax | (75.6) | 107.8 | |
Tax | |||
Total other comprehensive income (loss), tax | 0 | 0 | 0 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Total other comprehensive income (loss), net of tax | (75.6) | 107.8 | |
Net gain (loss) arising during the year | |||
Pre-tax | |||
Other comprehensive income (loss) before reclassifications, before tax | 12 | (1.5) | (7.4) |
Tax | |||
Other comprehensive income (loss) before reclassifications, tax | (2.9) | 0.1 | 2.4 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Other comprehensive income (loss) before reclassifications, net of tax | 9.1 | (1.4) | (5) |
Amortization and settlement loss, net of curtailment gain | |||
Pre-tax | |||
Reclassifications from AOCI before tax | 10.3 | 2.9 | 2.8 |
Tax | |||
Reclassification from AOCI, tax | (2.4) | (0.1) | (0.9) |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Reclassification from AOCI, net of tax | 7.9 | 2.8 | 1.9 |
Pension and other postretirement adjustments | |||
Pre-tax | |||
Other comprehensive income (loss), pre-tax | 22.3 | 1.4 | (4.6) |
Tax | |||
Total other comprehensive income (loss), tax | (5.3) | 0 | 1.5 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Total other comprehensive income (loss), net of tax | 17 | 1.4 | (3.1) |
Reclassification adjustments for derivatives | |||
Pre-tax | |||
Other comprehensive income (loss), pre-tax | 3.3 | 6 | 6.3 |
Tax | |||
Total other comprehensive income (loss), tax | (0.8) | (1.4) | (1.4) |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||
Total other comprehensive income (loss), net of tax | $ 2.5 | $ 4.6 | $ 4.9 |
Other Comprehensive (Loss) In_4
Other Comprehensive (Loss) Income - Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other expense - net | $ 16.2 | $ 5.6 | $ 1.8 |
Interest expense | 41 | 44.8 | 44.3 |
Income before income taxes | (579.8) | (470.3) | (532.9) |
Provision for income taxes | 130.5 | 92.5 | 107.4 |
Total net of tax | (449.4) | (377.8) | (425.5) |
Reclassification out of Accumulated Other Comprehensive Income | Retirement Benefits Adjustments | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Income before income taxes | 10.3 | 2.9 | 2.8 |
Provision for income taxes | (2.4) | (0.1) | (0.9) |
Total net of tax | 7.9 | 2.8 | 1.9 |
Reclassification out of Accumulated Other Comprehensive Income | Amortization and settlement loss, net of curtailment gain | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other expense - net | 1.8 | 2.9 | 2.9 |
Reclassification out of Accumulated Other Comprehensive Income | Settlement loss recognized | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other expense - net | 10.5 | 0 | (0.1) |
Reclassification out of Accumulated Other Comprehensive Income | Curtailment gain recognized | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other expense - net | (2) | 0 | 0 |
Reclassification out of Accumulated Other Comprehensive Income | Cumulative Unrealized Gain (Loss) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Interest expense | 3.3 | 6 | 6.3 |
Income before income taxes | 3.3 | 6 | 6.3 |
Provision for income taxes | (0.8) | (1.4) | (1.4) |
Total net of tax | $ 2.5 | $ 4.6 | $ 4.9 |
Other Comprehensive Income (Los
Other Comprehensive Income (Loss) - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Debt Instrument [Line Items] | |||
Net income (loss) | $ (449.4) | $ (377.8) | $ (425.5) |
Senior Notes | 4.20% Senior Notes, repaid in June 2021 | |||
Debt Instrument [Line Items] | |||
Interest rate on senior notes | 4.20% | ||
Reclassification out of Accumulated Other Comprehensive Income | Cumulative Unrealized Gain (Loss) on Derivatives | |||
Debt Instrument [Line Items] | |||
Net income (loss) | $ 2.5 | $ 4.6 | $ 4.9 |
Retirement Benefits - Narrative
Retirement Benefits - Narrative (Details) $ in Millions | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2020USD ($) | Dec. 31, 2021USD ($)employeeshares | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Sep. 30, 2019employee | |
Defined Benefit Plan Disclosure [Line Items] | |||||
Actuarial loss (gain) | $ 9.7 | ||||
Deferred pension cost (reversal of cost) | 10.7 | ||||
Plan assets, period increase (decrease) | 1 | ||||
Funded status | 10.2 | ||||
Accumulated benefit obligation for all defined benefit pension plans | $ 110.7 | $ 204.4 | |||
Percentage of excess gains and losses over benefit obligation or market value of assets amortized | 10.00% | ||||
Costs of defined contribution plans | $ 12.8 | 12.5 | $ 12.4 | ||
Number of participants covering under multi employer pension plan | employee | 212 | ||||
Costs of bargaining unit-sponsored multi-employer plans and defined contribution plans | $ 1 | 1.1 | 1.1 | ||
Weighted average annual rate of increase in the per capita cost of covered health care benefits assumed | 5.45% | ||||
Assumed decrease of weighted average health care cost trend rate | 4.45% | ||||
Year that reaches assumed decrease of weighted average health care cost trend rate | 2040 | ||||
Stock held in plan assets (in shares) | shares | 0 | ||||
Estimated Future Benefit Payments | |||||
2022 | $ 6.4 | ||||
2023 | 6 | ||||
2024 | 6 | ||||
2025 | 6.3 | ||||
2026 | 6.3 | ||||
2027 to 2031 | 31.8 | ||||
Other (Income) Expense Net | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Settlement loss recognized | $ 0.9 | 0.7 | |||
Net periodic benefit cost | 1 | ||||
Defined Contribution Plan | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined contribution plan, expected contribution for next fiscal year | 15.1 | ||||
401k | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Defined contribution plan, expected contribution for next fiscal year | $ 10.2 | ||||
U.S. | Equity Securities | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 10.00% | ||||
U.S. | Fixed Income Securities | Minimum | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 90.00% | ||||
UK | Equity Securities | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 62.00% | ||||
UK | Equity Securities | Minimum | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 60.00% | ||||
UK | Equity Securities | Maximum | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 65.00% | ||||
UK | Fixed Income Securities | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 38.00% | ||||
UK | Fixed Income Securities | Minimum | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 35.00% | ||||
UK | Fixed Income Securities | Maximum | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 40.00% | ||||
Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Participants affected due to plan freeze | employee | 60 | ||||
Defined benefit plan, expected contribution for next fiscal year | $ 4 | ||||
Pension Benefits | U.S. | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Settlement loss recognized | 10.5 | 0.9 | 0.7 | ||
Net periodic benefit cost | (10.4) | 0.3 | (2.7) | ||
Actuarial loss (gain) | 1.9 | (6.5) | |||
Funded status | 6.4 | 6 | |||
Pension Benefits | Non-U.S. | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Settlement loss recognized | 0 | (0.4) | 0 | ||
Net periodic benefit cost | (3.8) | (3.4) | $ (3.4) | ||
Actuarial loss (gain) | 5.3 | (7.3) | |||
Funded status | $ (58.2) | (73.5) | |||
Pension Benefits | UK | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Target allocation of fund assets in equities | 3.10% | ||||
Other Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Actuarial loss (gain) | $ 0.8 | (3.2) | |||
Funded status | (23.6) | $ (24.2) | |||
Defined benefit plan, expected contribution for next fiscal year | $ 1.2 |
Retirement Benefits - Reconcili
Retirement Benefits - Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
CHANGE IN BENEFIT OBLIGATION | |||
Actuarial loss (gain) | $ (9,700) | ||
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 142,100 | ||
Fair value of plan assets at December 31 | 63,100 | $ 142,100 | |
Funded status at December 31 | 10,200 | ||
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS | |||
Other noncurrent liabilities | (82,200) | (99,400) | |
Pension Benefits | |||
CHANGE IN BENEFIT OBLIGATION | |||
Other | 0 | ||
Pension Benefits | U.S. | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 94,000 | 95,900 | |
Service cost | 100 | 100 | $ 600 |
Interest cost | 300 | 1,300 | 2,800 |
Plan amendments | 0 | 200 | |
Benefits paid | (3,300) | (4,000) | |
Actuarial loss (gain) | (1,900) | 6,500 | |
Currency translation | 0 | 0 | |
Settlements | (78,600) | (6,000) | |
Curtailments | 0 | 0 | |
Other | 0 | ||
Obligation at December 31 | 10,600 | 94,000 | 95,900 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 100,000 | 93,400 | |
Actual return on plan assets | (500) | 16,200 | |
Employer contributions | 400 | 400 | |
Benefits paid | (3,300) | (4,000) | |
Currency translation | 0 | 0 | |
Settlements | (78,600) | (6,000) | |
Acquisition/Divestiture | 0 | 0 | |
Other | (1,000) | 0 | |
Fair value of plan assets at December 31 | 17,000 | 100,000 | 93,400 |
Funded status at December 31 | 6,400 | 6,000 | |
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS | |||
Other current assets | 10,200 | 0 | |
Other current assets | 0 | 10,700 | |
Current liabilities | (800) | (500) | |
Other noncurrent liabilities | (3,000) | (4,200) | |
Net asset (liability) at December 31 | 6,400 | 6,000 | |
Pension Benefits | Non-U.S. | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 115,700 | 102,000 | |
Service cost | 2,000 | 2,200 | 1,800 |
Interest cost | 700 | 1,100 | 1,500 |
Plan amendments | (500) | 0 | |
Benefits paid | (3,000) | (2,600) | |
Actuarial loss (gain) | (5,300) | 7,300 | |
Currency translation | (6,000) | 8,900 | |
Settlements | 0 | (3,800) | |
Curtailments | 0 | 0 | |
Other | 700 | 600 | |
Obligation at December 31 | 104,300 | 115,700 | 102,000 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 42,200 | 39,300 | |
Actual return on plan assets | 4,200 | 3,600 | |
Employer contributions | 2,900 | 2,400 | |
Benefits paid | (3,000) | (2,600) | |
Currency translation | (900) | 2,700 | |
Settlements | 0 | (3,800) | |
Acquisition/Divestiture | 0 | 0 | |
Other | 700 | 600 | |
Fair value of plan assets at December 31 | 46,100 | 42,200 | 39,300 |
Funded status at December 31 | (58,200) | (73,500) | |
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS | |||
Other current assets | 0 | 0 | |
Other current assets | 100 | 0 | |
Current liabilities | (1,500) | (1,500) | |
Other noncurrent liabilities | (56,800) | (72,000) | |
Net asset (liability) at December 31 | (58,200) | (73,500) | |
Other Benefits | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 24,200 | 23,300 | |
Service cost | 700 | 600 | |
Interest cost | 400 | 600 | |
Plan amendments | 0 | (2,900) | |
Benefits paid | (700) | (700) | |
Actuarial loss (gain) | (800) | 3,200 | |
Currency translation | 0 | 100 | |
Settlements | 0 | 0 | |
Curtailments | (200) | 0 | |
Other | 0 | 0 | |
Obligation at December 31 | 23,600 | 24,200 | 23,300 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Employer contributions | 700 | 700 | |
Benefits paid | (700) | (700) | |
Currency translation | 0 | 0 | |
Settlements | 0 | 0 | |
Acquisition/Divestiture | 0 | 0 | |
Other | 0 | 0 | |
Fair value of plan assets at December 31 | 0 | 0 | $ 0 |
Funded status at December 31 | (23,600) | (24,200) | |
COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS | |||
Other current assets | 0 | 0 | |
Other current assets | 0 | 0 | |
Current liabilities | (1,200) | (1,000) | |
Other noncurrent liabilities | (22,400) | (23,200) | |
Net asset (liability) at December 31 | $ (23,600) | $ (24,200) |
Retirement Benefits - Weighted
Retirement Benefits - Weighted Average Assumptions Used in the Measurement of Benefit Obligation (Details) | Dec. 31, 2021 | Dec. 31, 2020 |
Pension Benefits | U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Discount rate | 2.52% | 2.14% |
Rate of compensation increase | 0.00% | 0.00% |
Cash balance interest credit rate | 0.00% | 4.00% |
Pension Benefits | Non-U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Discount rate | 1.25% | 0.95% |
Rate of compensation increase | 2.31% | 2.32% |
Cash balance interest credit rate | 1.00% | 1.00% |
Other Benefits | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Discount rate | 2.70% | 2.20% |
Rate of compensation increase | 0.00% | 0.00% |
Cash balance interest credit rate | 0.00% | 0.00% |
Retirement Benefits - Amounts i
Retirement Benefits - Amounts in Accumulated Other Comprehensive Income Loss Expected to be Recognized as Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Pension Benefits | U.S. | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Prior service cost (credit) | $ 0.1 | $ 0.2 |
Net loss (gain) | 2.1 | 13.4 |
Total | 2.2 | 13.6 |
Pension Benefits | Non-U.S. | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Prior service cost (credit) | (0.5) | (0.1) |
Net loss (gain) | 12.6 | 24.5 |
Total | 12.1 | 24.4 |
Other Benefits | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Prior service cost (credit) | (0.5) | (2.9) |
Net loss (gain) | (3) | (2.3) |
Total | $ (3.5) | $ (5.2) |
Retirement Benefits - Component
Retirement Benefits - Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Pension Benefits | U.S. Plans | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | $ 100 | $ 100 | $ 600 |
Interest cost | 300 | 1,300 | 2,800 |
Curtailment gain recognized | 0 | 0 | |
Expected return on plan assets | (900) | (3,800) | (3,300) |
Settlement loss recognized | 10,500 | 900 | 700 |
Special termination benefit recognized | 0 | 0 | 300 |
Net amortization | 400 | 1,200 | 1,600 |
Net periodic cost (benefit) | 10,400 | (300) | 2,700 |
Pension Benefits | Non-U.S. Plans | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | 2,000 | 2,200 | 1,800 |
Interest cost | 700 | 1,100 | 1,500 |
Curtailment gain recognized | 0 | 0 | |
Expected return on plan assets | (1,000) | (1,200) | (1,000) |
Settlement loss recognized | 0 | (400) | 0 |
Special termination benefit recognized | 0 | 0 | 0 |
Net amortization | 2,100 | 1,700 | 1,100 |
Net periodic cost (benefit) | 3,800 | 3,400 | 3,400 |
Other Benefits | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | 700 | 600 | |
Interest cost | 400 | 600 | |
Curtailment gain recognized | 200 | 0 | |
Other Benefits | Cost of goods sold | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | 700 | 600 | 600 |
Interest cost | 400 | 600 | 800 |
Curtailment gain recognized | (2,000) | 0 | 0 |
Net amortization | (600) | (500) | (600) |
Net periodic cost (benefit) | $ (1,500) | $ 700 | $ 800 |
Retirement Benefits - Weighte_2
Retirement Benefits - Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans (Details) | 3 Months Ended | 4 Months Ended | 6 Months Ended | 8 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2021 | Dec. 31, 2020 | Aug. 31, 2019 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Other Benefits | ||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
Discount rate | 2.20% | 3.09% | 4.11% | |||||||||
Expected return on plan assets | 0.00% | 0.00% | 0.00% | |||||||||
Rate of compensation increase | 0.00% | 4.00% | 4.00% | |||||||||
Pension Benefits | U.S. Plans | ||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
Discount rate | 2.99% | 4.11% | 2.14% | |||||||||
Expected return on plan assets | 2.40% | 4.00% | 4.00% | |||||||||
Rate of compensation increase | 0.00% | 0.00% | 4.00% | |||||||||
Pension Benefits | U.S. Plans | IDEX Corporation Retirement Plan | ||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
Discount rate | 2.36% | 2.41% | 2.97% | 3.07% | ||||||||
Pension Benefits | U.S. Plans | Pulsafeeder, Inc. Pension Plan | ||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
Discount rate | 3.21% | 2.62% | ||||||||||
Pension Benefits | Non-U.S. Plans | ||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||||||||
Discount rate | 0.95% | 1.33% | 2.07% | |||||||||
Expected return on plan assets | 2.41% | 3.00% | 3.12% | |||||||||
Rate of compensation increase | 2.32% | 2.29% | 2.13% |
Retirement Benefits - Pretax Am
Retirement Benefits - Pretax Amounts Recognized in Accumulated Other Comprehensive Income Loss (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Pension Benefits | U.S. Plans | |
Defined Benefit Plan Disclosure [Line Items] | |
Net gain (loss) in current year | $ 0.5 |
Prior service cost | 0 |
Amortization of prior service cost (credit) | 0.1 |
Amortization of net loss (gain) | 10.8 |
Exchange rate effect on amounts in other comprehensive income | 0 |
Total | 11.4 |
Pension Benefits | Non-U.S. Plans | |
Defined Benefit Plan Disclosure [Line Items] | |
Net gain (loss) in current year | 8.5 |
Prior service cost | 0.5 |
Amortization of prior service cost (credit) | 0 |
Amortization of net loss (gain) | 2.1 |
Exchange rate effect on amounts in other comprehensive income | 1.5 |
Total | 12.6 |
Other Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
Net gain (loss) in current year | 1 |
Prior service cost | 0 |
Amortization of prior service cost (credit) | (2.4) |
Amortization of net loss (gain) | (0.3) |
Exchange rate effect on amounts in other comprehensive income | 0 |
Total | $ (1.7) |
Retirement Benefits - Pension P
Retirement Benefits - Pension Plan Weighted Average Asset Allocations (Details) - Pension Benefits | Dec. 31, 2021 | Dec. 31, 2020 |
U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 100.00% | 100.00% |
U.S. Plans | Equity Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 4.00% | 7.00% |
U.S. Plans | Fixed Income Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 33.00% | 65.00% |
U.S. Plans | Cash/Commingled Funds/Other | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 63.00% | 28.00% |
Non-U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 100.00% | 100.00% |
Non-U.S. Plans | Equity Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 18.00% | 17.00% |
Non-U.S. Plans | Fixed Income Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 22.00% | 24.00% |
Non-U.S. Plans | Cash/Commingled Funds/Other | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 60.00% | 59.00% |
Retirement Benefits - Summary o
Retirement Benefits - Summary of Basis Used to Measure Defined Benefit Plans Assets at Fair Value (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | $ 63.1 | $ 142.1 |
U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0.3 | 3.7 |
U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 4.6 | 0.4 |
International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 4.2 | 10.4 |
U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1.9 | 14.3 |
U.S. Long Term | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 5.4 | 51.9 |
U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0.7 | 0.3 |
International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 7.5 | 8.4 |
Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 23.7 | 20.7 |
Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 12.1 | 28.5 |
Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 2.7 | 3.5 |
Level 1 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 12.6 | 36.2 |
Level 1 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0.3 | 3.7 |
Level 1 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1 | 4.4 |
Level 1 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | U.S. Long Term | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0.3 | 0.3 |
Level 1 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 11 | 27.8 |
Level 1 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 26.8 | 85.2 |
Level 2 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 4.6 | 0.4 |
Level 2 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 3.2 | 6 |
Level 2 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1.9 | 14.3 |
Level 2 | U.S. Long Term | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 5.4 | 51.9 |
Level 2 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0.7 | 0.3 |
Level 2 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 7.2 | 8.1 |
Level 2 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1.1 | 0.7 |
Level 2 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 2.7 | 3.5 |
Level 3 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 23.7 | 20.7 |
Level 3 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Long Term | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 23.7 | 20.7 |
Level 3 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | $ 0 | $ 0 |
Subsequent Events (Details)
Subsequent Events (Details) $ in Millions | Nov. 23, 2021USD ($) |
Nexsight, LLC | |
Subsequent Event [Line Items] | |
Business combination, cash consideration paid | $ 120 |